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Abstract
In drug discovery, domain experts from different fields such as medicinal chemistry,
biology, and computer science often collaborate to develop novel pharmaceutical agents.
Computational models developed in this process must be correct and reliable, but at
the same time interpretable. Their findings have to be accessible by experts from other
fields than computer science to validate and improve them with domain knowledge. Only
if this is the case, the interdisciplinary teams are able to communicate their scientific
results both precisely and intuitively.
This work is concerned with the development and interpretation of machine learning
models for drug discovery. To this end, it describes the design and application of compu-
tational models for specialized use cases, such as compound profiling and hit expansion.
Novel insights into machine learning for ligand-based virtual screening are presented, and
limitations in the modeling of compound potency values are highlighted. It is shown that
compound activity can be predicted based on high-dimensional target profiles, without
the presence of molecular structures. Moreover, support vector regression for potency
prediction is carefully analyzed, and a systematic misprediction of highly potent ligands
is discovered.
Furthermore, a key aspect is the interpretation and chemically accessible represen-
tation of the models. Therefore, this thesis focuses especially on methods to better
understand and communicate modeling results. To this end, two interactive visualiza-
tions for the assessment of na¨ıve Bayes and support vector machine models on molecular
fingerprints are presented. These visual representations of virtual screening models are
designed to provide an intuitive chemical interpretation of the results.
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1 Motivation
In the past century, the systematic discovery and development of drugs has tremen-
dously changed our ability to treat diseases. While until the late 19th century, only
naturally occurring drugs were known, the advent of molecular synthesis disclosed a
whole new field of research [1, 2]. Since then, the field of drug development has evolved
rapidly, enabling the treatment of formerly immedicable conditions such as syphilis or
polio. However, the progress of finding a drug to treat a certain disease is a compli-
cated, expensive, and time-consuming process: a recent study estimates the cost for the
development of one new drug at US $2.6 billion [3, 4].
Today, computational or in silico modeling is applied during many steps of the drug
development process. In contrast to in vitro testing, i.e., the generation of experimental
data in a laboratory, computer-based methods are comparably fast and cheap. How-
ever, in silico models are far from perfect and can as such only complement and never
substitute in vitro modeling. Nevertheless, they are important tools for pre-screening
compound libraries or, maybe even more importantly, for understanding certain chemi-
cal phenomena. Here, the idea is to use elements from the field of machine learning and
pattern extraction to explain observed aspects of medicinal chemistry.
The main focus of this thesis is the development and interpretation of machine learning
models for pharmaceutical tasks. In drug discovery, project teams usually consist of ex-
perts from a variety of disciplines, including biology, chemistry, pharmacy, and computer
science. In silico models therefore do not only need to be as accurate as possible and
numerically interpretable to the computer scientist, but also chemically interpretable to
the experts from the life sciences. This thesis focuses on the understanding of compu-
tational models for drug discovery, and introduces chemically intuitive interpretations.
Thereby, we hope to contribute to further enhanced communication in interdisciplinary
drug development teams.
3
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2 The drug development process
Drug development describes the process of developing a pharmaceutical agent to treat
a certain disease. This process can be divided into five major steps (cf. figure 1): (1) Tar-
get selection, (2) hit compound identification, (3) hit-to-lead optimization, (4) preclinical
and (5) clinical drug development.
Target identification aims to find a biological target that can be activated or inhibited
to prevent or cure the disease. This can be, for example, an ion channel, a receptor,
or an enzyme. Popular drug targets include G-protein coupled receptors (GPCRs) or
protein kinases [5, 6]. Once a target is identified, one searches for a so-called hit com-
pound. This is a small molecule that has an activity against the target, but lacks other
characteristics important for the final drug. For example, the hit compound may only
have intermediate potency, lack specificity, or be toxic. In order to find a hit compound,
a large library of molecules has to be screened against the target. This can be either
modeled computationally or done in vitro by high-throughput screening (HTS).
After one or more hit compounds are identified, they are subjected to hit-to-lead op-
timization. The hits are optimized by exchanging functional groups to obtain ligands
that are also active against the target, but act more potent, display less side effects, or
have other preferred characteristics. Important parameters are for instance the absorp-
tion, distribution, metabolism and excretion (ADME) properties that describe how a
drug behaves in the human body. To optimize these parameters for “drug-likeliness”,
Lipinski and colleagues introduced their famous “rule of five” that ligands should obey,
including for example a molecular weight below 500 Da or at most five hydrogen bond
donors [7, 8].
From the ligands that are obtained from hit-to-lead optimization, one or more lead
compounds are chosen. These are then subjected to preclinical research, which includes
further in vitro and first in vivo tests. The major goal of the preclinical stage is to
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Figure 1: The major steps of the drug development process.
5
determine whether it is safe to test the drug in clinical trials, where the drug is tested
in a group of different individuals to finally evaluate how it interacts with the human
organism.
If all these stages have successfully been passed, the drug can be submitted to the
responsible administration facility. Passing all stages of drug development takes several
years, and failures become more expensive the later they occur in the process. Thus, it
is desirable to optimize the earlier stages of drug development, so that only the most
promising compounds will enter the expensive preclinical and clinical trials.
Computational modeling is applied in the first three states of the drug development
process, which form the task of drug discovery. In this context, one also often speaks
of chemoinformatics. Disease pathways are modeled and analyzed in order to identify
targets. Furthermore, computational approaches for the design of maximally diverse
and promising compound libraries are applied in the hit identification stage. If the
crystal structure of the target is known and its binding sites are identified, docking can
be applied to find active hits. Docking is a type of structure-based virtual screening
(SBVS), where one tries to find ligand conformations that best fit into the binding
pocket of the target.
In contrast, the main theme of this thesis is ligand-based virtual screening (LBVS).
Here, the idea is to extrapolate from ligands with known activity to previously untested
ones. As such, it is applicable in the lead optimization stage, when at least one active
compound has been identified. LBVS studies covered in this thesis include the prediction
of compound activity, the modeling of potency values, and the profiling of ligands against
a panel of related targets.
Aside from the development of LBVS methods, understanding the resulting models
is a key aspect in drug discovery. Beneath the correct identification of active or highly
potent ligands, it is crucial to understand what features of the compounds determine
the desired effect. These results then need to be communicated to the pharmaceutical
experts to validate or improve the models using domain knowledge. An intuitive expla-
nation of a model’s decision can also help to better understand the structure-activity
relationship of the ligand-target complex, aid in the improvement of the model itself,
and is of great importance for communication in an interdisciplinary team. Furthermore,
interpreting an LBVS model can provide a ligand-centric view on the characteristics that
determine biological activity. This is opposed to the target-centric view that structure-
based modeling provides, and is especially important when the target’s crystal structure
is unknown.
In this thesis, both the development and the interpretation of machine learning for
LBVS will be covered. Hence, the following chapter will introduce some basic concepts
of in silico modeling for drug discovery.
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3 Concepts
Machine learning models for drug discovery mostly try to model the structure-activity
relationship of ligand-target interactions. To build a predictive model, several compo-
nents are required: (a) molecular data in a suitable representation, (b) a similarity
metric that quantitatively compares two molecules (depending on the algorithm), and
(c) a learning algorithm to compute the parameters of the final model. This chapter will
first introduce the concept of structure-activity relationship. Then, small molecule data
sources and possible representations are discussed. Next, common similarity metrics and
learning algorithms are introduced.
3.1 Structure-activity relationship
While there are efforts to model the physicochemical properties of ligands [9–11] or pre-
dict drug-likeliness [12, 13], most LBVS approaches aim to model the structure-activity
relationship (SAR) of ligands [14]. As the name suggests, structure-activity relationship
(SAR) analysis aims to explain the relationship between a compound’s chemical struc-
ture and its activity against a certain target. SAR modeling approaches are usually
based on the similarity property principle, which states that compounds with similar
structure should exhibit similar properties [15]. Hence, most models try to extrapolate
from the activity of known ligands to the activity of structurally similar ones. How-
ever, in LBVS one is usually interested in recovering new active ligands that are distinct
from the known ones to a certain extent [16]. This is because for the discovery of close
analogs, a complex machine learning algorithm is not required. Hence, the goal is to
identify ligands that are similar enough to the known actives to share their activity, but
distinct enough to expand to new regions of the chemical space.
If the similarity property principle holds and similar structures share similar activities,
one also speaks of continuous SAR. Contrary, the term discontinuous SAR is used if
similar structures exhibit large differences in their potencies [17]. SAR continuity and
discontinuity can be expressed both locally and globally, quantitatively by scores such
as the SAR index (SARI) [18], or qualitatively through visualization techniques. An
extreme form of SAR discontinuity are so-called activity cliffs, pairs of similar ligands
with a large potency difference [19]. Despite the known fact that SAR continuity and
discontinuity strongly depends on the chosen molecular representation and similarity
measure, activity cliffs are believed to be focal points of SAR analysis and therefore
widely studied [20–23].
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Figure 2: Exemplary 2D and 3D SAR landscapes for a set of human thrombin ligands.
SARs are often studied qualitatively in visual form. Therefore, a number of visu-
alization methods has been developed focusing on different SAR characteristics [24,
25]. The probably most intuitive visualizations include two-dimensional (2D) and three-
dimensional (3D) SAR landscapes [26]. Here, the compounds are projected into 2D
space by a similarity-preserving mapping, for example derived by multidimensional scal-
ing [27]. Then, they are augmented by their potency annotations, which are visualized
by coloring (2D landscapes) or as coordinates on a third axis (3D landscapes). The
advantage of these visualizations is that continuous and discontinuous SAR can be in-
tuitively accessed, as can be seen from figure 2. A variety of other visualizations have
been developed, including network-like similarity graphs (NSGs) [28], layered skeleton-
scaffold organization (LASSO) graphs [29], or structure-activity similarity (SAS) maps
[30].
In chapter 4, both quantitative and qualitative measures of SAR continuity are used
to provide a critical view on potency modeling using support vector regression.
3.2 Molecule data sources and potency
measurements
Typically, ligands are small organic molecules with a molecular weight lower than
500 Da [31]. Millions of structures are available in publicly accessible compound data-
bases, and even more in proprietary portfolios. Some of the largest public databases are
ZINC [32], PubChem [33, 34], and ChEMBL [35].
ZINC contains the 3D structures of over 35 million commercially available compounds.
Furthermore, subsets of lead-like, fragment-like, and drug-like compounds are provided,
as well as shards. PubChem is split into three main databases: PubChem Substance,
Compound, and BioAssay. While the Substance database contains all chemical names
and structures submitted to PubChem, the PubChem Compound database contains
only unique and validated compounds. The BioAssay depository contains descriptions of
assays and the associated bioactivity data, which are linked to the other two databases.
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As of April 2015, PubChem contains over 68 million compounds, of which roughly 2
million were tested in 1.15 million bioactivity assays, leading to more than 220 million
activity annotations. ChEMBL contains more than 13.5 million activities of roughly 1.7
million compounds against 10,000 targets (version 20). It is a collection of manually
curated data from primary published literature and updated regularly.
In some parts of this thesis, compounds are either classified as active or inactive,
depending on whether the strength of their interaction with the target exceeds a certain
threshold. Other chapters use their potency values for regression analysis. The way
these potencies are measured however depends on the data source and the information
provided.
In chapter 1 and chapter 3, percentages of residual kinase activity at a given compound
concentration are utilized. Here, the activity of a kinase is first measured in absence of
the compound to be tested, and the obtained value is set to 100 %. Then, the compound
is added at a defined concentration. If it inhibits the kinase activity, only a reduced value
of activity will be measured: this is the relative residual activity. The compounds used in
chapter 3 were also tested for their residual activity. Furthermore, for all compounds that
inhibited a kinase to less than 35 % of its original activity, a Kd value was determined.
The Kd value is the thermodynamic dissociation constant. The lower this concentration,
the higher is the binding affinity, or potency, of the compound.
In chapter 4, the ligands considered for modeling are required to have a Ki value be-
low 100 µM. Ki values are absolute inhibition constants, which can be used to compare
potencies across assays with different conditions. They can be determined from half-
maximal inhibitory concentrations (IC50 values). In contrast to the Kd values used in
chapter 1 and chapter 3, IC50 values are not determined at a single compound concentra-
tion. Instead, a dose-response curve is generated at different compound concentrations,
and the concentration is determined at which half-maximal inhibition is reached. Since
the IC50 value depends on the assay conditions, i.e., it can be influenced by the en-
zyme or substrate concentrations, it can be converted into a Ki value [36, 37]. Here,
assay concentrations are considered and the values are hence comparable across different
assays.
Besides Kd, Ki, or IC50 values, literature often reports logarithmically transformed
pKd, pKi, or pIC50 values. Here, one calculates the negative logarithm of the original
potency value in molar, i.e., pKi = − log10(Ki). This scale is usually seen as more
intuitive, since higher values indicate stronger binding affinity. Furthermore, negative
logarithmic values remain interpretable in the sense that each integer corresponds to one
order of magnitude, i.e., a value of 6 pKi corresponds to 1 µM Ki, while a value of 9 pKi
corresponds to 1 nM Ki.
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3.3 Data representation
Small molecules are most naturally represented as graphs, where each node corre-
sponds to an atom and each edge to a bond. 2D molecular graphs can be easily visualized
on screen and paper, and are intuitively comprehensible by medicinal chemists.
However, molecular graph representations for computational screening have the dis-
advantage that they require a lot of digital resources compared to other representations.
First, all graph nodes and edges have to be stored, and second, graph comparisons are
computationally expensive. Therefore, many digital representations have been developed
that require less computational resources. Probably the most popular example for a dig-
ital molecular representation are simplified molecular-input line entry system (SMILES)
strings [38–41]. SMILES encode the molecular graph as a linear ASCII string. The ele-
mental symbol of each atom is used, and single bonds are omitted between neighboring
atoms. Parentheses denote branching, and there are special symbols for aromaticity,
stereochemistry, or isotopes. Furthermore, an extension called SMILES arbitrary tar-
get specification (SMARTS) has been developed that allows the use of wild cards and
patterns for database queries.
While SMILES strings are suitable for storing large amounts of molecules with minimal
storage requirements, they still have to be converted back to a molecular graph to work
with them. However, for fast similarity assessment, it is reasonable to describe ligands
not by their structure, but by certain features. For this purpose, molecules are often
represented as vectors of real-valued descriptors, or as molecular fingerprints. A large
variety of molecular descriptors exist, from simple atom counts or defined values like
the molecular weight or water solubility of a compound to more complex ones, such as
shape indices [42, 43]. Several of these descriptors together in a vector can serve as an
abstract, yet discriminative description of a molecule. They are numerically accessible
and can be compared in fast and clearly defined ways.
A prominent case of numerical compound descriptions are molecular fingerprints.
These are bit vectors where each position is set to 1 or 0, depending on whether a
certain feature is present or absent in the given molecule. A variety of molecular finger-
prints have been developed. The most common ones can be divided into substructural,
pharmacophore, and extended connectivity fingerprints. Substructural fingerprints are
fixed-length sets of pre-defined substructures, where each substructure is associated with
a certain position in the bit string. To encode a molecule, the bit positions of all sub-
structures that are present are set to 1, while the other positions are set to 0. One
of the most popular substructural fingerprint are molecular access system (MACCS)
keys, which consist of 166 pre-defined substructures [44]. Pharmacophore fingerprints
usually proceed by assigning each atom one pre-defined type, for instance “hydrogen
donor” (D), “hydrogen acceptor” (A), or “hydrophobic” (H). Then, all sets of atoms
of a certain length are encoded using the graph distances between the sets’ members
and their atom types. Common pharmacophore fingerprints implemented in the molec-
ular operating environment (MOE) are GpiDAPH3, typed graph triangles (TGT), or
piDAPH4, which encode pairs, triplets, or quadruplets of atoms, respectively [45]. Ex-
tended connectivity fingerprints are a class of topological fingerprints, where for each
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Figure 3: Molecular graphs of phenol and phenylalanine, their SMILES representations,
and schematic visualization of the MACCS, TGT, and ECFP4 fingerprints. Black
squares indicate set bits, ie., present structures, whereas white squares represent bits
that are set to 0.
atom, its circular environment up to a specific bond length is enumerated [46]. Then,
each unique environment is mapped to a number using a hash function. By design,
extended connectivity fingerprints do not have a fixed length. Instead, the number of
bits is variable and depends on the data set. Figure 3 schematically compares a sub-
structural, pharmacophore, and extended connectivity fingerprint with four bits each on
the example of two small molecules.
Throughout this thesis, MACCS and the extended connectivity fingerprint with bond
diameter 4 (ECFP4) are used to represent ligands. Both can be computed from the 2D
molecular graph and do not require a known 3D conformation. Additionally, matched
molecular pairs and activity-based fingerprints are used in chapter 2 and chapter 3,
respectively. The decision to use fingerprints over real-valued descriptor vectors is mo-
tivated by two reasons. First, calculations on binary fingerprints are fast and not prone
to floating point errors. Second, it is possible to back-project any set feature back
onto the molecular graph and hence provide a visual explanation of each fingerprint.
Thereby, molecular fingerprints are more easily interpretable than value ranges of other
descriptors. We will exploit this especially in part III of this thesis.
The specific fingerprints MACCS and ECFP4 were chosen because they represent two
separate classes of fingerprints with very different complexity. While MACCS has a
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fixed length of 166 bits, each encoding a specifically predefined substructure, ECFP4 is
of variable length and the substructures encoded by each bit depend on the data sets.
Furthermore, their typical similarity value distributions across data sets show different
characteristics: while MACCS usually produces broad normal distributions of Tanimoto
coefficient values centered around 0.4 to 0.6, the Tanimoto coefficient distributions of
ECFP4 are not normally distributed, have small standard deviations and a mean below
0.25 [47].
3.4 Similarity assessment
Many learning algorithms require a similarity assessment to quantitatively compare
two compounds. Several methods exist to derive ligand similarity, depending on the
chosen molecular representation. If molecules are represented by graphs, subgraph iso-
morphisms or graph assignments can be used to determine their similarity. However,
the computation of graph kernels is computationally inefficient, since the subgraph iso-
morphism problem is NP hard [48]. Nevertheless, several similarity metrics for graphs
have been introduced, e.g., based on labeled pairs of graph walks [48, 49].
Another popular formalism of similarity for chemical structures is the concept of
matched molecular pairs (MMPs). An MMP is defined as a pair of compounds that share
a common core and only differ in a limited number of substructures [50] (cf. figure 4).
Usually, MMPs are size-restricted, which means that the common core is required to have
a minimum size, while the different substructures can only have a maximum number of
heavy atoms. Furthermore, the number of exchangable substructures is limited: often,
only one substructure is allowed to differ in an MMP. While the MMP formalism induces
a rather strict measure of similarity (either a pair of ligands forms an MMP or not), it has
the advantage that it is extremely intuitive. Furthermore, the exchanged substructures
can often directly be translated to synthesis rules.
In the case of molecular descriptor vectors or fingerprints, similarity can be determined
straightforward by existing metrics. Common metrics are for instance the Euclidean,
cosine, or cityblock distance. For fingerprints, the Tanimoto similarity [51] has become
particularly popular [52]. In this thesis, it is often used as a support vector machine
(SVM) kernel.
Cl
N
N N
Cl
N
N N
Cl
Figure 4: Example for an MMP. The common core is depicted black, while the exchanged
substructure is highlighted in red.
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Figure 5: Schematic visualization of unsupervised and supervised learning algorithms.
3.5 Learning algorithms
The final ingredient for a virtual screening model is the learning algorithm. Here, one
can distinguish between unsupervised and supervised methods. Unsupervised learning
means that the algorithm is given a number of molecules, and aims to detect hidden
structure in the data. This can mean to derive groups or clusters of compounds that
belong together, or to find and reduce correlated dimensions. In contrast, supervised
learning algorithms take a number of molecules and their corresponding labels as in-
put. From both together, they derive a model that is able to predict the label of new,
previously unseen instances. Figure 5 schematically illustrates both types of learning.
If all possible supervised labels belong to a finite set, the prediction process is called
classification, whereas one speaks of regression in the case of continuous values.
For the purpose of LBVS, one typically employs supervised learning. Here, a set
of tested ligands are augmented with their labels, which are often categorical activity
annotations (i.e., “active” vs. “inactive”) or continuous potency values. The learning
algorithm is then supplied with these compounds and labels as the training set. From
the training set, the model is derived, which can then be used to predict labels for new
and untested compounds. The set of compounds that are previously unknown and used
for prediction is called the test set.
Many supervised learning algorithms however do not only require a training set of
inputs and labels, but also a number of hyperparameters. These parameters have to be
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set prior to modeling, as opposed to the model parameters that are determined by the
respective algorithm. Example for hyperparameters are the choice of k for k-nearest
neighbors, the kernel of an SVM, or the number of trees in a random forest. While
there may be cases where the choice of hyperparameter values can be determined from
the nature of the data or the problem, hyperparameter selection is non-trivial in most
settings. Here, one usually employs cross-validation to determine the best parameter
choices from a set of pre-selected ranges. First, the training data is split into a number
of k equally sized folds (hence, one also speaks of k-fold cross-validation). Then, for
each hyperparameter choice, the learning algorithm is run k times using the data from
(k − 1) folds as a training set, and the remaining fold as the validation set. The data
from the validation set is unknown to the learning algorithm, and the resulting model
is used to predict the labels of this set. Then, an evaluation metric is used to assess
the performance of the model on the validation set. This process is repeated for all
k folds, and the average performance on the validation sets is used as an indicator of
how well the current hyperparameters perform on the given data. Figure 6 visualizes
this approach on the example of a learning algorithm that fits a polynomial to classify
the data. Here, the order of the polynomial has to be given as a hyperparameter, and
polynomials of the first, second, and third order are validated.
While it is generally possible to use k equal to the number of training compounds,
and hence produce a so-called leave-one-out estimate of hyperparameter performance, k
is often chosen to be 5 or 10 in practice. In fact, there are studies recommending to use
10-fold over n-fold cross validation [53]. Using a limited number of folds also reduces
the time complexity of the cross-validation, which can be an important factor especially
when several hyperparameters with large ranges have to be evaluated.
The most commonly applied learning algorithms in chemoinformatics include artificial
neural networks (ANNs), decision trees and random forests, SVMs, k nearest neighbors,
and na¨ıve Bayes [52, 54]. ANNs use layers of single perceptron units, inspired by the
network of neurons in the human brain [55]. Usually, there is one layer of artificial input
neurons, one layer of output neurons, and a number of neurons organized in one or
more hidden neuron layers in between. All layers are interconnected, and the algorithm
proceeds by learning the weights of the neurons’ functions. While multi-layered ANNs
can be extremely powerful, they are also hard to interpret, especially when the number
of hidden layers and units grows [56].
Decision trees derive a set of rules from the training data, which can then be used to
classify the test data [57]. Here, the training data is recursively split into subsets by
the descriptor that best separates the remaining data. Overall, this recursive procedure
creates a tree of if-then-else decision rules. Single decision tree models are therefore
easily interpretable, yet can be prone to overfitting [58]. Hence, ensemble classifiers using
multiple trees have been developed, the so-called random forests [59]. Here, several trees
are grown and then combined by a voting procedure to arrive at a final classification.
SVMs are classifiers developed for the separation of two different classes [60]. The
idea is to fit a plane in high-dimensional space through the training data, and classify
the test data based on the side of the hyperplane they fall. Since SVM models are used
extensively in this thesis, they will be discussed in detail in the following chapter.
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Figure 6: Schematic depiction of cross-validation for hyperparameter selection. The
training data is divided k times into a training set (red and green circles) and a validation
set (circles with blue border). Each hyperparameter is once used to build a model, and
the number of correctly predicted compounds from the validation set is reported. The
parameter that gives the best performance, here the polynomial of degree 2, is chosen
to build the final model on the complete training set. This final model is then used to
predict the classes of the test instances (gray circles).
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The k nearest neighbor algorithm is one of the simplest classifiers and often used
for chemical similarity searching [61]. Here, one calculates the distances of the test
compounds to each training compound. The class label of the k nearest neighbors is
then chosen as the prediction for the test compounds. This approach can also be applied
if only one class, for instance active ligands, are given. Test compounds are then ranked
by their average similarity to the k nearest neighbors of the unlabeled training set.
While k nearest neighbor classification is simple and interpretable, it is computationally
expensive due to the pairwise distance calculations, and often less powerful than more
sophisticated learning algorithms [62].
Na¨ıve Bayes classifiers are generative models that use Bayes’ theorem to predict the
probability of each test instance to belong to each possible class [63]. They will be used
in this thesis for different problem settings and therefore be introduced in more detail
in the next chapter.
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4 Prediction models
This chapter discusses the two main models used in this thesis: na¨ıve Bayes and
SVMs. The following notation will be used consistently throughout the chapter:
n is the number of training or test compounds,
x will be used to denote training or test compounds,
y denotes the target value, i.e., the class label or potency value, of a compound,
x(i), y(i) is used to refer to the i’th compound and target value,
Y denotes the set of all possible labels,
D is the number of dimensions that represent one compound x,
xd refers to the d’th dimension of compound x,
δ(a, b) will be the abbreviated notation for the function δ(a, b) =
{
1 if a = b
0 otherwise
Unless stated otherwise, formulas containing x(i), y(i) usually hold for all i ∈ {1, . . . , n};
this information will be omitted for brevity.
4.1 Na¨ıve Bayes
In LBVS, na¨ıve Bayes classifiers are often used to predict biological activity. They are
less frequently used for other prediction tasks, such as the prediction of physicochemical
properties [52]. The na¨ıve Bayes classifier is a generative model that uses Bayes’ theorem
to model the posterior probability P (y|x):
P (y|x) = P (x|y)P (y)
P (x)
(1)
Here, P (x|y) is the class likelihood of compound x given class y, P (y) is the prior
probability of class y, and P (x) is the evidence, i.e., the marginal probability for a certain
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compound x [55]. Since the evidence of the same compound x in the denominator in
equation (1) is constant, it is sufficient to estimate the prior and the class likelihood:
P (y|x) ∝ P (x|y)P (y) (2)
To classify new instances, they are assigned to the class with the maximum posterior
probability:
y = argmaxyˆ∈Y P (yˆ|x) (3)
The term na¨ıve refers to the underlying assumption of descriptor independence, i.e.,
the class likelihood is modeled as a product of individual descriptor contributions [63]:
P (x|y) =
D∏
d=1
P (xd|y) (4)
In practice, descriptor independence is usually not given. Therefore, it can make sense
to perform a careful preprocessing of descriptors, e.g., via principal component analysis.
However, it has also been shown that na¨ıve Bayes can perform well also on correlated
input data [64]. According to equation (3), the model parameters of na¨ıve Bayes are the
estimates of the class likelihood according to equation (4) and the prior. The prior can
be either given if the probability distribution of the classes is known, or estimated from
the training data as the fraction of samples from each class:
P (y) =
∑n
i=1 δ(y
(i), y)
n
(5)
However, the modeling of the individual descriptors’ class likelihoods depends on the
nature of the data [55]. If the descriptors are continuous and normally distributed, they
are modeled using univariate Gaussians:
P (xd = z|y) = 1√
2piσ2yxd
exp(−(z − µyxd)
2
2σ2yxd
) (6)
Hence, the mean µyxd and variance σ
2
yxd
of the descriptors xd for each class y have to
be computed from the training data using maximum likelihood estimation:
µyxd =
1
ny
ny∑
i=1
δ(y(i), y)xd (7)
σ2yxd =
1
ny
ny∑
i=1
δ(y(i), y)(xd − µyxd)2 (8)
ny =
n∑
i=1
δ(y(i), y) (9)
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In the case of categorical descriptor values, the multinomial distribution is used:
P (xd = z|y) =
n∏
i=1
pδ(x
(i),z)
yz (10)
In this case, pyz is the joint probability of class y and descriptor value z, which is
estimated as
pyz =
∑n
i=1 δ(y
(i), y)δ(x
(i)
d , z)∑n
i=1 δ(y
(i), y)
(11)
Finally, if all descriptors are binary, which is the case for molecular fingerprints, the
Bernoulli distribution is used:
P (xd = z|y) =
n∏
i=1
pzyz(1− pyz)(1−z) (12)
Since in the binary case, P (xd = 0|y) = 1 − P (xd = 1|y) holds, it is sufficient to
estimate P (xd = 1|y):
P (xd = 1|y) =
n∏
i=1
pyxd (13)
=
∑n
i=1 δ(y
(i), y)δ(x
(i)
d , xd)∑n
i=1 δ(y
(i), y)
(14)
=
∑n
i=1 δ(y
(i), y)x
(i)
d∑n
i=1 δ(y
(i), y)
(15)
In practice, one usually applies Laplacian smoothing to equation (11) and equa-
tion (15) to prevent ill-defined probabilities for fingerprint bits that are always or never
set. Then, the Laplacian smoothing factor α is the only hyperparameter that needs to
be given; otherwise, na¨ıve Bayes classification is hyperparameter-free.
In chapter 3 of this thesis, we will use na¨ıve Bayes classification for the prediction
of compound activity profiles. Here, the assumption of feature independence will be
exploited to enable the training on incomplete data. Furthermore, chapter 5 introduces
an interactive graphical representation for the interpretation of na¨ıve Bayes classifiers
using the Bernoulli distribution. For this purpose, the log odds ratio of P (xd = 1|y) is
leveraged to explain both the complete model and individual classification decisions.
4.2 Support vector machines
Support vector machines (SVMs) are supervised, discriminative models that aim to
separate instances from two classes [60]. As such, they are primarily designed for binary
classification problems. However, formulations for regression and structured output
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w · x− b = 0
w·x
||w|| w · xi − b ≥ +1
w · xi − b ≤ −1
Figure 7: Schematic visualization of a linear SVM. The training examples of both classes
are depicted using red and green circles, respectively. Support vectors are visualized
using blue borders. The continuous and dashed blue lines represent the separating plane
and its margins, respectively.
have also been proposed [65, 66]. Since SVMs are used for different types of problems
throughout this thesis, all three SVM variants will be introduced in the following.
4.2.1 Classification
The concept of SVMs has originally been developed for binary classification of linearly
separable data [60]. In the following years, extensions for inseparable training data, non-
linear data, and imbalanced problems have been introduced [67–69]. Here, the linearly
separable case is discussed first, and then the modifications for other use cases are briefly
explained. A detailed derivation of the formulas used in the classification case can be
found in the appendix.
Linearly separable data
The idea of an SVM is to separate two classes by a plane in high-dimensional space
[60]. If the training labels y are expressed numerically in the set {−1,+1}, the plane
should be able to separate all training instances such that the following holds for all
training instances and labels:
y(i)(w · x(i) − b) ≥ 1 (16)
Hence, the model parameters are the normal vector w and the bias b. New test
instances are then classified by the side of the hyperplane they fall on, corresponding to
the sign of the following function:
f(x) = w · x− b (17)
If the data is separable according to equation (16), there are infinitely many hyper-
planes that separate the data. Out of these, the optimal one is chosen, i.e., the one that
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maximizes the distance between the closest training examples from different classes, the
so-called margin. Figure 7 depicts a linearly separable 2D problem, where the margins
are depicted by dashed lines. This leads to the primal optimization problem for linear
maximum margin hyperplanes:
min
1
2
w ·w (18)
subject to y(i)(w · x(i) − b) ≥ 1 (19)
This is a convex quadratic programming problem with only linear constraints and can
as such be solved directly [70]. However, the elegance of SVMs lies in the expression of
the problem in dual space. Without assuming convexity, the Lagrangian of equation (18)
and equation (19) can be defined as [60, 71]:
Λ(w, b, λ) =
1
2
w ·w −
n∑
i=1
λ(i)[y(i)(w · x(i) − b)− 1] (20)
This function is maximized with respect to λ(i) with the additional constraints λ(i) ≥ 0
for all λ(i) [71]. Furthermore, it has to satisfy the Karush-Kuhn-Tucker (KKT) conditions
[71]. If the KKT conditions and the partial derivatives of the Lagrangian are considered
(see appendix for details), w can be expressed as:
w =
∑
support vectors
λ(i)y(i)x(i) (21)
Here, it is sufficient to consider those training examples where λ(i) > 0, the so-called
support vectors. This means that the number of summands in equation (21) can drop
dramatically, which reduces both storage and computational requirements. The classifi-
cation rule can then be expressed as the sign of:
f(x) =
∑
support vectors
λ(i)y(i)(x(i) · x)− b (22)
The advantage of solving the dual instead of the primal optimization problem lies not
only in the reduction of operations required for the final classification. It also enables
two extensions that make SVMs especially powerful: the separation of (a) noisy and
(b) nonlinear data.
Noisy data
In the case of noisy training data, it is not possible to separate all instances without
error. Therefore, non-negative slack variables ξ(i) are introduced that allow some in-
stances to be misclassified or lie inside the margin [67]. The primal optimization then
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φ(·)
Figure 8: For problems that are not linearly separable, a mapping φ(·) projects the data
into a higher-dimensional space where linear separation becomes feasible.
changes to:
min
1
2
w ·w + C
n∑
i=1
ξ(i) (23)
subject to y(i)(w · x(i) − b) ≥ 1− ξ(i) (24)
ξ(i) ≥ 0 (25)
In this formulation, the regularization parameter C controls the trade-off between
margin maximization and permitted amount of training error. As such, it has to be
determined in advance and given to the algorithm as a hyperparameter.
If the dual problem is solved and the KKT conditions are considered, the slack vari-
ables and their corresponding dual variables ν vanish from the problem [67]. Altogether,
it yields the same function as in the linearly separable case, which has to be maximized
subject to:
n∑
i=1
λ(i)y(i) = 0 (26)
0 ≤ λ(i) ≤ C (27)
Hence, the computation of w and the classification rule stays the same as in the
separable case (see appendix for details).
Nonlinear data
In the case of the data that is not linearly separable, the training instances x(i) are
projected into a higher-dimensional space by a mapping φ(·) [68]. Then, w is no longer
D-dimensional, but has the dimension of φ(x(i)). Figure 8 exemplifies this idea using
a mapping from 1D to 2D space. This change alters the Lagrangian as follows (see
appendix for details):
Λ(λ) =
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(φ(x(i)) · φ(x(j))) (28)
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Using Mercer’s theorem [72], it is possible to provide a positive semidefinite kernel
function K(u, v) that implicitly calculates the inner product φ(x(i)) · φ(x(j)). Then, the
dual problem can be rewritten as:
Λ(λ) =
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)K(x(i),x(j)) (29)
Hence, it is possible to derive and use the SVM model without explicitly computing
the mapping φ(·). However, there is one drawback: the normal vector w is expressed
in the domain of φ(·), which may be infinite. As a consequence, it cannot be computed
explicitly anymore, making the interpretation of the resulting model hard or even im-
possible. Therefore, SVMs using kernels are often referred to as “black box” models
[14].
Nevertheless, they are widely used in chemoinformatics for different problem settings
[14]. Popular kernels include the linear, polynomial, sigmoid, and Gaussian or radial
basis function (RBF) kernels:
Klinear(u, v) = u · v (30)
Kpolynomial(u, v) = (a(u · v) + b)c (31)
Ksigmoid(u, v) = tanh(a(u · v) + b) (32)
KGaussian(u, v) = exp(−γ||u− v||2) (33)
Here, the parameters a, b, c, and γ are additional kernel parameters that have to be
given as hyperparameters to the algorithm. In chemoinformatics, the Gaussian kernel
is often chosen for nonlinear problems over the polynomial or sigmoid kernel [52]. Fur-
thermore, a variety of kernel functions have been developed especially for the prediction
of compound activity in LBVS [14]. One of the most widely applied kernels is the Tani-
moto kernel, which was developed in accordance with the Tanimoto coefficient (Tc) [51,
73]:
KTanimoto(u, v) =
u · v
u · u+ v · v − u · v (34)
The Tanimoto kernel is often used together with molecular fingerprints [52], because
it is fast to compute on binary data and furthermore parameter-free. Other special-
ized kernel functions include pharmacophore kernels [74], target-ligand kernels [75], or
structure-activity kernels [76].
Imbalanced Problems
In LBVS, often there are more inactive than active compounds available, inducing an
imbalance of positive and negative training instances. For problem settings like this,
Morik et al. [69] have suggested to use two regularization terms C+ and C− obeying the
ratio:
C+
C−
=
|{i|y(i) = −1}|
|{i|y(i) = +1}| (35)
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C+ and C− are then used to balance the cost of slack variables associated with positive
and negative training examples, respectively.
The minimization problem changes accordingly:
min
1
2
w ·w + C+
∑
{i|y(i)=+1}
ξ(i) + C−
∑
{i|y(i)=−1}
ξ(i) (36)
Geometrically spoken, this alters the margin size: while it was symmetric in the
balanced case, i.e., λ(i) ≤ C for all i, the margin on the side of the minority class is now
larger than the one on the majority classes side.
4.2.2 Regression
SVMs can also be used for regression, i.e., the prediction of real-valued target values
[65]. In this case, a so-called -insensitive loss function is applied, which results in a
loss of zero if the predicted value f(x) deviates by less than  from the expected target
value y [60]:
|y − f(x)| =
{
0 if |y − f(x)| ≤ 
|y − f(x)| −  otherwise (37)
For support vector regression (SVR), two sets of slack variables ξ and ξ∗ are used to
account for positive and negative deviations from the target values. This defines an “-
tube“ around the desired values in which misclassifications are not punished. Figure 9
visualizes this concept. The primal optimization problem for support vector regression
(SVR) is given as [77]:
min
1
2
w ·w + C
n∑
i=1
(ξ(i) + ξ(i)∗ ) (38)
subject to y(i) −w · x(i) − b ≤ + ξ(i) (39)
w · x(i) + b− y(i) ≤ + ξ(i)∗ (40)
with nonnegative ξ(i), ξ
(i)
∗ . The regression function can then be written analogously to
the classification case:
f(x) =
∑
support vectors
(λ(i) + λ(i)∗ )K(x
(i),x) + b (41)
4.2.3 Structured output
The concept of SVMs has also been adjusted for the prediction of structured output
[66, 78]. Here, the idea is to learn a function that maps the input vectors to com-
plex output vectors. This is achieved via maximization over a discriminant function
F (x, y,w):
f(x,w) = arg maxy∈Y F (x, y,w) (42)
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|y − f(x)| > 0
|y − f(x)| = 0
support vectors
Figure 9: SVMs for regression fit an -insensitive tube through the data.
Here, w has the dimensionality of ψ(x, y), a combined feature representation of inputs
and outputs that has to be defined specifically for the given problem. The optimization
problem is given as [66]:
min
1
2
w ·w + C
n∑
i=1
ξ(i) (43)
subject to F (x(i), y(i),w)− F (x(i), y,w) ≥ 1− ξ(i)y ∈ Y \ y(i) (44)
The constraints express that the discriminant function for the true output y(i) is at
least 1− ξ(i) larger than for any other output. Furthermore, since the outputs y can be
arbitrarily complex, a specialized loss function ∆(y, yˆ) is required. Tsochantaridis et al.
[66] propose two ways to incorporate this loss into the optimization: slack rescaling and
margin rescaling. The constraints from equation (44) then change:
F (x(i), y(i),w)− F (x(i), y,w) ≥ 1− ξ
(i)
∆(y(i), y)
slack rescaling (45)
F (x(i), y(i),w)− F (x(i), y,w) ≥ ∆(y(i), y)− ξ(i) margin rescaling (46)
Again, this problem can be expressed in dual space, enabling the use of kernel func-
tions. However, the number of constraints for structural SVMs is large with n|Y|. In
many cases, the output space Y can be very large, which in turn requires a larger number
of training examples. Therefore, structural SVM problems are not always solvable by
standard quadratic programming techniques. Tsochantaridis et al. [66] propose to use
only a subset of constraints, which is chosen such that a ”sufficiently accurate solution“
is found [66]. In their algorithm, a working set of constraints is kept for every train-
ing example, and the dual problem is optimized using all constraints of these working
sets. This process is iteratively repeated while constraints are added, until no further
constraint is found which is violated more than some . The authors show that their
algorithm finds a solution which is close to optimal [66], and provide an implementation
in the publicly available SVM software SVMlight [79]. In chapter 1, the structural SVM
formalism is used to predict complete compound activity profiles, and compared to a set
of individual classification SVMs.
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4.3 Model interpretation
While many machine learning models have been shown to work well on a variety of
problems related to drug discovery [14, 52], their interpretability strongly depends on
the combination of molecular representation and learning algorithm. Models based on
matched molecular pairs are often easily interpretable [80, 81], but their applicability
is restricted to compounds forming MMP relationships. An example for a model based
on MMPs will be given in chapter 2 of this thesis. While the resulting predictions are
intuitively comprehensible, the discussed approach is only applicable to data sets of
a certain constitution. On the other hand, models derived on the basis of molecular
descriptors are applicable to any compound data set, but harder to interpret. Some
machine learning algorithms, e.g., decision trees, can produce “rule sets” explaining the
internal decision process of the model. However, these rules can become arbitrarily
complex for large models. An advantage of molecular fingerprints is that it is possible
to project each set bit back to the molecular graph [82–84]. This way, it is possible to
visualize feature mappings in a way that is directly accessible for the medicinal chemist.
In chapter 5 and chapter 6, we will use visual feature mappings to explain individual
model decisions. However, these and similar methods require a measure of importance
for each descriptor or fingerprint bit.
Whether individual feature contributions can be extracted for an individual model
strongly depends on the learning algorithm. Individual decision trees and their ensemble
in random forests for instance offer to assess the importance of each feature in terms
of the number and order of splits they appear in. Feature contributions of na¨ıve Bayes
classification can be statistically measured by their log odds ratio, as will be done in
chapter 5. For SVMs using the linear kernel, it is possible to compute the normal
vector w, which can be seen as a vector of weights for each dimension of the input.
For ANNs with a single layer, a weight vector can also be computed. However, ANNs
are most successful when they contain one or more hidden layers; the same holds for
SVMs using kernels. These models can be extremely powerful, yet at the same time
impossible to interpret in terms of the input representation. Still, interpretable models
are of high interest, especially in life sciences where machine learning is often used to
explain phenomena that are not completely theoretically understood.
One popular approach to the explanation of black box models is rule extraction by
mimicry [85, 86]. Here, one first trains a successful, yet uninterpretable model like an
ANN or SVM. In the next step, a highly intuitive learning algorithm is used with the
aim not to model the original input data, but to mimic the complex model as closely as
possible. The interpretable rules of this model are then thought to explain the workings
of the black box predictor. In chapter 6, we will use a different approach to explain the
classification decisions of SVMs. While our method is not as general as rule extraction
approaches, it is able to directly disclose the inner workings of SVMs using the Tanimoto
kernel on molecular fingerprints.
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5 Thesis outline
This thesis is divided into three main parts. Part I describes the development of two
methods for specialized use cases in LBVS. Herein, chapter 1 uses structural SVMs to
model compound profiling experiments, and chapter 2 describes a new prediction method
for hit expansion based on activity probabilities derived from matching molecular series.
Next, part II reveals opportunities and challenges for machine learning applications in
drug discovery. The first study in chapter 3 shows how the feature independence assump-
tion of the na¨ıve Bayes approach can be exploited to learn and predict on incomplete
data. Furthermore, it is shown that the advent of publicly available chemogenomics data
can be used for activity prediction, even in the absence of molecular structures. On the
other hand, chapter 4 highlights limitations of SVR modeling for potency prediction.
While these models may work well globally, they often fail to correctly predict the most
potent, and therefore most important, compounds in the data sets. Finally, the topic of
part III is the intuitive assessment and interpretation of LBVS models using molecular
fingerprints. Here, we aim to bridge the gap between the highly active field of visual
SAR visualization and the application of machine learning in drug discovery. Finally,
conclusions are drawn and opportunities for future research are discussed.
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Part I
Model Development for
Pharmaceutical Tasks
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1
Modeling of Compound Profiling
Experiments Using Support Vector
Machines
Introduction
The modeling of compound activity profiles is a complex task that becomes more and
more important with the availability of chemogenomics data. In this study, we attempt
to model compound profiling experiments using na¨ıve Bayes classifiers and SVMs. For
each compound, not only a single activity, but a range of activities against multiple
targets is predicted. Since the number of possible compound activity profiles increases
exponentially with the number of targets, this classification task is non-trivial. Further-
more, the public availability of complete compound profiling matrices is still limited, and
activity profiling matrices are usually sparse in nature. Due to the complex character
of the activity profiles, standard performance measures cannot be applied or have to be
very carefully considered and analyzed.
To address these challenges, we develop and compare different classification models:
a number of binary na¨ıve Bayes and SVM models applied for each target individually,
an SVR-based full profile classifier, and a profile predictor based on the structural SVM
formalism. These models are applied to a set of 429 pyridinyl imidazole-based inhibitors
that were screened against 24 different kinases.
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Profiling of compounds against target families has
become an important approach in pharmaceutical
research for the identification of hits and analysis of
selectivity and promiscuity patterns. We report on
modeling of profiling experiments involving 429 poten-
tial inhibitors and a panel of 24 different kinases using
support vector machine (SVM) techniques and na€ıve
Bayesian classification. The experimental matrix con-
tained many different activity profiles. SVM predictions
achieved overall high accuracy due to consistently low
false-positive and consistently high true-negative
rates. However, predictions for promiscuous inhibitors
were affected by false-negative rates. Combined tar-
get-based SVM classifiers reached or exceeded the
performance of SVM profile prediction methods and
were superior to Bayesian classification. The classifi-
ers displayed different prediction characteristics
including diverse combinations of false-positive and
true-negative rates. Predicted and experimentally
observed compound activity profiles were compared
in detail, revealing activity patterns modeled with dif-
ferent accuracy.
Key words: activity profile prediction, Bayesian classification,
compound profiling, inhibitors, machine learning, protein
kinases, support vector machines, target families
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Experimental testing of compound libraries against arrays
of therapeutically relevant targets such as protein kinases
or G protein-coupled receptors is often carried out in phar-
maceutical research (1–4). Compound profiling against tar-
get families makes it possible to identify novel active
compounds, assess their selectivity and promiscuity, and
collect structure–activity relationship (SAR) information.
Experimental evaluation of inhibitors across different kinase
subfamilies has identified many promiscuous compounds
(5) and a variety of activity and selectivity patterns (6,7).
Profiling experiments are also of interest for computational
analysis and design. For example, profiling data have been
utilized to build models for the identification of kinase
inhibitors (8,9) and promiscuous compounds (9). Further-
more, machine learning and similarity search methods
have been applied to predict multiple activities of drugs
and activity profiles (10–13).
In this study, we have modeled a kinase inhibitor profiling
experiment and carried out systematic profile predictions
using different support vector machines (SVMs) and
Bayesian classification. The underlying complete experi-
mental matrix contained 429 pyridinyl imidazole inhibitors
assayed against 24 different kinase targets (14). In the fol-
lowing, the results of profiling matrix and individual activity
profile predictions are reported.
Profiling Data Analysis
Data sets
For our analysis, a set of 429 compounds sharing a pyridi-
nyl imidazole core (Figure 1) were used that were assayed
against a panel of 24 different kinases (14).a These com-
pounds represented potential ATP site-directed kinase
inhibitors. A complete 429 9 24 activity matrix was
obtained. By design, the library was focused on the p38-a
kinase, but many imidazole derivatives displayed notable
kinase differentiation potential, with small structural modifi-
cations leading to significant changes in activity profiles
(14). Hence, the prediction of activity profiles comprising
this profiling matrix was considered a challenging task.
Data preprocessing
Activities were measured as ‘% residual activity’ at 10 lM
compound concentration (14).a Hence, no IC50 or Ki was
available, and it was expected that activity data were
noisy. For computational modeling, ‘% residual activity’
values were transformed into a binary activity readout (i.e.
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active versus inactive) applying a threshold value of a 20%
residual activity (i.e. 80% inhibition) or, as a control, 40%
residual activity (i.e. 60% inhibition). Compounds inhibiting
a kinase below these thresholds were considered active
(and inactive otherwise). The stringent 20% threshold was
initially applied to exclude very weak kinase activities from
consideration and put emphasis on activity profiles with
strong inhibitory interactions. Figure 2 reports a small sec-
tion of the binary data matrix. In this section, three com-
pounds (mf286, mf265, mf258) only inhibit kinase p38-a,
while three others (mf249, mf203, mf135) are active
against several kinases. The remaining 9 compounds are
inactive against all targets.
The binary matrix (20% threshold) yielded a total of 10 296
data points including 9384 inactive and 912 active ones.
Hence, the activity matrix was overall sparsely populated
with active data points. A total 115 of 429 compounds
were inactive against all 24 kinases, and 106 compounds
exclusively inhibited p38-a. Table 1 summarizes the most
frequently observed activity profiles. There was a significant
variety of profiles. In addition to the profiles reported in
Table 1, 100 other profiles were found that were exhibited
by only one or two compounds.
Molecular representations
For compounds, the MACCSb and ECFP4 (15) fingerprints
were calculated (i.e. a fragment and a layered atom envi-
ronment fingerprint) using the molecular operating environ-
ment (MOE).c Fingerprint overlap was quantified as a
measure of molecular similarity by applying the Tanimoto
coefficient (Tc) (16).
Although all compounds shared the same (small) structural
core (Figure 1), their calculated similarities yielded a wide
range of Tc values, as illustrated in Figure 3. More than
half of the compounds yielded Tc values of < 0.5 using
MACCS, which corresponds to a low range (17). Similar
observations were made for ECFP4 where Tc values of
< 0.2 were frequently observed.
Taken together, the following data characteristics made
this profiling matrix a challenging test case for machine
learning: There was significant variation in activity profiles
and small structural changes often led to significant activity
profile variations.
Support Vector Machine Theory
SVM modeling
In previous studies, SVM models were derived to distin-
guish between compounds with related activities (18) and
closely related ligands with different mechanisms of action
(19). In our current analysis, we applied different SVM vari-
ants including a ‘structural SVM’ that has formerly been
N
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N SR4
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R3
Figure 1: Inhibitor core structure. Shown is the pyridinyl
imidazole structure upon which the compound library was based.
R-group/substitution sites are indicated.
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Figure 2: Binary data matrix. A
small section of the binary data
matrix comprising 15 compounds is
shown. White squares indicate
inactivity, black squares activity.
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used for biological sequence comparison (20–22) and
compound ranking against single targets (23,24).
In the following, a brief account of SVM theory relevant for
our study is provided. SVMs are discriminative models that
attempt to derive a hyperplane (w  x) – b = 0 to best sep-
arate objects with different class labels (e.g. ‘positive’ or
‘negative’) (25). Therefore, SVMs must be trained using n
training instances with known labels.
Classification SVM
The classification SVM uses the hyperplane (w  x) – b = 0
to separate positive from negative instances (25). A new
instance xi can be classified depending on the side of the
hyperplane it falls: xi is considered positive if (w  xi) –
b > 0 and negative otherwise. Assuming the binary labels
1 for negative and +1 for positive training instances, the
optimal hyperplane can be constructed by minimizing
/ðwÞ ¼ 1
2
ðw  wÞ
subject to
yi½ðw  xiÞ  b  1; i ¼ 1; 2; . . .; n
It is possible that the training data are not separable with-
out errors. Therefore, so-called slack variables ξi ≥ 0 are
introduced (26), and a soft-margin separating hyperplane
is derived by minimizing
/ðw; nÞ ¼ 1
2
ðw  wÞ þ C
Xn
i¼1
ni
subject to
yi½ðw  xiÞ  b  1 ni; i ¼ 1; 2; . . .; n
In this equation, C is a given parameter that penalizes
large slack variables; if it is small, large ξi are permitted
and many training errors are tolerated. If C is large, small
ξi are favored and training errors are suppressed by learn-
ing a more complex hyperplane. To enable arbitrary com-
plex decision boundaries, the inner product (w  x) is
replaced by a kernel function K(u,v) (27). Kernel functions
implicitly generate the inner product of u and v in a high-
dimensional space, thereby circumventing the need to
explicitly map u and v to this space.
Regression SVM
It is also possible to utilize SVMs for the estimation of
regression functions, that is, the prediction of real values.
Instead of predicting a positive class if (w  x) – b > 0, the
value of (w  x) – b is predicted. To determine w and b,
the empirical risk R(w, b) is minimized over the n training
examples (25):
Rðw;bÞ ¼ 1
n
Xn
i¼1
yi  ðw  xi  bÞj je
Here, the subscript e indicates that R(w,b) describes the
e-insensitive loss function, that is, the loss is considered
zero if yi  ðw  xi  bÞj j\e (25). Similar to the classifica-
tion SVM, the optimization problem is solved by minimizing
/ðw; n; nÞ ¼ 1
2
ðw  wÞ þ C
Xn
i¼1
ni þ
Xn
i¼1
ni
 !
subject to
yi  ðw  xiÞ  b eþ ni ;
ðw  xiÞ þ b yi  eþ ni
; i ¼ 1; 2; . . .; n
Table 1: Most frequently occurring activity profiles
Inhibited kinases
No.
ligands
None 115
p38-alpha 106
brafve, p38-alpha 31
igf1-r, src, p38-alpha 11
igf1-r, src 8
egf-r 8
jnk3, p38-alpha 8
egf-r, p38-alpha 7
egf-r, igf1-r, src, vegf-r2 4
brafve, egf-r, erbb2, p38-alpha 4
brafve, egf-r, p38-alpha, tie2 4
brafve, src, p38-alpha 4
brafve 4
egf-r, erbb2, p38-alpha 3
p38-alpha, tie2 3
egf-r, erbb2, jnk3, p38-alpha 3
egf-r, erbb2, src, jnk3, p38-alpha, sak, tie2 3
brafve, egf-r, erbb2, src, vegf-r2, jnk3, p38-alpha, tie2 3
The most frequent kinase activity profiles of data set compounds
are reported for the stringent 80% inhibition threshold.
Figure 3: Pairwise Tanimoto similarities. The matrix reports
MACCS Tanimoto coefficient values for pairwise comparison of all
library compounds.
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For SVM regression, two sets of non-negative slack vari-
ables are required to account for both the positive and the
negative deviation of the output value from its expected
value.
Structural SVM
Other non-numeric outputs can also be predicted. In con-
trast to classification and regression, structural SVMs (21)
learn a function f depending on w and x that is maximal
for the best output y:
fðx;wÞ ¼ argmax
y2Y
ðw Wðx; yÞÞ
Here, Ψ(x,y) is a combined feature representation of
inputs and outputs. The underlying idea of structural
SVMs is that for any input and output, a function can be
learned that will yield a maximal value for the correct
input/output pair and smaller values for all incorrect pair-
ings. Therefore, structural SVMs do not necessarily sepa-
rate positive and negative pairs by a maximum margin
hyperplane, but rather learn a scoring scheme for input/
output pairs. The structure of the combined feature rep-
resentation Ψ(x,y) is generally unknown; it is problem-
specific and has to be specifically implemented for each
individual application.
The minimization problem is then given as
min
1
2
ðw  wÞ þ C
Xn
i¼1
ni
subject to
8y 2 Ynyi : w  ðWðxi; yiÞ Wðxi; yÞÞ 1 ni; i ¼ 1; 2; . . .; n
As the structure of Y is unknown and the space of all pos-
sible y 2 Y can be infinitive, there is no trivial solution to
this minimization problem. In fact, the minimization prob-
lem contains one constraint for each y 2 Y and can practi-
cally only be solved for a restricted subspace of Y.
Therefore, Tsochantaridis et al. (21) introduced an algo-
rithm that only considers a polynomially-sized subset of
constraints and thereby makes the solution of the minimi-
zation feasible. Thus, a function is required to determine
the most violated of all constraints:
y^ ¼ argmax
y2Y
HðyÞ
where H(y) represents the cost of predicting y if the true
label is yi. If it is possible to provide a combined feature
representation Ψ(x, y) of inputs and outputs and, in addi-
tion, determine the most violated constraint for a given
problem, structural SVMs can be generated.
Profiling Matrix Prediction
For modeling profiling experiments, several SVM modeling
strategies can be applied. First, binary SVM classifiers can
be derived for each target, as illustrated in Figure 4A.
While this target-based (or per target) classifier is an ele-
gant way to simplify the complex problem of predicting
complete activity profiles, it does not take correlations
between different kinase activities into account. Second,
SVM models can be derived to directly predict activity pro-
files for given compounds, as illustrated in Figure 4B. One
approach is based on SVM regression and termed full pro-
file classifier, the other is based on the structural SVM and
termed svmstruct classifier.
Target-based classifier
Twenty-four different SVM classification models were
trained to predict the activity of each compound–target
combination. Individual predictions were then combined to
generate the complete activity profile of each compound.
For training and prediction, the Tanimoto kernel (28) was
used to compare two compound fingerprints u and v:
KTanimotoðu; vÞ ¼ u  v
u  uþ v  v  u  v
Full profile classifier
The full profile prediction derived only a single SVM model
to predict the complete profiling matrix. During training,
many different activity profiles were generated for each
compound and used in combination with its fingerprint as
inputs xi. The outputs yi were the regression scores
obtained by the sum of correct profile positions (bits)
minus the sum of incorrect bits in the generated profile.
Thus, the regression value was maximal for the true profile
of a training compound and minimal for the inverted true
profile. For prediction, a number of possible profiles were
generated, and the one yielding the highest regression
score was selected. Because the input data xi contained
the compound’s structure and its activity profile, we used
a combined structure-profile kernel (13,29) for SVM train-
ing and prediction:
Kcombinedðu; vÞ ¼ KTanimotoðucompound; vcompoundÞ
 ð/ðuprofileÞ  /ðvprofileÞÞ
A
B
Figure 4: SVM classification principles. (A) The target-based
classifier uses 24 binary SVMs to predict the activity of a
compound against each individual target. The resulting predictions
are then combined to yield the activity profile. (B) Both the full
profile and the svmstruct classifier use a single SVM model to
directly predict the activity profile of a compound.
78 Chem Biol Drug Des 2014; 84: 75–85
Balfer et al.
where /(x) is a function that maps a binary activity profile
into a higher-dimensional space representing the correla-
tion of profile positions:
/ðxÞ ¼
t0 ¼ 1½  t0 ¼ 1½ 
t0 ¼ 1½  t0 ¼ þ1½ 
t0 ¼ 1½  t1 ¼ 1½ 
..
. ..
.
tn ¼ þ1½  tn ¼ þ1½ 
0
BBBBB@
1
CCCCCA
Here, ti ¼ a½  tj ¼ b
 
is 1 if position i has value a and posi-
tion j value b for a,b 2 {1, +1}; otherwise, the value is 0
(30).
Svmstruct model
The svmstruct approach yields one model to predict a
profiling matrix, which is distinct from the full profile model.
As combined input representation Ψ(x,y), compound struc-
ture and activity profile were required and hence the com-
bined structure-profile kernel was used. To identify the
most violated constraint for svmstruct, a greedy approxi-
mation was applied that produced different profiles and
selected the constraint associated with the profile yielding
the highest cost H(y).
Na€ıve Bayesian classification
We have compared the SVM predictions to na€ıve Bayesian
classifiers (NB) (31), a popular activity prediction approach
(32,33). These classifiers are based on Bayes theorem and
have often been successfully applied in the context of in
silico target and activity prediction (33).
Calculation Setup
Calculation protocol
To predict the complete profiling matrix, we carried out 10
independent trials for each combination of an SVM strat-
egy, fingerprint and inhibition threshold. For each trial, 100
training compounds were randomly selected and used to
generate an SVM model. The model was then used to
predict the activity profiles of the remaining 329 com-
pounds. If the same position in the profiling matrix was
predicted differently in independent trials, the final predic-
tion was determined via a consensus voting, that is, the
most frequent prediction was considered the final one. In
addition, positions with the same number of positive and
negative predictions were classified as inconclusive. The
libraries SVMlight and SVMstruct (34) were used to build the
different models. Standard parameters were applied, with
one exception: The regularization parameter C = 1000
was consistently used to generate SVMs (34). For NB con-
trol calculations, the freely available Python package scikit-
learn (35) was used. The Bernoulli na€ıve Bayes formulation
was applied to account for the binary nature of fingerprint
representations. NB calculations were carried out using
different prior probabilities. First, uniform prior probabilities
were applied, that is the same prior probabilities were
used for positive and negative predictions. Second, prior
probabilities were determined from training data, that is,
these prior probabilities were set to account for the ratio of
active and inactive data set compounds.
Performance evaluation
For each individual compound–kinase interaction, it was
determined whether a prediction was a true negative
(TN, predicted and experimentally inactive), true positive
(TP, predicted and experimentally active), false negative
(FN, predicted inactive but experimentally active), or false
positive (FP, predicted active but experimentally inactive).
On the basis of this categorization, overall ‘balanced’
and ‘unbalanced’ prediction accuracy was determined
as:
Aunbalanced ¼ #TNþ #TP
#activesþ #inactives
Abalanced ¼ 0:5  #TP
#actives
þ 0:5  #TN
#inactives
The accuracy A is the fraction of individual matrix entries
that were correctly predicted and thus provides a measure
of the overall quality of the predictions. In contrast
to unbalanced prediction accuracy, balanced accuracy
equally weights TPs and TNs, regardless of the composition
Table 2: Global prediction statistics
Experimental data
Active Inactive
Target-based
Active 405 164
Inactive 461 9154
Inconclusive 46 66
Full profile
Active 256 60
Inactive 629 9300
Inconclusive 27 24
SVM structure
Active 340 132
Inactive 532 9204
Inconclusive 40 48
Na€ıve Bayes
Active 370 328
Inactive 514 8970
Inconclusive 28 86
Reported is the absolute number of true positives, true negatives,
false positives, and false negatives for different prediction meth-
ods. For example, ‘active/experimentally active’ reports true posi-
tives and ‘active/experimentally inactive’ false positives. Activity
profile positions with the same number of positive and negative
predictions over all 10 trials were classified as ‘inconclusive’.
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of data sets and distribution of actives versus inactives.
However, globally determined A cannot account for the
quality of individual compound profile predictions. Simple
numerical values are unable to account for different combi-
nations of TNs, TPs, FNs, and FPs in predicted activity pro-
files. Therefore, predicted activity profiles were analyzed in
detail.
Results and Discussion
Descriptor evaluation
The full profiling matrix had 429 9 24 = 10 296 entries,
which were systematically predicted using all classifiers
with two fingerprints as descriptors. The performance of
the models was very similar for the alternative descriptors.
The only notable difference was that the use of ECFP4
resulted in an overall larger number of FN predictions
(likely due to its smaller pairwise compound similarity val-
ues compared to MACCS). Therefore, we report the
results obtained with MACCS.
Global prediction accuracy
The first round of predictions was carried out applying a
threshold value of 80% inhibition to the compound data
(see Methods). The target-based classifier correctly
predicted 9559 of 10 296 entries, yielding an unbal-
anced accuracy of 92.84% and a balanced accuracy of
Figure 5: Prediction accuracy.
Bars report the total number of true
and false positives, true and false
negatives, and the number of
inconclusive bits in predicted
compound activity profiles.
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70.98%. The full profile classifier produced 9556 correct
predictions (92.81% unbalanced accuracy versus
63.59% balanced accuracy) and the svmstruct classifier
9544 (92.70% unbalanced, 67.68% balanced accuracy).
The na€ıve Bayesian classifier reached a global accuracy
of 90.71% (unbalanced) and 68.08% (balanced) using
uniform prior probabilities, and of 92.15% (unbalanced)
and 64.96% (balanced) using prior probabilities
determined from data. Generally high unbalanced predic-
tion accuracy was achieved by producing only very few
FN predictions. When the threshold value was lowered
to 60% (resulting in more active compounds), unbal-
anced prediction accuracy was reduced by 6.84%
(target-based SVM classifier) to 8.2% (NB with data-
dependent priors). The balanced accuracy was improved
by 2.61% (target-based SVM classifier) to 7.96% (full
profile classifier).
Because the NB classifier using uniform prior probabilities
for active and inactive predictions resulted in a slightly
higher balanced accuracy, these values are discussed in
the following.
Table 2 reports absolute numbers of TNs, TPs, FNs, and
FPs for the different classifiers. Despite comparable accu-
racy, different calculation characteristics emerged. The tar-
get-based SVM classifier predicted TPs at a high rate,
with 405 correctly predicted inhibitors, compared to only
256 for the full profile and 340 for the svmstruct classifier.
NB also correctly predicted 370 inhibitory interactions, but
nearly doubled the FP rate of the target-based SVM classi-
fier (with 328 versus 164 FPs). Moreover, the more com-
plex SVM models even further reduced false-positive
rates, with 132 and only 60 FPs for svmstruct and the full
profile classifier, respectively. Overall, the SVM and NB tar-
get classifier predicted most TPs, but also yielded most
inconclusive predictions, whereas the more complex SVM
classifiers had slightly higher TN rates and lower FP rates.
TN rates were lowest and FP rates highest for NB classifi-
cation.
Activity profile analysis
Global accuracy assessment did not provide information
regarding the activity profile locations and contexts of
incorrect predictions. Did misclassifications predominantly
affect a subset of compounds or were limited prediction
errors widely distributed over compounds? How did pre-
dicted profiles compare in detail to experimentally
observed ones? To answer these questions, activity
profiles were analyzed in detail.
Figure 5 reports true and false positives and negatives for
a representative subset of 35 compounds. The chart at
the top shows the number of targets the compounds
were active or inactive against. Many ligands were con-
sistently inactive or only inhibited a small number of kin-
ases. In Figure 5, exceptions included compounds hj48,
dh143 and mf315, which were active against nine, six,
and seven kinases, respectively. The other three charts
report the number of TNs, TPs, FNs, FPs, and inconclu-
sive positions in the predicted activity profiles. The major-
ity of predicted interactions were TNs. However, FNs also
consistently occurred throughout the profiles of all SVM
classifiers. There were often more FNs than TPs, which
points at a general weakness of the predictions. By con-
trast, FPs and inconclusive predictions were rare for all
classifiers.
Figure 6 shows experimental profiles for a subset of 12
ligands and their SVM predictions. Profiles with low activ-
ity density were mostly correctly predicted. For instance,
hj48
hj75
hj117
dh72
ru191
ru205
mf292
ru284
mf315
ru332
dh14
dh73a
Experimental
data
Per target
prediction
Full profile
prediction
Svmstruct
prediction
True negative
True positive
False negative
False positive
Figure 6: Exemplary observed and
predicted activity profiles.
Experimental profiles of inhibitors
with no, single, or multiple kinase
activity are shown and compared to
profiles predicted using different
SVM models. The target-based
classifier yields the lowest number
of false-negative predictions but
slightly more false-positive
predictions than profile SVM
models.
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profiles of compounds ru191, ru205, ru284, dh14, and
dh73a were correctly reproduced by all SVM classifiers.
Three predictions using target-based classifier (ru191,
ru284, and dh73a) yielded a single FP, consistent with
the observation that target-based classification had a
higher FP rate than the SVM profile models. Most pre-
dicted profiles did not contain FPs. FNs were detected in
profiles of compounds with multikinase activities such as
hj48 or mf315. Learning such multikinase profiles was dif-
ficult for SVMs because such profiles were underrepre-
sented in the data set. In the case of compound hj48,
predictions using the target-based, full profile, and svm-
struct classifier yielded four, eight, and seven FNs,
respectively. By contrast, the profile of mf292 (another
compound with multikinase activity) was correctly pre-
dicted by the target-based classifier and incorrectly by
the others.
Profile prediction characteristics
Figures 5 and 6 provide representative views of the profile
predictions. Compound profiles with only few activity
annotations were generally correctly predicted, whereas
predictions of profiles with multiple kinase activities were
more challenging and prone to FNs. Nonetheless, all clas-
sifiers were able to predict a variety of profiles. The target-
based SVM classifier accurately predicted more different
profiles than the other classifiers.
Figure 7 reports all combinations of true- and false-nega-
tive and positive predictions for the classifiers when 80%
(Figure 7A) and 60% (Figure 7B) inhibition thresholds
were applied. Each circle marks an observed combina-
tion of active/inactive profile positions and is scaled in
size by the number of profiles having this combination.
In the experimental matrix (top graph), most profiles
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Figure 7: Profile predictions. Graphs reporting the count of active versus inactive profile positions are shown for data sets resulting from
the application of a threshold of (A) 80% or (B) 60% inhibition. The size of the circles scales with the number of profiles having a given
composition. In the upper graph, the distribution of experimental profiles (blue) is reported. The other four graphs report true (green) and
false (red) predictions for the different SVM and NB models.
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contained at most one positive positions and hence 24
or 23 negative positions. Most predicted profiles con-
tained no or very few FPs and also only small number
of FNs. Figure 7A shows that profiles with more than
nine positive positions were not reproduced in any calcu-
lation when the stringent inhibition threshold was applied
and also reveals further differences between the classifi-
ers. NB calculations produced only a low number of pro-
files without any false predictions and predicted profiles
with more than 10 FPs, which was not observed for
SVMs. The full profile SVM classifier produced fewer FPs
than the others, but also fewer TPs. In addition, the
svmstruct classifier correctly predicted a slightly larger
number of profiles with more than five active bits than
the target-based classifier. Applying the less stringent
60% inhibition threshold significantly reduced the number
of profiles with no kinase activity and resulted in profiles
with more than 15 active positions. (Figure 7B). In addi-
tion, a larger number of activity profiles occurred only
once, making predictions more challenging. All classifiers
predicted profiles with larger numbers of active positions,
thereby increasing TP and also FP rates (Figure 7B). All
methods failed to correctly predict profiles with more
than 16 active positions. As observed for the more strin-
gent inhibition threshold, the NB classifier produced the
lowest number of profiles without any prediction errors
and the SVM full profile classifier yielded fewer FPs and
TPs than the other classifiers. Hence, for both inhibition
thresholds, equivalent profile prediction characteristics
were observed. For the lower inhibition threshold, more
active positions were consistently predicted. In both
cases, SVM performance was superior to NB classifica-
tion and the target-based SVM classifier exceeded the
performance of profile prediction methods.
Conclusions
Compound profiling data are rarely publicly available, and
there are not many opportunities for the evaluation of
machine learning methods to predict activity profiles and
profiling matrices. We have modeled a recently reported
kinase profiling experiment using different SVM methods
including target- and regression-based as well as struc-
tural SVM classifiers. In addition, target-based NB classifi-
cation, a popular approach in target prediction, was
carried out as a reference.
The experimental profiling matrix provided a challenging
task for machine learning and predictions. Activity profiles
significantly varied, but kinase activities were only sparsely
distributed over the matrix. Small structural differences
between data set compounds that shared a pyridinyl imid-
azole core often led to significant activity profile changes.
In addition, only single-concentration percent inhibition
activity data were available. Therefore, we applied different
inhibition thresholds to convert these data into a binary
format for modeling.
Activity profile predictions revealed systematic trends. SVM
classifiers reached more than 90% global accuracy because
FP and TN rates were consistently low and high, respec-
tively. A general weakness of the models was that less than
half of the available TPs were detected. When a low inhibi-
tion threshold was applied, TP and FP rates increased.
Importantly, target-based SVM classifier reached or
exceeded the performance of the profile classifiers and
yielded higher prediction accuracy than NB calculations.
The profile prediction characteristics of all models varied, as
revealed by detailed activity profile analysis. SVM profile
classifiers also accurately predicted many profiles containing
only small numbers of active positions and had very low FP
rates.
The results also have implications for practical applica-
tions. Serially applied target SVM classifiers can be effec-
tively utilized to prescreen candidate compounds for
activity profiling including libraries. On the basis of our
findings, these classifiers would have a high potential to
effectively eliminate candidates having a low propensity
to be active against individual kinases. This would be
especially relevant when searching for specific kinase
inhibitors when compound promiscuity should be low
and activity annotations sparsely distributed over profiling
matrices. Models reported herein should thus be useful
when the pyridinyl imidazole or related chemical libraries
are further expanded in the search for specific kinase
inhibitors.
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Summary
In this study, different machine learning models were built and developed for the task of
compound activity profiling. Profiling compounds against a library of related targets is
often carried out in the lead optimization stage of the drug discovery process. This way,
it is possible to assess the activity probability of a compound target interaction, if it is
known that this compound is active or inactive against a related target. Furthermore,
compound profiling can be carried out for the analysis of compound promiscuity and
selectivity.
Our results show that the models produced quite different profile predictions. Most
inactive compound target combinations were correctly reproduced, while the underrep-
resented class of active compound target interactions was underpredicted by all classi-
fiers. Furthermore, the combination of individual target-based binary SVMs achieved
the highest prediction accuracy.
The following chapter deals with the development of a probabilistic prediction method
for hit expansion. In contrast to finding similar compounds that are active against
related targets, here we seek to discover compounds with increasing structural diversity
that are all active against the same target. Furthermore, the predictions should be
comprehensible and chemically intuitive to enable prediction-driven compound design.
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2
Hit Expansion from Screening Data
Based upon Conditional
Probabilities of Activity Derived
from SAR Matrices
Introduction
The goal of the previous study was to identify compounds with characteristic promis-
cuity or selectivity patterns against related targets. In this chapter, the development of
a probabilistic prediction method for hit expansion is described. Here, one or several
promising hits have already been identified. The goal is to expand the chemical space
around them, i.e., to find compounds with increasing structural diversity in the chemical
neighborhood of existing hits. These neighbors should be identified by defined chemical
transformations to enable the synthesis by substitution of certain R-groups. Further-
more, it is desirable for the predictions to be intuitively explainable, enabling medicinal
chemists to make informed decisions about the compounds to synthesize next.
To address these needs, we develop a conditional probability-based prediction method,
where the probabilities are derived from SAR matrices. SAR matrices are data structures
that organize MMPs, i.e., compounds with related core and substructure fragments.
Hence, predictions derived by the described method are chemically interpretable and
the prioritized compounds have defined transformation pathways from existing ones.
The data selection, preprocessing, and study design was carried out by Disha Gupta-
Ostermann. My main contribution is the formal derivation of the conditional probability
framework, which is described in the following section. The full study has been published
as follows:
Gupta-Ostermann, D.; Balfer, J.; Bajorath, J. Hit Expansion from Screening Data
Based upon Conditional Probabilities of Activity Derived from SAR Matrices. Mol.
Inf. 2015, 34, 134–146.
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Fundamentals
An SAR matrix is a data structure that organizes compounds from matching molecular
series (MMS) in a 2D table [87]. First, all MMPs with a single exchanged substructure
are derived from a set of compounds, and these are then subjected to another round of
fragmentation. This approach gives rise to several sets of related MMS, each of which
consists of several compounds with a shared core. All series whose cores again form an
MMS are then organized together in an SAR matrix. Figure 10 shows an exemplary SAR
matrix derived from three MMS. Here, each filled cell represents one compound from
the data set, colored by its activity annotation. Since not all exchanged substructures
are present in every single MMS in the matrix, some cells are empty. These empty
cells represent so-called virtual compounds, which have not yet been synthesized. Their
activity is to be predicted using the information from the SAR matrix.
A given compound data set can contain an arbitrary number of related MMS, lead-
ing to a possibly large number of SAR matrices. Furthermore, there can be matrices
where the number of virtual compounds largely exceeds the number of actual data set
compounds. Other matrices consist exclusively of active or inactive compounds. Both
sparsely populated matrices and matrices with a single class label are not suitable for
our modeling approach. In the full study, we have therefore filtered the matrices that
are considered [88].
Contribution
The SAR matrix-based prediction approach derives activity probabilities for each core
and substructure occurring in an MMS. To predict the activity probability of a virtual
compound, the probabilities of its core and substructure are combined. The underly-
ing idea is that the higher a core’s or substructure’s activity probability, the more it
influences the prediction of a virtual compound. To give an example, if all data set
compounds with a certain core are active, then a virtual compound with the same core
will most likely also be active. On the contrary, if half of data set compounds with a
certain core are active and half of them are inactive, the exchanged substructures of the
virtual compound must strongly influence its binding affinity. This concept is encoded
in a probabilistic framework, which is schematically shown in figure 11.
As a first step, core and substructure class probabilities are derived by estimating the
conditional probabilities P (y|c) and P (y|s) from the training data. Here, c(i) and s(i)
are used to refer to the core and substructure of compound i, respectively.
P (y|c) =
∑n
i=1 δ(c
(i), c)δ(y(i), y)∑n
i=1 δ(c
(i), c)
(47)
P (y|s) =
∑n
i=1 δ(s
(i), s)δ(y(i), y)∑n
i=1 δ(s
(i), s)
(48)
Figure 11 (a) reports the core and substructure class probabilities of the matrix from
figure 10. While the substructure in the second column has a probability of 1 for the
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Figure 10: An exemplary SAR matrix derived from nine compounds forming three MMS.
The rows of the matrix correspond to the common cores of each series, and each column
represents one exchanged substructure. Exchanged substructures in each series and cores
in the matrix are highlighted in red and blue, respectively. The figure is adapted from
the original publication [88].
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active and 0 for the inactive class, both probabilities are uniform for the third column’s
substructure. Hence, it is likely that the virtual compound in the second column will be
active, whereas no information whatsoever can be inferred about the virtual compound
of the third column if only the exchanged substructure is considered.
The major step of the proposed method is therefore to derive core and substructure
class contributions, which transfer the uncertainty of the matrices’ cores onto the sub-
structures and vice versa. To recall the underlying concept, a virtual compound’s core
should have a high contribution to the prediction if its substructure cannot determine
activity. On the other hand, if it is clear that a core determines the activity of a virtual
compound, its substructure does not have to be considered. In the example, the virtual
compound in the second column is likely to be active just because it contains the second
substructure, whereas the activity of the virtual compound in the third column has to
be determined by its core. This idea is formalized by first deriving class-dependent core
and a substructure weights, respectively, and use these to compute class contributions.
The core and substructure weights, w(c, y) and w(s, y), are simply given by their inverse
class probabilities. The core weights are then used to calculate the substructure class
contributions and vice versa:
w(c, y) = P (y|c)−1 (49)
w(s, y) = P (y|s)−1 (50)
c(c, y) =
∑n
i=1 w(s, y)δ(c
(i), c)δ(y(i), y) + α
δ(c(i), c) + 2α
(51)
c(s, y) =
∑n
i=1 w(c, y)δ(s
(i), s)δ(y(i), y) + α
δ(s(i), s) + 2α
(52)
Here, Laplacian smoothing is applied using a hyperparameter α. This prevents ill-defined
probabilities for the cases when a certain core or substructure never appears in training
compounds of a certain class.
In equation (51) and equation (52), the calculation of the core class contribution c(c, y)
using the substructure weight w(s, y) and vice versa is the key aspect. It formulates the
principle that a core contributes more to the final prediction of one class if the weights
of the corresponding substructures are high, i.e., the class is underrepresented in the
substructures. An example is the core class contribution of the second core and the
active class in figure 11 (c). First of all, the majority of training compounds with the
second core are active. Second, and most importantly, the substructures of the active
training compounds with the second core do not contribute to an active prediction.
While the third substructure does not convey any information about activity (i.e., P (y =
active|s(3)) = P (y = inactive|s(3)) = 0.5), the presence of the fourth substructure is an
indicator for inactivity (P (y = active|s(4)) < P (y = inactive|s(4))). Therefore, the
contribution of core c(2) is likely to render the respective training compounds active,
which is reflected in a high core class contribution c(c(2), active).
Finally, the core and substructure class contributions are normalized to arrive at a
final estimate of core and value class probabilities, denoted by P ′(y|c) and P ′(y|s), re-
spectively. The final class probability of a virtual compound, P (y|x(i)), is then predicted
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Figure 11: Schematic illustration of the SAR matrix-based prediction approach. Shown
are (a) the derivation of core and substructure class probabilities, (b) the class-dependent
core weights (in the matrix cells) and the substructure contributions derived from them,
(c) the class-dependent substructure weights (in the matrix cells) and the core contri-
butions derived from them, (d) the final estimates of core and value class probabilities
and the activity probabilities for the virtual compounds. The figure is adapted from the
original publication [88].
51
as a combination of both:
P ′(y|c) = c(c, y)∑
yˆ∈Y c(c, yˆ)
(53)
P ′(y|s) = c(s, y)∑
yˆ∈Y c(s, yˆ)
(54)
P (y|x(i)) = P
′(y|c(i))P ′(y|s(i))∑
yˆ∈Y P
′(yˆ|c(i))P ′(yˆ|s(i)) (55)
Exemplary class probabilities for the active class are shown in figure 11 (d).
We have compared this approach to classifications derived by na¨ıve Bayes classifica-
tion, random forests, and SVMs using ECFP4 fingerprints. In many cases, comparable
performances could be achieved [88]. Furthermore, the SAR matrix-based approach is
easily interpretable by visualization of the matrices that contributed to a prediction.
Summary
This chapter derived a formalism to extract conditional activity probabilities from SAR
matrices, and explained how they can be utilized to predict activities of untested com-
pounds. In the original study, we have organized nine different compound data sets in
SAR matrices, and carried out systematic benchmark calculations using our approach.
Furthermore, the same compound data sets were represented using ECFP4 fingerprints,
and predictions were derived using na¨ıve Bayes classifiers, random forests, and SVMs.
Our results show that the probabilistic SAR matrix-based approach performs comparable
to these state-of-the-art machine learning algorithms [88]. These methods are however
not generally comparable, because the matrix approach requires specific structural re-
lationship between data set compounds. Furthermore, the results of the matrix-based
predictions are intuitively explainable as chemical transformations and their contribu-
tions.
This and the last chapter have focused on the application and development of su-
pervised learning algorithms for specific use cases in drug discovery. Beyond these, the
next part of this thesis contains two studies that provide novel insights into machine
learning when applied to pharmaceutically relevant questions. The focus is not on the
development of new methods, but on the understanding of machine learning algorithms
and their workings in the drug discovery context.
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Part II
Insights into Machine Learning in
Chemoinformatics
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3
Compound Structure-Independent
Activity Prediction in
High-Dimensional Target Space
Introduction
In the last part, two methods for the prediction of compound activity profiles and single-
target compound activities, respectively, were introduced. The focus of these studies was
on method development and benchmarking of these methods. The following part, how-
ever, emphasizes insights into computational methods for compound activity prediction
that can be gained by careful analysis. In this chapter, we introduce a method for com-
pound structure-independent activity prediction in the presence of high-dimensional
profiling data. As such, our study highlights a “paradigm-shift” in chemoinformatics
that becomes feasible in the presence of publicly available chemogenomics data: com-
pound activity is not only predicted based on the structures (traditional SAR), but also
based on their activities against other targets [89, 90].
This chapter compares na¨ıve Bayes classifiers based on compound structures with
those based on compound activity profiles. The na¨ıve Bayes approach is chosen because
it can be adjusted to treat incomplete target annotations, which usually limits activity-
based predictions in practical scenarios. The results are compared to structure-based
SVMs and a na¨ıve Bayes hybrid approach designed to incorporate both structure and
activity information. All classifiers are applied to a high-dimensional profiling data set
with compound annotations against 383 kinases. Interestingly, the activity-based na¨ıve
Bayes classifier is able to outperform the other methods in the presence of this high-
dimensional target space. An in-depth feature analysis furthermore reveals the influence
of different kinase activity annotations on the prediction accuracy of other kinases.
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High-Dimensional Target Space
Jenny Balfer,[a] Ye Hu,[a] and Jrgen Bajorath*[a]
1 Introduction
Assessing multi-target activities of compounds through
target profiling has become an important exercise in phar-
maceutical research.[1–5] In a typical profiling experiment,
a collection of compounds is screened against an array of
related or distinct targets. Compound profiling may have
varying goals including, for example, the identification of
active compounds that are selective for a target of interest
over others (e.g. , closely related targets and/or anti-targets)
or the assessment of compound promiscuity across a given
target family. In addition, compound profiling might also
be carried out to establish compound-based relationships
between multiple targets, which is of particular interest for
chemical biology or chemogenomics.[6]
Regardless of specific goals, compound profiling often
focuses on important therapeutic targets. In addition to G
protein coupled receptors,[1] protein kinases are one of the
major target families subjected to profiling.[2–5] Given the
high interest in protein kinases as drug targets, many inhib-
itors directed against the ATP (cofactor) binding site in kin-
ases have been developed over the past decade, especially
for use in cancer treatment.[2,7] Because the ATP binding
site in kinases is largely considered, many ATP site-directed
inhibitors are active against multiple kinases,[2,7] although
such inhibitors might also display a considerable degree of
selectivity for individual kinases or subfamilies.[8] Profiling of
compounds against kinases, especially of ATP site-directed
inhibitors, is often carried out to better understand their
promiscuity or selectivity patterns across the kinome and
select inhibitors with higher or lower degrees of promiscui-
ty for specific therapeutic applications.[7]
In the pharmaceutical industry, such profiling experi-
ments typically produce large volumes of data, which are
only rarely released into the public domain,[4] given their
mostly confidential nature. In academia, compound profil-
ing is less common (often due to resource constraints,
rather than lack of interest). Consequently, there is only lim-
ited availability of compound profiling data in the public
domain. At the same time, there is high interest in the che-
moinformatics community in the development and assess-
ment of computational approaches to model profiling ex-
periments and predict multi-target compound activities, for
several reasons. First, from a methodological perspective,
multi-target activity prediction is a topic of interest for ad-
vanced machine learning approaches.[9] In addition, further
extension of existing experimental data through interaction
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predictions is also of considerable interest, especially for
chemogenomics.[7,8,10] Furthermore, methods for activity
profile prediction can be practically applied to aid in the
study of drug polypharmacology[11] including the prediction
of alternative drug targets,[12] side effects,[13] or new thera-
peutic applications.[14] Given the attractiveness of these ap-
plications, it is not surprising that a number of computa-
tional investigations have attempted multi-target activity
predictions.[15–20]
From a methodological point of view, experimental
profiling data can also serve as an input to compound ac-
tivity prediction. Instead of predicting compound-target in-
teractions based on chemical structures, which represents
a conventional approach in chemoinformatics, bioactivity-
based descriptors of compounds have been increasingly
used in the past years.[21–25] For example, the use of bioac-
tivity fingerprints, also called “affinity fingerprints”[21,25] or
“high-throughput fingerprints”,[23,24] for activity prediction
has been explored, often leading to promising results in vir-
tual screening benchmark calculations.[23,25] The derivation
of such bioactivity-based descriptors typically requires large
amounts of activity measurements for test compounds on
multiple targets and has thus predominantly been explored
in the pharmaceutical industry.
Despite limited public availability of profiling data, first
efforts have also been made to analyze and predict kinase
profiling campaigns.[19,20] In a recent study, it was attempted
to reproduce a kinase profiling experiment involving a set
of 429 pyridinyl-imidazole ATP site-directed inhibitors
tested against a panel of 24 different kinases.[20] Because
the design of these kinase inhibitors was primarily focused
on the p38-a (MAPK14) kinase, a popular cancer target, the
compounds were often inactive against distantly related
kinases. Hence, active data points were sparsely distributed
over the profiling matrix.[20] Nonetheless, a significant varie-
ty of compound profiles was observed. Under these condi-
tions, serially applied target-based support vector machine
(SVM) classifiers using structural fingerprint descriptors for
compounds predicted profiles more accurately than profile-
based regression or structural SVM models and naı¨ve Baye-
sian (NB) classifiers.[20]
In this study, we have addressed a principally different
activity prediction task using a kinase profiling data set
consisting of 72 reference inhibitors including marketed
drugs and 383 kinases covering major parts of the kinome.
In this case, profiling data were available for only a limited
number of compounds but many kinases, thus represent-
ing a high-dimensional target space with only little com-
pound coverage. In our analysis, we have found that NB
models derived by learning from activity profile data yield-
ed more accurate activity predictions than compound
structure-based SVM or NB classifiers, although profiling
data available for learning was incomplete. Prediction accu-
racy based on activity profiles could not be further im-
proved (or was reduced) using hybrid models that com-
bined activity profile and compound structure information.
Taken together, the results indicate that profile information
is sufficient for activity predictions in high-dimensional
target space, i.e. , the activity of compounds against novel
targets could be accurately predicted on the basis of activi-
ty profiles for other targets.
2 Materials and Methods
2.1 Kinase Profiling Data Set
We manually assembled a high-dimensional profiling data
set with the aid of DiscoveRx’s[26] KINOMEscan data and
kinase interaction maps,[27] which are based upon a study
by Davis et al.[28] The interaction maps report profiling data
for 72 known kinase inhibitors including marketed drugs
from a large-scale kinase screen.[27] According to the experi-
mental protocol,[26] all compounds were first tested at
a single concentration screen of 10 mM. Subsequently, Kd
values were determined for all compounds that yielded less
than 35% of positive control activity for a given kinase
target. Kd values obtained for pairwise compound-kinase in-
teractions ranged from 20 pM to 2.9 mM.
To assemble a profiling data set, we retrieved the struc-
tures of tested inhibitors from the ChEMBL database,[29]
standardized the structures, and downloaded their available
activity annotations from TREEspot kinase interaction
maps.[26,27] These efforts resulted in a complete profiling
matrix for the 72 inhibitors and a total of 383 different
kinase targets belonging to 11 subfamilies, hence providing
extensive coverage of the human kinome (including a total
of 518 known kinases). All compounds were competitive
ATP site-directed inhibitors. On the basis of assays with
phosphorylated and unphosphorylated ABL1 kinase, 37
compounds were classified as type I inhibitors and 13 as
type II inhibitors[28] (which block the ATP site by binding to
different subsites) ; for 22 compounds no assignment could
be made. This classification was preliminary because it was
carried out on the basis of only one kinase (and ABL1
mutant forms).[28] Since type 1 and type 2 inhibitors typical-
ly display different selectivity profiles,[28] they were both
considered for our profile analysis, hence increasing the va-
riety of activity readouts. This also ensured that a sufficient
number of compounds were available for machine learn-
ing.
For the purpose of our analysis, we then binarized the
profiling matrix by designating all compound-kinase inter-
actions for which a measured Kd value was available as
“true” (i.e. , the compound was considered active against
this kinase) and all others as “false” (i.e. , the compound
was considered inactive). The resulting matrix contained
6,203 “active” and 21,373 “inactive” compound-kinase pair-
ings. Figure 1 shows histograms of enumerated activities
per kinase target and compound, respectively. While the
majority of targets were inhibited by less than 30 active
compounds (Figure 1a), there were also targets that were
inhibited by most of the 72 compounds (e.g. , kinase YSK4
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was inhibited by 49 of the 72 compounds). In addition, the
inhibitors displayed a variety of promiscuity patterns (Fig-
ure 1b). Nearly all compounds were active against more
than one kinase. The well-known broad spectrum kinase in-
hibitor staurosporine was active against 336 of all 383 kin-
ases. Notably, each of the 72 compounds exhibited
a unique activity profile, i.e. , no compounds shared the
same activity annotations against all 383 kinases. Pairwise
structural and profile similarities of the 72 compounds are
provided in Figure S1 of the Supporting Information.
2.2 Naı¨ve Bayesian Classification
In Bayesian classification, a desired class is modeled as
a random variable Y, which is dependent on a set of ob-
served features X.[30] Given a compound represented as
a feature vector x, we are interested in the conditional
probabilities P(yjx) that x belongs to each class y2{active,
inactive}. Using Bayes’ rule, these posterior probabilities can
be written as
P y xjð Þ ¼ P x yjð ÞP yð Þ
P xð Þ ð1Þ
Here, P(xjy) is the class likelihood that describes how
likely the observation x is given a specific classy. P(y) is the
prior probability accounting for the likelihood of class y re-
gardless of the observation x. In addition, P(x) is called the
evidence, which is the marginal probability of observation
x, regardless of the class y.[30] A classification is then ach-
ieved by choosing the class with the highest posterior
probability:
y^ ¼ argmax
y2Y
PðxjyÞPðyÞ
PðxÞ ð2Þ
In this equation, the evidence serves as a normalization
factor to conserve the probability :
X
y2Y
PðxjyÞPðyÞ
PðxÞ ¼ 1 ð3Þ
To determine the class with the maximum posterior
probability, the evidence does not need to be explicitly de-
termined because the features of any given instance are
constant. Thus, to enable the application of the decision
rule, only the prior probabilities and the class likelihoods
for each class need to be determined:
PðyjxÞ / PðxjyÞ PðyÞ ð4Þ
The naı¨ve Bayesian (NB) classification assumes that all ob-
served features are independent of each other.[31] Even
though the feature independence assumption often is an
approximation in practice, naı¨ve Bayesian classifiers have
shown to perform well on a number of classification tasks,
for instance, spam classification.[32,33] Using the independ-
ence assumption, the class likelihoods can be written as
PðxjyÞ ¼
Yd
j¼1
PðxjjyÞ ð5Þ
where d is the number of input dimensions and xj the
value of x at position j.
The prior probability P(y) can be estimated from the
training data using maximum likelihood estimation.[30] Be-
cause one is interested in a binary classification (e.g. , 0=
“inactive” or 1= “active”), it is possible to model Y as a Ber-
noulli random variable:
PðyÞ ¼ py ð1pÞ1y y 2 f0,1g ð6Þ
Figure 1. Activity histograms. (a) Number of active compounds
per target. Most targets were inhibited by fewer than 30 com-
pounds. (b) Number of inhibited targets per compound. Nearly all
inhibitors displayed varying levels of promiscuity; a few com-
pounds inhibited more than 200 kinases.
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Given n training examples, where instance i has class
label y(i), the maximum likelihood estimate for p is
p^ ¼
Pn
i¼1 y
ðiÞ
n
ð7Þ
Hence, p can be estimated from the training data as the
ratio of active compounds over all compounds in the train-
ing set. For the estimation of class likelihoods, individual
formulations for different feature representations were
used, as further explained below.
2.3 Prediction Models
2.3.1 Structure-Based Classification
For structure-based classification, we represent compounds
using structural fingerprints. One example of a (sub)structur-
al fingerprint is MACCS,[34] a binary vector consisting of 166
bits in which each bit encodes the presence or absence of
a specific substructure. Hence, in this case, the observations
X are binary feature vectors. The class likelihoods are esti-
mated from the training data as
p^ðxjjy ¼ 1Þ ¼
P
n
i¼1 x
ðiÞ
j y
ðiÞ
P
n
i¼1 y
ðiÞ ð8aÞ
p^ðxjjy ¼ 0Þ ¼
P
n
i¼1 x
ðiÞ
j ð1yðiÞÞP
n
i¼1ð1yðiÞÞ
ð8bÞ
That is, the class likelihood of each feature is estimated
by the ratio of training samples in the active class that con-
tain this feature.[30]
2.3.2 Profile-Based Classification
In profile-based classification, each compound is “indirectly”
represented by its profile, i.e. , its known activities against
a set of targets. In principle, these profiles also represent
binary feature vectors in which each bit indicates if the
compound is active or inactive against a given target. How-
ever, while features for structure-based classification are
always known, this is not necessarily the case for profile-
based classification. In practice, a given compound might
have only been tested against a subset of targets in
a panel. This situation is simulated in our analysis by profil-
ing matrix modifications, as further detailed below. Conse-
quently, an observation xj in profile-based classification can
be assigned to three different states: active, inactive, or un-
known. Only two of these states are informative (i.e. , active
and inactive) and these two can be modeled as Bernoulli
features. Hence, we estimate the class likelihood for each
feature using a modified version of the maximum likeli-
hood estimate where the unknown state is excluded. Let dij
be a function that returns 1 if the activity of compound
i against target j is known and 0 otherwise. Then we can
estimate the class likelihood for the known positions as
p^ðxjjy ¼ 1Þ ¼
P
n
i¼1 x
ðiÞ
j y
ðiÞdijP
n
i¼1 y
ðiÞdij
ð8cÞ
p^ðxjjy ¼ 0Þ ¼
Pn
i¼1 x
ðiÞ
j ð1yðiÞÞdijP
n
i¼1ð1yðiÞÞdij
ð8dÞ
The classification rule is also altered to take only those
feature positions into account that are known in the test in-
stance x(t):
y^ ¼ argmax
y2Y
PðyÞ
Yd
j¼1
dtjPðxðtÞj jyÞ þ ð1 dtjÞ ð9Þ
Importantly, both modifications explicitly exploit the fea-
ture independence assumption of the naı¨ve Bayesian classifi-
er by separating the different features from each other.
2.3.3 Hybrid Classifiers
Instead of taking structural or bioactivity features exclusive-
ly into account, we also design hybrid naı¨ve Bayesian classi-
fiers. For this purpose, the availability of explicit prior prob-
abilities for each class is exploited (cf. Equation 4). In the
first step, class priors are modeled by the maximum likeli-
hood estimation according to Equation 7. Then, either the
structure-based or the profile-based classification is applied,
as described above. However, instead of choosing the class
with the maximum posterior probability, we explicitly calcu-
late the posterior probabilities (see Equation 1). These pos-
teriors then serve as prior probabilities for the next round
of classification when the alternative classifier is used (see
Figure 2). Hence, in the case of hybrid classifiers, the notion
of prior knowledge changes: during the first round, the
prior probability of each compound-target interaction rep-
resents the estimated general probability that any com-
pound is active against a certain target. During subsequent
rounds, the prior probability of a compound-target interac-
tion is the predicted posterior probability of another classi-
fier, i.e. , the predicted probability that the given compound
is active against the given target. At a first glance, this
might look like a violation of the original NB formulation
because the marginal prior probability P(y) is replaced by
the conditional probability P(yjx). However, it is important
to note that the condition x has a different meaning during
two subsequent rounds. In structure-based prediction,
x represents a compound’s structure, whereas in profile-
based prediction, it represents a compound’s activity pro-
file. Having made a prediction P(yjx1) in either case, the
subsequent one facilitates a prediction P(yjx2), which does
not involve x1. Hence, P(y) is conditioned on a variable that
is not involved in the subsequent computation, which does
not represent a violation of Bayes Theorem.
Furthermore, for each unknown position in the profiling
matrix, we derive an individual model that uses the predic-
tion of the previous round as training input for the current
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classification task. That is, the classifiers of any prediction
after the first round can be trained on a complete profiling
matrix, even though this complete matrix is the output of
another classifier and can therefore only be regarded as an
“educated guess”. The process of using posterior probabili-
ties as priors for the next prediction continues iteratively
until convergence is reached (see Figure 2). As a conver-
gence criterion, predicted class labels of all test instances
were required to remain constant for at least three itera-
tions.
2.4 Calculation Set-Up and Performance Assessment
In order to modify the complete profiling matrix and intro-
duce unknown states for prediction, 50% of the com-
pound-target interactions were randomly removed from
the data matrix. The remaining 50% of the data were then
used to train a structure-based classifier, a profile-based
classifier, and two hybrid classifiers, i.e. , one beginning with
structure-based prediction, termed structure-profile classifier
and the other beginning with profile-based prediction,
termed profile-structure classifier. Hence, training com-
pounds for the classifiers had incomplete activity profiles
and the number of known active and inactive compounds
varied for each target. The so-derived classification models
were then used to predict the missing data points in the
matrix.
One might also exclude entire rows or columns of the
data matrix, which would correspond to activity profile pre-
diction of a formerly untested compound or compound ac-
tivity prediction against an orphan target, respectively. The
former application is not feasible using purely structure-
based approaches and the latter is not feasible applying
any of the methods explored in this study because no
training data for the target model would be available.
Nonetheless, these additional predictions should represent
interesting opportunities for future work.
As control calculations, we have also carried out struc-
ture-based support vector machine (SVM) predictions.[30,35]
As rationalized above, activity profile-based classification
was not feasible for SVMs, due to the underlying feature in-
dependence assumption. SVMs have often produced best
results in standard compound activity prediction[36–38] and
therefore become a machine learning “gold standard” in
chemoinformatics.
Matrix modifications, model derivation, and test calcula-
tions were repeated 100 times to obtain statistically mean-
ingful results, which are reported in the following as aver-
ages over 100 independent trials.
Structure-based classifiers were derived using MACCS[34]
and the extended connectivity fingerprint with bond diam-
eter 4 (ECFP4)[39] as molecular representations. Both finger-
prints were calculated using an in-house implementation
based upon OpenEye’s OEChem toolkit.[40] For MACCS, we
used SMARTS patterns adapted from RDKit.[41] For naı¨ve
Bayesian and SVM classifiers, the freely available Python im-
plementation scikit-learn was used.[42] For structure-based
naı¨ve Bayes classification, the Bernoulli naı¨ve Bayes formu-
lation was applied and the partial model for profile-based
naı¨ve Bayes classification was generated with an in-house
Python script. The SVM models were built using the Tani-
moto kernel[43] with automated class weights. Otherwise,
standard parameters were applied to ensure reproducibility
of the calculations. That is, we used Laplacian smoothing
using a=1 for NB modeling, and support vector classifica-
tion using C=1.
To assess the performance of the classifiers, precision,
recall, and balanced/imbalanced accuracy were calculated.
These performance measures are defined as follows (TP:
true positive, FP: false positive, TN: true negative, and FN:
false negative):
Precision ¼ TP
TPþ FP
Recall ¼ TP
TPþ FN
Accuracybalanced ¼ 0:5 
TP
TPþ FNþ
TN
TPþ FP

Accuracyimbalanced ¼
TPþ TN
TPþ FPþ TNþ FN
Figure 2. Hybrid classification concept. First, prior probabilities are
estimated from the data. The posterior probabilities of compound
structure-based prediction are then used as priors for activity pro-
file-based prediction and vice versa (structure-profile classifier). The
process is continued until convergence is reached. Alternatively,
posterior probabilities of profile-based prediction are first deter-
mined and used as priors for structure-based prediction (profile-
structure classifier).
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TP, FP, TN, and FN were only calculated for unknown
matrix positions; training positions were not considered. All
performance measures range from zero to one. The com-
parison of imbalanced and balanced accuracy reflects the
influence of the imbalanced data composition on the clas-
sification results (given, in this case, by the prevalence of
negative over positive interactions).
3 Results and Discussion
3.1 Analysis Concept and Aims
A major goal of our study has been the exploration of
multi-target activity predictions in high-dimensional target
space in the context of compound profiling. Experimental
data for such an analysis are currently difficult to obtain.
Therefore, we have manually assembled a complete profil-
ing matrix for 72 inhibitors involving nearly 400 related
kinase targets. Thus, while the compound set was of limit-
ed size, it populated a truly high-dimensional target space.
Through iterative random removal of 50% of the activity
data from this profiling matrix, a sparsely populated high-
dimensional matrix was obtained, hence presenting a chal-
lenging prediction task. Through matrix modification it was
simulated that profiling was incomplete, i.e. , not all com-
pounds were tested against all targets. Hence, predictions
of unknown target-compound combinations corresponded
to the computational extension of experimental data,
a task of practical relevance for chemogenomics. We have
explored both compound structure-based activity predic-
tion, the conventional approach in chemoinformatics, and
activity profile-based prediction, which is much less ex-
Figure 3. Convergence of hybrid classifiers. Reported is the iterative performance evaluation of structure-profile and profile-structure clas-
sification using the MACCS and ECFP4 fingerprints as structural descriptors, respectively. Each iteration is represented by two data points
reporting two predictions per round. For both classifiers, the performance level was maximal after the first iteration and then remained es-
sentially constant (structure-profile) or was slightly reduced (profile-structure) until convergence was reached. Standard deviations were
consistently below 0.02 and are therefore not reported in this figure.
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plored. Profile-based prediction, as carried out herein, is re-
lated to the experimental concept of affinity fingerprint-
ing,[21] which has been applied in biological screening to
small target sets. Profile-based classification requires the
prediction of the activity of a compound against a novel
target on the basis of activity data available for other close-
ly or distantly related targets. Hence, profile-based predic-
tion does not involve consideration of compound structure.
In addition to structure- and profile-based classification,
hybrid prediction models were designed taking both struc-
ture- and profile information into account. These models
were more complex than individual classifiers, but would in
principle be expected to maximize prediction performance
as they utilized all available information.
In the following, the performance of the different types
of classifiers is compared and an in-depth feature analysis
is provided. We begin with analyzing the convergence
characteristics and prediction performance of the hybrid
models, given their new design.
3.2 Convergence and Performance of Hybrid Classifiers
Hybrid classification models were derived with two alterna-
tive molecular representations. Using the MACCS finger-
print, hybrid classifiers converged on average after 11.1 iter-
ations in profile-structure and after 16.6 iterations in struc-
ture-profile prediction, with standard deviations (SD) of 4.9
and 6.4 iterations, respectively. Using ECFP4, the profile-
structure classifier converged after 14.3 iterations (SD=6.3),
Figure 4. Performance of NB classifiers. Mean and standard deviations of precision, recall, imbalanced, and balanced accuracy are reported
for all classification models using (a) MACCS and (b) ECFP4 as descriptors for structure-based classification.
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and the structure-profile classifier after 17.7 iterations (SD=
6.2). Six individual trials of the structure-profile and 11 trials
of the profile-structure classification using ECFP4 did not
converge during the first 100 iterations and were discontin-
ued.
Figure 3 reports different performance measures moni-
toring iterative classification. Interestingly, the general
trend was observed that performance was essentially maxi-
mal after the initial iteration and did not notably improve
during subsequent rounds; a rather unexpected finding.
Both structure-profile and profile-structure models appear
to be dominated by the profile-based prediction; this can
be inferred from the finding that following the first data
point in profile-structure and the second data point in
structure-profile prediction, no further improvement is ob-
served. It is likely that the posterior probabilities following
profile-based prediction dominated the priors during the
next round such that no further changes were observed.
Hence, at least for our data set, iterative learning with in-
ferred class labels did not provide an advantage over
single-step classification, indicating that the results were
stable after initial conditional probability assignment.
Therefore, in the following, we consider the performance of
the hybrid classifiers after the initial iteration.
3.3 Performance Comparison of Alternative Classification
Models
Figure 4 reports the mean and SD of the prediction per-
formance of all classifiers including structure-based SVM
control calculations using MACCS (Figure 4a) and ECFP4
(Figure 4b) as descriptors. First, the results are discussed for
MACCS. In this case, the SVM classifier produced the lowest
Figure 4b
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precision with only 33.72%, but had higher recall (49.23%)
than the structure-based NB classifier. Accordingly, its im-
balanced accuracy was lowest with 66.77% and the bal-
anced accuracy was comparable to the structure-based NB
classifier (60.55%). The structure-based NB classifier gener-
ally predicted fewer active positions, which resulted in
higher precision (44.04%) and lower recall (33.73%) than
the SVM classifier. Accordingly, the imbalanced accuracy of
the structure-based NB classifier was higher (by 8.66%), be-
cause negative positions were overrepresented in the data.
Strikingly, all classifiers using activity profile information
for prediction outperformed structural classifiers by all per-
formance measures. Moreover, the structure-profile classifier
produced lower performance (58.86% precision, 56.01%
recall, 81.28% imbalanced, and 72.32% balanced accuracy)
than the profile-based NB and the profile-structure classifier.
Both the profile-structure and the profile-based NB classifier
produced comparable results, with precision of 61.56% and
59.53%, recall of 63.19% and 65.11%, imbalanced accuracy
of 82.83% and 82.18%, and balanced accuracy of 75.86%
and 76.12%, respectively. Hence, overall promising predic-
tions were obtained. Furthermore, these findings revealed
that profile-based prediction was superior to structure-based
prediction in the case of the high-dimensional kinase profil-
ing matrix and that overall best performance was achieved
by single-step profile-based classification.
Since the MACCS fingerprint consists of 166 structural
features, while 382 activity features were available for pro-
file-based learning, we also investigated the higher-dimen-
sional ECFP4 atom environment fingerprint[39] for structure-
based classification. This fingerprint does not have a con-
stant format, but generates varying numbers of topological
features in a molecule-specific manner.
Figure 4b shows the performance of the ECFP4-based
structural classifiers compared to profile-based and hybrid
classifiers. In this case, both SVM and NB classifications dis-
played a significant increase in precision, i.e. , 26.49% to
60.21% for SVM and 15.66% to 59.70% for NB, but the
recall was substantially reduced to 27.55% and 14.44%, re-
spectively. This means that the structure-based classifiers
predicted fewer active instances with ECFP4 than with
MACCS. Hence, imbalanced accuracy was further increased,
whereas balanced accuracy was reduced for the ECFP4
structure-based NB classifier (while it remained approxi-
mately at the same level for ECFP4-based SVM classifica-
tion). A similar picture emerged for structure-profile predic-
tion. Here, precision was improved by 20% to 78.86% and
recall reduced from 56.01% to 24.19%. Therefore, balanced
accuracy also decreased nearly to the level of the structure-
based classifiers. However, profile-structure prediction suf-
fered significantly less from these effects, i.e. , precision was
only increased by 6.17% and recall was decreased by only
7.62%. Taken together, the results revealed an expected fin-
gerprint dependence of structure-based classification, but
also showed that increasing fingerprint feature space did
not improve these predictions.
Figure S4 of the Supporting Information reports the per-
formance of the different classifiers from a more profile-
centric perspective. Here, the number of individual profiles
is plotted against their number of incorrect positions. Using
structure-based SVM and MACCS, on average, at least 20
positions were incorrectly predicted in each profile. Half of
all 72 profiles could be predicted with a maximum error of
50 positions and for all profiles, the average maximum
error was 100 interactions. Profile-based NB predictions
were able to generate profiles with only one incorrect posi-
tion, and half and all of the profiles could be predicted
with a maximum error of 21 and 103 positions, respectively.
On the other hand, when the structural representation was
changed to ECFP4, the SVM classifier was able to predict
profiles with only four false positions. Predicting half and
all of the compound profiles could be done with a mean
error of 24 and 119 positions, respectively.
Overall, profile-based activity predictions were clearly su-
perior to structure-based classification in the case of our
high-dimensional kinase data set. In fact, the incorporation
of structural information in hybrid models partly compro-
mised profile-based activity prediction. Thus, in this case,
the dominance of profile-based prediction in hybrid classifi-
ers was not a conceptual flaw, but desirable.
The results indicate that profile-based predictions pro-
vide a viable complement and/or alternative to ligand-
based approaches in cases where ligand data is sparse but
a sufficient number of biological annotations is available.
Hence, for high-dimensional activity spaces, profile-based
modeling should be a highly attractive approach. In cases
where large numbers of compounds are available, it should
be interesting to compare profile- and ligand-based predic-
tions in detail. We would expect that they might be com-
plementary dependent on the compound classes under
study. For practical applications, an advantage of profile-
based modeling as reported herein is the fact that no struc-
ture information is required at all to achieve accurate pre-
dictions, which circumvents the generally observed com-
pound class dependence of ligand-based methods and
supports transferability of the approach to high-dimension-
al activity spaces of different target composition. Given
that ligand data was sparse in our case, it should also be
noted that different estimation strategies exist to handle
sparse ligand-target data and complement available data
with computational extrapolations.[44] This points at another
attractive feature of profile-based predictions because in
this case, it was not required to further extend ligand data.
3.4 Feature Analysis
In order to explore possible reasons for the superior per-
formance of profile-based predictions, classification models
were analyzed in detail and it was attempted to identify
features leading to accurate predictions. Initially, we investi-
gated which targets were most influenced by replacing
structural with profile descriptors. As a reference, the
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MACCS-based NB classifier was used because it produced
higher balanced accuracy than the ECFP4-based classifier.
Figure 5 reports the average difference in correctly pre-
dicted compound activities per target for the structure-
and the profile-based NB classifier. The per-target results ra-
tionalize the observed global performance difference, as
discussed above. For 125 targets, structure-based classifica-
tion yielded more correct predictions (with up to, on aver-
age, 27.14 correctly predicted positions vs. 21.83 for the
profile-based classifier), whereas more correct predictions
were obtained by profile-based classification for 257 targets
(up to, on average, 24.01 correctly predicted positions vs.
14.33 for the structure-based classifier). Only one target
had the same number of correct predictions for both classi-
fiers. The five kinase targets with largest gain in positive
predictions in profile-based classification and the five tar-
gets with largest loss are listed in Table 1. In the following,
the profile-based prediction models for the kinase with the
largest performance improvement (Yamaguchi sarcoma
viral oncogene homolog 1; YES) and the largest per-
formance reduction (mitogen-activated protein kinase 4;
ERK4) are analyzed.
3.4.1 Target with Largest Performance Improvement
On average, 43.59 reference compounds were utilized for
YES, 19.94 of which were active and 23.65 inactive. Figure 6
compares the experimentally observed activities of the 72
compounds against YES with the results of structure- and
profile-based predictions. Shading indicates the percentage
of all trials in which a given compound was predicted to
be active or inactive. The structure-based classifier yielded
a larger number of shaded profile positions indicating that
the predictions were less stable than for the profile-based
classifier. Table 2 gives the average number of true and
false positive and negative predictions for the two classifi-
ers. It is evident that the profile-based classifier produced
substantially fewer false positive, but more true negative
predictions than the structure-based classifier. To better un-
derstand this performance ratio, the inhibitor crizotinib is
considered (Figure 7). The compound was active against
YES and used as a test instance in 34 of the 100 trials. It
was predicted to be active by the profile-based classifier in
all 34 trials, whereas the structure-based classifier only pre-
dicted it to be active in two trials. Considering the meth-
Figure 5. Difference between true prediction rates. Reported is the difference between true (correct) predictions of profile- and structure-
based NB classification. Correct predictions were averaged over all trials. For clarity, targets were sorted according to the observed differ-
ence. For approximately 1/3 of the targets, structure-based classification produced, on average, up to five more true predictions (red). By
contrast, for approx. 2/3 of the targets, profile-based classification improved the performance over structure-based prediction by, on aver-
age, up to 10 individual activity predictions (green).
Table 1. Targets with largest improvement and reduction in pre-
diction performance. Reported are averaged unknown positions
and true predictions for the top five targets with largest improve-
ment and the top five targets with largest reduction in prediction
performance by profile- compared to structure-based classification.
Target Unknown
positions
True predictions
(profile-based)
True predictions
(structure-based)
Top 5 targets with largest performance improvement
YES 28.41 24.01 (84.51%) 14.33 (50.44%)
TNIK 27.82 21.57 (77.53%) 12.18 (43.78%)
MAP3K2 28.51 25.26 (88.60%) 15.89 (55.73%)
FYN 28.75 24.11 (83.86%) 14.85 (51.65%)
JAK2 27.91 26.16 (93.73%) 17.3 (61.98%)
Top 5 targets with largest performance reduction
ERK4 27.84 21.83 (78.41%) 27.14 (97.49%)
TRPM6 27.96 22.74 (81.33%) 27.61 (98.75%)
ERK1 28.07 22.83 (81.33%) 27.53 (98.08%)
VRK2 29.44 24.3 (82.54%) 28.69 (97.45%)
ERK2 28.34 23.66 (83.49%) 27.86 (98.31%)
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odological basis for the predictions, as discussed above,
the following criterion had to be met for an active predic-
tion (cf. Equation 9):
PðactiveÞ
Yd
j¼1
dtjPðxðtÞj jactiveÞ þ ð1 dtjÞ
>PðinactiveÞ
Yd
j¼1
dtjPðxðtÞj jinactiveÞ þ ð1 dtjÞ
ð10Þ
The equation can be rearranged as follows:
Yd
j¼1
dtjPðxðtÞj jactiveÞ þ ð1 dtjÞ
dtjPðxðtÞj jinactiveÞ þ ð1 dtjÞ
>
PðinactiveÞ
PðactiveÞ ð11Þ
For a given target, prior probabilities for both class labels
are constant and the dtj functions are constant for the
same compound and prediction model. It follows that we
need to analyze the features xj yielding the highest ratio
P(xjjactive)/P(xjjinactive) to rationalize a classification result.
This ratio of conditional feature probabilities was aver-
aged over the 34 trials in which crizotinib was a test com-
pound and the kinases with the highest ratio are listed in
Table 3. Interestingly, only targets against which crizotinib
was also active significantly influenced the active classifica-
tion of crizotinib for YES. For example, it was known from
the training data that crizotinib was active against SYK. The
NB classifier then utilized this information by comparing
the conditional probabilities for the observation “activity
against SYK”, given the possible cases “active against YES”
and “inactive against YES”. The remaining conditional prob-
abilities P(SYK=inactive jYES=active) and P(SYK=inactive j
YES= inactive) were not considered because the observa-
tion “SYK= inactive” was not true for crizotinib.
Figure 6. Predicted vs. observed compound activities for kinase YES. The profile at the top shows the experimentally determined activities
of the 72 compounds against YES. Profile positions are color-coded by observed inhibition: dark blue indicates inhibition and white no in-
hibition. The middle and bottom profiles show averaged activity predictions from the structure- and profile-based classification, respective-
ly. A dark blue or white position indicates that a compound was predicted to be active or inactive in all (or nearly all) of the independent
trials. Blue shading of profile positions indicates the ratio of active vs. inactive predictions; i.e. the darker the blue shade, the more active
predictions were observed over all trials.
Table 2. True and false predictions for kinase YES. For YES, average
numbers of true (Active/Active, Inactive/Inactive) and false (Active/
Inactive, Inactive/Active) predictions are reported for structure- and
profile-based classification.
Experiment Structure-based prediction Profile-based prediction
Active Inactive Active Inactive
Active 26.59 6.41 28.83 4.17
Inactive 7.67 31.33 0.23 38.77
Figure 7. Crizotinib. The structure of this exemplary inhibitor is
shown (with conventional atom coloring) whose activity against
kinase YES was consistently correctly predicted in profile-based,
but not structure-based classification.
Table 3. Targets with largest influence on the crizotinib/YES clas-
sification. Listed are kinase targets with the highest ratio
P(xjjactive)/P(xjjinactive) for test compound crizotinib and the pro-
file-based classification model for target YES. Crizotinib was experi-
mentally active against all listed targets. For each target, average
conditional feature probabilities are reported.
Target xj P(xjjinactive) P(xjjactive)
SYK active 0.0665 0.4108
FGR active 0.1651 0.9072
EPHA3 active 0.1063 0.6061
TXK active 0.0826 0.4802
ITK active 0.0707 0.4678
SIK2 active 0.0964 0.6580
AMPK-a1 active 0.0625 0.4988
MAP4K3 active 0.0923 0.6823
DLK active 0.0633 0.5085
LZK active 0.0614 0.5441
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The conditional probability for crizotinib to be active
against SYK, given the possible case that it was also active
against YES, was given by P(SYK=active jYES=active)=
0.4108. On the other hand, the conditional probability for
crizotinib to be active against SYK, given the possible case
of inactivity against YES, was given by P(SYK=active jYES=
inactive)=0.0665. Hence, the observation that crizotinib
was active against SYK was, on the basis of the NB model,
due to activity of crizotinib against YES (41.08%) with
much higher probability than due to inactivity (6.65%).
Thus, the fact that crizotinib was active against SYK played
a major role for the prediction of this compound as active
against YES. Analogous considerations apply to the other
targets listed in Table 3. For example, the conditional prob-
abilities of crizotinib to be active against FGR (which had
a lower P(xjjactive)/P(xjjinactive) ratio than SYK), given inac-
tivity/activity against YES, were 16.51% and 90.72%, re-
spectively.
Furthermore, to explain the correlation between condi-
tional feature probabilities and correct predictions not only
for a given compound, but all predictions for YES (thus
generalizing the analysis for a given target), we have distin-
guished between true positive and true negative predic-
tions. For each true positive prediction in each trial, targets
were selected that met the condition P(xjjinactive)/
P(xjjactive)2, i.e. , only those targets were taken into ac-
count that had at least a two times higher probability to
(correctly) vote for the active than (incorrectly) for the inac-
tive class. Analogously, for each true negative prediction,
targets were selected meeting the condition P(xjjinactive)/
P(xjjactive)2. Moreover, we have distinguished the case
where xj=active and xj= inactive to account for all possible
conditional probabilities involving xj and y and the states
active and inactive.
On the basis of the above criteria, only targets with the
highest influence on correct predictions were considered,
depending on their own inhibition by a specific compound.
Targets meeting these criteria in at least 50% of all trials
are listed in Table 4. Because there were 889 true positive
predictions for YES over all trials, a selected target had to
meet the above criteria at least 445 times. Analogously,
a target selected to have a significant influence on negative
predictions had to meet the above criteria for at least 756
of all 1512 true negative predictions.
The results in Table 4 show that only targets against
which a given compound was active strongly influenced
true positive predictions for YES, and only target against
which a compound was inactive strongly influenced true
negative predictions. Hence, the presence of target-activity
correlation effects played a major role for the quality of the
predictions. While most of the targets having a significant
influence on correct predictions belonged to the same sub-
family as YES (i.e. , subfamily TK), kinases from other subfa-
milies such as STE and CAMK were also found. There were
15 targets influencing true positive predictions, given they
were also inhibited, but only five targets influencing true
negative predictions, given they were not inhibited. Inter-
estingly, these five targets including FGR, FYN, and SRC
from the TK subfamily, MAP4K3 from STE, and SIK2 from
CAMK, also had a significant influence on true positive pre-
dictions.
3.4.2 Target with Largest Performance Reduction
ERK4 was the kinase with the largest reduction in true pre-
dictions for profile-based compared to structure-based clas-
sification. On average, 27.14 compound activities were cor-
rectly predicted using structure-based classification in this
case, but only 21.83 compound activities using profile-
based classification. Figure 8 compares the experimentally
observed activities of the 72 compounds against ERK4 with
the results of structure- and profile-based predictions and
Table 5 reports the average number of true and false posi-
tive and negative predictions for the two classifiers. ERK4
was inhibited by only two compounds in the data set, i.e. ,
erlotinib and PD-173955. Both classifiers were able to cor-
rectly predict these two interactions in most of the trials;
however, in this case, the profile-based classifier produced
more false positives.
In accordance with our analysis on YES, false positive
and false negative predictions for ERK4 in all trials were
considered. For each false positive prediction, targets were
selected meeting the condition P(xjjinactive)/P(xjjactive)2,
and for each false negative prediction, targets were select-
Table 4. Kinases with strong influence on true predictions for
target YES. Listed are kinases with significance influence on individ-
ual true positive and true negative predictions for target YES and
the subfamilies[28] they belong to. These targets were required to
have an at least two times higher conditional probability for cor-
rect than incorrect predictions in at least 50% of all test cases (see
text for details).
Target Subfamily xj Prediction
AXL TK active active
BLK TK active active
FGFR2 TK active active
FGR TK active active
FYN TK active active
HPK1 STE active active
JAK2 TK active active
JAK3 TK active active
MAP3K2 STE active active
MAP4K2 STE active active
MAP4K3 STE active active
MERTK TK active active
SIK2 CAMK active active
SRC TK active active
TNIK STE active active
FGR TK inactive inactive
FYN TK inactive inactive
MAP4K3 STE inactive inactive
SIK2 CAMK inactive inactive
SRC TK inactive inactive
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ed meeting the condition P(xjjinactive)/P(xjjactive)2.
Hence, the selected targets had the strongest influence on
incorrect predictions. Kinases meeting the above criteria in
at least 50% of the trials are listed in Table 6. Here, false
negative predictions were detected in only 63 of all possi-
ble instances but false positive predictions were detected
538 times.
Again, only targets that were also inhibited had a notable
influence on “active” predictions and only targets that were
not inhibited influenced “inactive” predictions. We identi-
fied a total of 21 kinases with an incorrect influence on
positive predictions (most of them belonging to the TK
subfamily, whereas ERK4 belonged to CMGC). However, no
target from the CMGC subfamily was found to compromise
prediction of ERK4. There was only one target (AXL) that in-
fluenced both false positive and false negative predictions.
To put our analysis into perspective, we have also calcu-
lated pairwise Tanimoto similarities of the targets with re-
spect to their compound activities. The so obtained Tc simi-
larity values were mostly low, as reported in Figure S2 of
the Supporting Information. For YES, Tc values ranged from
0.0 to 0.86, with a mean of 0.32. For ERK4, Tc values be-
tween 0.0 and 0.29 with a mean of 0.03 were obtained (Fig-
ure S3 of the Supporting Information). In addition, Tables
S1 and S2 of the Supporting Information list the Tc values
of the most influential targets listed in Tables 4 and 6, re-
spectively. The Tc values of the most influential targets for
YES ranged from 0.58 to 0.86 and were thus relatively high.
However, there were also other targets having a high Tc rel-
ative to YES that were not influential (e.g. , LYN with a Tc of
0.73). On the other hand, Tc values of ERK4 and its influen-
tial targets ranged from 0.0 to 0.08, which means that none
of the targets with high Tc influenced the performance of
the ERK4 model in a negative way. Hence, these findings
might indicate that sharing the same inhibitors is a necessa-
ry, but insufficient condition for a target to strongly influ-
ence profile-based NB predictions.
4 Concluding Remarks
In this work, we have carried out machine learning-based
activity predictions in high-dimensional target space with
Figure 8. Predicted vs. observed compound activities for kinase ERK4. Experimentally determined (top) and predicted (middle: structure-,
bottom: profile-based) compound activities are shown for ERK4. The representation is according to Figure 6.
Table 5. True and false predictions for kinase ERK4. For ERK4, aver-
age numbers of true (Active/Active, Inactive/Inactive) and false
(Active/Inactive, Inactive/Active) predictions are reported for struc-
ture- and profile-based classification.
Experiment Structure-based prediction Profile-based prediction
Active Inactive Active Inactive
Active 1.30 0.70 1.37 0.63
Inactive 0.00 70.00 5.38 64.62
Table 6. Targets with significant influence on false predictions for
target ERK4. Listed are kinases with significance influence on indi-
vidual false positive and false negative predictions for target ERK4.
Target Subfamily xj Prediction
ALK TK active active
AXL TK active active
EPHB1 TK active active
FER TK active active
FES TK active active
FGFR3 TK active active
FRK TK active active
INSR TK active active
JAK1 TK active active
LIMK2 TKL active active
MAP3K15 STE active active
MAP3K3 STE active active
MAP3K4 STE active active
MAP3K2 STE active active
PRKX AGC active active
SGK3 AGC active active
SIK CAMK active active
SNARK CAMK active active
SYK TK active active
TLK2 OTHER active active
ULK2 OTHER active active
AXL TK inactive inactive
LTK TK inactive inactive
MEK4 STE inactive inactive
PDGFRA TK inactive inactive
SIK2 CAMK inactive inactive
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the aid of compound profiling data, focusing on inhibition
of nearly 400 protein kinases. Predictions were carried out
to complete experimental observations in a profiling matrix
by assigning activity states of unknown compound-target
combinations. This corresponds to a computational exten-
sion of experimental profiling data, which is of practical
relevance, especially for chemogenomics applications. The
presence of incomplete profiling data principally challenges
conventional machine learning approaches for class label
prediction. Therefore, different prediction approaches were
explored including compound structure- and activity pro-
file-based classification as well as hybrid methods taking
structure and profile information into account. Profile-
based prediction conceptually benefited from the applica-
tion of a feature independence assumption and utilization
of three possible activity states (i.e. , active, inactive, and un-
known). Therefore, naı¨ve Bayesian classification was chosen
as the method of choice for prediction and complemented
with support vector machine control calculations. It was an-
ticipated that iterative hybrid classification utilizing struc-
ture and profile information might provide the best basis
to maximize prediction performance. However, activity pro-
file-based NB classifiers yielded overall more accurate pre-
dictions than hybrid methods or SVM or NB classifiers using
molecular representations. Thus, consideration of com-
pound structure was not required for accurate activity pre-
diction in high-dimensional target space. Moreover, its in-
clusion was even unfavorable in a number of cases. This
observation was likely due to the often high degree of
structural similarity of the ATP site-directed kinase inhibitors
under study. Of course, one needs to consider that com-
pound structure information was by default limited and
that structure-based predictions might also be further im-
proved once more compounds become publicly available
that have been extensively profiled against large numbers
of targets. On the other hand, using more compounds for
model building would also further increase the number of
available training profiles and thus support profile-based
prediction. Taken together, our results clearly emphasize
the value of profile information for activity prediction in
high-dimensional target space, at least in the context of
Bayesian classification. Interesting questions for follow-up
work include, for example, to what extent these findings
are influenced by the similarity of ligands and the degree
of correlation between activity profiles. It should also be of
interest to explore high-dimensional data sets in which
ligand and profile data are balanced (that are, unfortunate-
ly, difficult to obtain at present). It is reasonable to assume
that in the presence of balanced and comparably informa-
tive structural and profiling data, hybrid classification meth-
ods would give an advantage over both individual ap-
proaches. Hence, although hybrid classification was inferior
to profile-based predictions in our current study, hybrid
methods continue to merit further exploration, for principal
reasons.
We have also attempted to rationalize the findings
through a detailed analysis of two exemplary profile-based
prediction models, which revealed that profile-based pre-
dictions were driven by implicitly learned target-activity
correlations. These correlation effects were not limited to
kinases belonging to the same subfamily but also involved
kinases from different subfamilies. Such correlation effects
favor activity profile-based predictions and are effectively
exploited through the derivation of conditional probabili-
ties of activity in the context of naı¨ve Bayesian classifica-
tion. Hence, in high-dimensional target spaces, such as the
kinase space investigated herein, activity prediction on the
basis of profile information is found to be a promising ap-
proach and can be effectively applied by learning from in-
complete profiling data. In addition, increasing compound
coverage of high-dimensional target space might also fur-
ther increase the performance of the hybrid classification
models introduced herein. Structures, molecular finger-
prints, and ChEMBL IDs of the compounds investigated
herein are made freely available.[45]
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Summary
This chapter covered the application of a na¨ıve Bayes classification approach to incom-
plete activity profiling data, and a detailed analysis of the resulting model. It was shown
that in high-dimensional target space, good prediction accuracy can be achieved without
taking compound structure information into account. Furthermore, the design of the
profile-based classifier exploited the na¨ıve assumption of feature independence to enable
the application to incomplete profiling data. This contribution is especially important in
practice, since publicly available chemogenomics data is seldomly complete and usually
only sparsely distributed. Moreover, the resulting models can be used for an analysis of
the target space at hand, in this case, the human kinome.
In the analysis, we showed which targets benefit most from the structure-independent
prediction, and which related kinases had most influence on compound-target interac-
tion classification. As such, our analysis provides two main insights into computational
activity profile modeling: First, in the presence of high-dimensional profiling data, it
has to be carefully investigated whether structural or profiling information should be
used for the prediction of compound-target interactions. Second, our approach makes
it possible to not only apply profile-based predictions to incomplete data, but it also
provides means to interpret how similar related targets are to each other in terms of
compound binding.
The following chapter deals with the task of compound activity prediction against
single targets. Instead of classifying active and inactive compounds, SVR is used to
model the potency values of presumably active compounds. Again, the focus is not on
the method application and benchmarking, but on understanding the mechanisms that
lead to success or failure of the applied models.
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4
Systematic Artifacts in Support
Vector Regression-Based Compound
Potency Prediction Revealed by
Statistical and Activity Landscape
Analysis
Introduction
While the previous chapters dealt with the classification of compound-target interactions
as active or inactive, the next study performs a potency regression task. Here, it is
assumed that all compounds in a given data set are active at different levels, and their
potency is to be predicted. This task is usually applied in the lead optimization stage,
where several active compounds have already been identified. Models are then built for
these compounds, with the aim of ranking them in order of their estimated potency. For
this task, SVR is one of the most popular models in the chemoinformatics community.
Failure or success of these models are usually measured statistically, in terms of R2
scores, squared or absolute errors.
In this study, we build SVR models for a variety of compound data sets with known
activity information. These models are then used to predict the potency values of
previously unseen compounds, and their statistical performance in terms of R2 scores and
mean absolute errors is derived. Furthermore, quantitative measures of SAR continuity
and discontinuity, as well as qualitative representations such as the SAR landscape,
are utilized. Our results show that even though the global prediction accuracy of the
models was at least acceptable and often good, the most interesting SAR regions are
systematically mispredicted.
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Abstract
Support vector machines are a popular machine learning method for many classification
tasks in biology and chemistry. In addition, the support vector regression (SVR) variant is
widely used for numerical property predictions. In chemoinformatics and pharmaceutical re-
search, SVR has become the probably most popular approach for modeling of non-linear
structure-activity relationships (SARs) and predicting compound potency values. Herein,
we have systematically generated and analyzed SVR prediction models for a variety of
compound data sets with different SAR characteristics. Although these SVRmodels were
accurate on the basis of global prediction statistics and not prone to overfitting, they were
found to consistently mispredict highly potent compounds. Hence, in regions of local SAR
discontinuity, SVR prediction models displayed clear limitations. Compared to observed ac-
tivity landscapes of compound data sets, landscapes generated on the basis of SVR poten-
cy predictions were partly flattened and activity cliff information was lost. Taken together,
these findings have implications for practical SVR applications. In particular, prospective
SVR-based potency predictions should be considered with caution because artificially low
predictions are very likely for highly potent candidate compounds, the most important
prediction targets.
Introduction
Support vector machines (SVMs) are algorithms for supervised machine learning [1] that have
become increasingly popular for object classification and ranking in bioinformatics [2,3] and
chemoinformatics [4,5], given their often observed high predictive performance compared to
other machine learning approaches [5]. The basic idea underlying SVMmodeling is to derive
classification models by separating positive and negative training data with the largest possible
margin. Furthermore, SVMs are often used in combination with kernel functions, which proj-
ect training sets into feature spaces of higher dimensionality where a linear separation of
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positive and negative training data might ultimately be feasible. The resulting models are then
used to predict test instances.
In addition to classification and ranking, the SVM approach has also been adapted for pre-
diction of numerical property values through support vector regression (SVR) [6,7]. Instead of
constructing a hyperplane for classification, SVR derives a function on the basis of training
data to predict numerical values. SVR is an intrinsically non-linear prediction approach be-
cause it projects data sets characterized by the presence of non-linear structure-property rela-
tionships in original feature spaces into higher-dimensional space representations where a
linear regression function can be fitted. Accordingly, SVR has been receiving much attention in
recent years in the context of quantitative structure-activity relationship analysis (QSAR) [8] to
predict activities of bioactive compounds. QSAR has been, and continues to be, the most widely
applied computational approach for potency prediction and compound design in
medicinal chemistry.
Classical QSAR modeling attempts to predict changes in compound potency that result
from small chemical modifications using linear regression models [8]. Therefore, these predic-
tions are typically limited to series of structural analogs in which the assumption of at least ap-
proximate linearity of structure-activity relationships (SARs) holds. By contrast, the prediction
of potency values of compounds from large and structurally heterogeneous data sets, in which
SARs are typically non-linear, fall outside the applicability domain of classical QSAR and re-
quire non-linear prediction methods such as neural networks [8] or SVR. In addition to poten-
cy prediction [9–11], SVR has also been applied to predict a variety of other compound-
associated property values [12–16]. SVR models derived for potency prediction reported in the
literature are typically statistically assessed and cross-validated following standard QSAR pro-
cedures, i.e., by calculating coefficients of determination to account for the ability of a model
to fit the potency values of the training data and predict test data not utilized for model build-
ing [8].
In this work, we have carried out an in-depth performance evaluation of SVR models for
potency prediction beyond standard statistics. SVR models were derived for a variety of data
sets with different SAR characteristics and systematically analyzed for their ability to predict
compound potency values and vulnerability to over- or underfitting potency data. Further-
more, SVR model regularization terms were systematically varied to balance model complexity
and permitted training errors in different ways. For all data sets, activity landscapes [17] were
generated from experimental measurements and compared to landscape representations de-
rived on the basis of SVR predictions. Although SVR models were generally statistically sound
due to accurate predictions of many intermediate potency values, the models were affected by
underfitting and consistently inaccurate predictions of the most potent compounds, leading to
a smoothing effect on modeled activity landscapes and loss of critical SAR information.
Materials and Methods
Compound data selection
From the public database ChEMBL [18], release 17, all sets of compounds active against
human targets were selected that contained at least 500 molecules. Furthermore, qualifying
compounds were required to be experimentally tested in a direct inhibition or binding assay
with highest ChEMBL confidence score. Only equilibrium constants (Ki values) below 100 μM
were considered, hence omitting weakly active compounds and assay-dependent measure-
ments. Multiple Ki values available for the same compound were averaged if they fell into the
same order of magnitude; otherwise, the compound was discarded. Furthermore, duplicates,
known pan-assay interference compounds [19], and other reactive molecules were removed
Support Vector Regression-Based Compound Potency Prediction
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from all data sets using in-house computational filters. On the basis of these stringent selection
criteria, 31 compounds sets with activities against diverse targets were obtained for SVR model-
ing, as summarized in Table 1. All data sets are freely available for download from the public
ZENODO platform [20].
Molecular representations
For all test compounds, two fingerprints were calculated as descriptors including molecular ac-
cess system (MACCS) keys [21] and the extended connectivity fingerprint with bond diameter
4 (ECFP4) [22]. MACCS is a fixed-length fingerprint consisting of 166 pre-defined substruc-
tural patterns and ECFP4 a topological atom environment fingerprint of higher chemical reso-
lution. ECFP generates all possible atom environments up to a layer of four bonds around each
Table 1. Data overview.
TID Target name no. of cpds. min.pKi max.pKi mean pKi
11 Thrombin 654 5.00 12.19 6.78
15 Carbonic anhydrase II 1221 5.00 9.41 6.97
51 Serotonin 1a (5-HT1a) receptor 1342 5.05 10.85 7.74
72 Dopamine D2 receptor 1791 5.00 10.24 6.97
87 Cannabinoid CB1 receptor 1661 5.00 10.10 6.92
100 Norepinephrine transporter 928 5.03 9.66 6.94
107 Serotonin 2a (5-HT2a) receptor 824 5.01 11.00 7.54
108 Serotonin 2c (5-HT2c) receptor 577 5.00 9.70 7.01
114 Adenosine A1 receptor 1911 5.01 10.52 6.61
121 Serotonin transporter 1229 5.02 10.89 7.44
129 Mu opioid receptor 1504 5.01 11.80 7.45
130 Dopamine D3 receptor 1142 5.05 10.05 7.37
136 Delta opioid receptor 1203 5.01 10.60 7.19
137 Kappa opioid receptor 1399 5.02 11.52 7.50
138 Nociceptin receptor 642 5.04 10.70 7.84
155 Dopamine transporter 745 5.04 9.80 6.70
165 HERG 701 5.00 9.26 6.14
176 Purinergic receptor P2Y12 536 5.36 9.40 7.81
194 Coagulation factor X 1129 5.02 11.40 8.05
252 Adenosine A2a receptor 2189 5.01 11.09 6.91
259 Cannabinoid CB2 receptor 1841 5.00 10.40 7.17
278 Adenosine A2b receptor 856 5.05 9.80 7.31
280 Adenosine A3 receptor 1766 5.02 10.56 7.20
10142 Melanocortin receptor 4 1199 5.01 9.40 6.96
10193 Carbonic anhydrase I 1134 5.00 10.68 6.33
10280 Histamine H3 receptor 1861 5.04 10.50 7.95
10627 Serotonin 6 (5-HT6) receptor 1157 5.06 10.30 7.76
11290 Histamine H4 receptor 596 5.04 10.40 7.08
12209 Carbonic anhydrase XII 717 5.00 9.52 7.24
12952 Carbonic anhydrase IX 1033 5.01 9.92 7.07
19905 Melanin-concentrating hormone receptor 1 701 5.03 9.77 7.42
For all 31 data sets used for SVR modeling, the ChEMBL target ID (TID), target name, number of compounds, and the minimum, maximum, and mean pKi
values are reported.
doi:10.1371/journal.pone.0119301.t001
Support Vector Regression-Based Compound Potency Prediction
PLOS ONE | DOI:10.1371/journal.pone.0119301 March 5, 2015 3 / 18
atom. The resulting atom environments represent a feature set of data-specific size. Both fin-
gerprint representations were calculated using in-house implementations based upon Open-
Eye’s OEChem toolkit [23].
SAR information content
The SAR characteristics of the 31 compound data sets used for SVR modeling were quantita-
tively described using the continuity and discontinuity score components of the SAR Index
(SARI) [24]. For all data sets, initial scores were calculated as follows:
contraw ¼ 1
X
i>j
wijTcði; jÞ
X
i>j
wij
ð1Þ
discraw ¼
X
fi;jjTcði;jÞt;i>jg
jpotðiÞ  potðjÞjTcði; jÞ
jfi; jjTcði; jÞ  t; i > jgj ð2Þ
Here, the Tc(i,j) is the Tanimoto coefficient [25,26] of ligands i and j, wij is a weight defined
as potðiÞpotðjÞ
1þjpotðiÞpotðjÞj, and pot(i) is the potency of compound i as pKi value [24]. For the discontinuity
score, we used corresponding Tc similarity threshold values of t = 0.85 for MACCS and
t = 0.56 for ECFP4 [27]. Raw scores were then converted into Z-scores and normalized using
the cumulative normal distribution. For this purpose, 120 compound data sets containing at
least 100 compounds each were extracted from ChEMBL on the basis of the selection criteria
specified above and used as an external reference panel.
Activity landscapes
In chemoinformatics and medicinal chemistry, activity landscapes of compound data sets are
generally defined as graphical representations that integrate molecular similarity and activity
relationships between compounds [17]. In addition to numerical SAR characterization, three-
dimensional (3D) activity landscape views [28] were calculated for all compound data sets sub-
jected to SVR modeling. The 3D activity landscape representation was calculated as described
previously based upon a two-dimensional (2D) projection of all pairwise Tc values for a com-
pound set using multi-dimensional scaling [28]. This projection provides a 2D similarity map
that is then complemented by an activity surface interpolated from compound potency values.
The potency surface is then added to the projection, yielding a 3D activity landscape represen-
tation reminiscent of geographical landscape views.
Support vector regression modeling
Support vector regression theory. Support vector regression (SVR) is a supervised ma-
chine learning method for the prediction of numerical target values [6,7]. For training, labeled
examples are mapped into a descriptor space and a function of the form
f ðxÞ ¼ hw; xi þ b ð3Þ
is derived that best predicts the target values for the examples x. The parameters w,b are
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derived via the following optimization:
min
1
2
kwk2 þ C
Xn
i¼1
ðxi þ xi Þ
subject to f yi  hw; xii  b  ϵþ xihw; xii þ b yi  ϵþ xi
xi; x

i  0
ð4Þ
This concept is derived from support vector machines (SVMs), which were introduced for
binary classification tasks. While SVMs attempt to maximize the margin between two classes,
SVR derives a so-called ε-insensitive tube around the target values [7]. The width of this tube,
ε, provides the amount of permitted error, i.e., target values that are mispredicted by less than
ε are not penalized by the optimization. Training examples that are predicted with a deviation
of more than ε from their true target value fall outside the tube and are called support vectors.
Furthermore, ξi ξi in formula (4) are sets of non-negative slack variables permitting a cer-
tain violation of the ε-tube’s bounds [29]. The regularization term C balances the cost of a com-
plex model with the cost of training errors: if C is large, training errors are strongly penalized
and the derived model is highly complex, thus entailing a risk of data overfitting. In contrast, if
the regularization term is small, low-complexity models are favored at the risk of underfitting.
In the linear case, the vector w can be written as a weighted combination of the support vec-
tors:
w ¼
X
i
ðai  ai Þxi ð5Þ
Hence, the prediction function can be expressed as:
f ðxÞ ¼
X
i
ðai  ai Þhxi; xi þ b ð6Þ
Importantly, if a linear regression modeling of the training data in the given space is not possi-
ble, the scalar product h,i can be replaced by a kernel function K(u,v) to project the data into
higher dimensional space in which a linear separation becomes feasible, in analogy to SVMs.
This procedure is generally referred to as the kernel trick [30]. If the kernel trick is applied, the
weight vector w can no longer be directly expressed and the prediction function changes to:
f ðxÞ ¼
X
i
ðai  ai ÞKðxi; xÞ þ b ð7Þ
In analogy to Tc-based similarity calculations, the Tanimoto kernel [31] is often used as a ker-
nel function for compound potency prediction:
Kðu; vÞ ¼ hu; vihu; ui þ hv; vi  hu; vi ð8Þ
Performance analysis. To assess the overall performance of the SVR modeling, we have
calculated absolute errors, mean absolute errors, and R2 values. According to equation (9), the
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absolute error was defined as given by the objective function:
Xn
i¼1
ðxi þ xi Þ ¼
Xn
i¼1
maxð0; jyi  f ðxiÞj  ϵÞ ð9Þ
While this is not the standard formula for the absolute error, it reflects the training of the mod-
els with a certain amount of permitted deviation. This value was used to determine the best reg-
ularization term for each model, provided by the value for C that resulted in the lowest
absolute error on the test set.
The mean absolute error is given as the absolute error divided by n, the number of com-
pounds. Furthermore, coefficients of determination (R2) values were computed. R2 quantifies
how much of the data variance can be explained by the model.
Calculation set-up
For each data set, 55 different SVR models were trained with C varying in {1, 2, 3. . ., 50, 100,
250, 500, 1000}. Hence, these models covered a wide range of regularization parameters en-
abling the analysis of potential under- and overfitting effects. All SVR models were derived
using the freely available Python implementation scikit-learn [32] with parameter setting
ε = 0.1. We have kept the parameter ε constant instead of optimizing it considering the nature
of the data. Because target values were pKi values (which are well-defined) setting ε to values
smaller than 0.1 would be beyond experimental detection limits. Moreover, variations of larger
values are also not meaningful because deviations of close to one order of magnitude or more
are biologically relevant and should not be treated as allowed deviations. For each of the 55 dif-
ferent C settings, 10 models were built with randomly chosen training and test sets, each com-
prising of 50% of the data (yielding a total of 550 models per set). In each case, prediction
performance was averaged over all 10 independently derived models.
Results and Discussion
Regularization analysis
Initially, the effects of regularization term variations on SVR model performance were evaluat-
ed in detail. Therefore, the mean training and test errors over all individual trials were deter-
mined for each setting of C. Because this regularization parameter balances model complexity
and permitted training errors, its variation makes it possible to elucidate the tendency of over-
or underfitting of the models. For small values of C, both training and test errors are typically
high, which then provides a clear indication of underfitting. Increasing values of C should then
lead to a decrease in training and test error, indicating a better fit of a model. The application
of increasingly large values of C values typically leads to increasing test errors in the presence
of constant or further decreased training errors, which indicates overfitting of a model.
On the basis of these general considerations, the value of C yielding the smallest test error
was selected as the preferred regularization term for each data set / fingerprint combination.
Table 2 reports the preferred values for all data sets and fingerprints. The performance of the
resulting models is further discussed in the following. It should be noted that in benchmark
studies, parameters are typically evaluated on an external validation set, while performance val-
ues are reported on a distinct test set. However, in this study, we have not aimed to benchmark
SVR models and deliberately introduced a positive bias towards model performance to empha-
size the consistently observed failure in correctly predicting the most important compounds, as
further discussed below. In our regularization analysis, consistent trends were observed across
all data sets. Fig. 1 reports the mean training and test errors under regularization term variation
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for an exemplary data set (melanocortin receptor 4 antagonists, TID 10142), which mirrors the
observed trends. First, both training and test errors were consistently higher for MACCS- than
for ECFP4-based models. As a consequence, effects of underfitting and, in part, overfitting de-
pending on the choice of C were clearly observed for MACCS but to a much lesser extent, if at
all, for ECFP4. The training error of the ECFP4 model reached its minimum of 0.0165 already
at C = 19, while the training error of the MACCS model continued to steadily decrease for in-
creasing values of C. However, for both models, the test error essentially remained constant
over most regularization term settings. Only for the highest C values, an overfitting effect be-
came apparent for MACCS. This was in contrast to the ECFP4 model that did not reveal an ap-
parent overfit at any point. Moreover, regardless of the data set and molecular representation
used, the difference between training and test errors was consistently large. These results
Table 2. Best regularization values.
TID MACCS ECFP4
11 23 8
15 10 3
51 17 3
72 7 5
87 8 3
100 6 2
107 7 3
108 7 3
114 11 4
121 9 4
129 16 7
130 9 7
136 12 4
137 14 3
138 6 3
155 7 3
165 9 3
176 12 2
194 11 5
252 14 4
259 9 4
278 9 3
280 27 6
10142 18 6
10193 11 2
10280 14 4
10627 12 3
11290 16 5
12209 16 5
12952 14 4
19905 5 6
Reported are the values of the regularization parameter C yielding the lowest test error for each data set
and fingerprint representation.
doi:10.1371/journal.pone.0119301.t002
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revealed that the SVR models in combination with a suitable high-dimensional representation
(i.e., ECFP4 instead of MACCS) did not display a notable tendency of overfitting, which often
severely affects QSAR modeling [8]. By contrast, underfitting of SVR models was observed for
low regularization terms.
Fig 1. Exemplary regularization profile. For each value of the regularization term C, the absolute training and test error averaged over all trials is reported
for data set TID 10280. Error bars give the standard deviations. Regularization values are plotted evenly on the x axis, regardless of their magnitude.
doi:10.1371/journal.pone.0119301.g001
Support Vector Regression-Based Compound Potency Prediction
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Regression performance
We next determined global regression accuracy of the SVR models on the basis of R2 values
and mean absolute errors calculated on the test set. Therefore, for each data set, the overall best
performing model identifed under systematic variation of regularization parameter C was se-
lected. R2 values and mean absolute errors of these models are shown in Fig. 2. For all data sets,
the performance using MACCS was lower than for the higher-resolution topological ECFP4
fingerprint. MACCS-based models also required generally higher regularization term values
than ECFP4-based models (Table 2). Overall, R2 values ranged from 0.31 and 0.65 (MACCS)
and from 0.44 and 0.75 (ECFP4). Hence, these values were of moderate magnitude. However,
mean prediction errors were generally low and fell into the pKi value intervals [0.32, 0.57] and
[0.26, 0.50] for MACCS and ECFP4, respectively. Thus, compound potencies were generally
predicted well within an order of magnitude, which is considered encouraging accuracy from a
QSAR perspective. Of course, the most interesting test compounds for prediction across large
data sets were those with high potency. However, prediction results for individual compounds
cannot be rationalized on the basis of average errors. Therefore, alternative measures were ap-
plied to evaluate the quality of the SVR predictions for potent compounds, as discussed in
the following.
SAR characteristics and predictive performance
SAR continuity and discontinuity scores were calculated for all data sets to characterize their
global SAR information and relate these SAR characteristics to SVR model performance. High
discontinuity scores indicate the presence of many structurally similar compounds with large
potency variations, whereas high continuity scores account for the presence of structurally sim-
ilar or dissimilar compounds with small to moderate variations in potency [24]. Activity cliffs,
which consist of pairs or groups of structurally analogous compounds with largest differences
in potency, represent the extreme form of SAR discontinuity in a data set [33]. They also repre-
sent the most prominent and informative features of activity landscapes [17]. In large and
structurally heterogeneous data sets, as investigated herein, continuous and discontinuous SAR
environments typically coexist and determine the global SAR phenotype [17,24].
To evaluate if differences in SAR characteristics influenced the fit of SVR models, the corre-
lation of continuity / discontinuity scores and test errors was assessed. To render test errors in-
dependent of data set size, the mean error over all test compounds was determined and the
Pearson product-moment correlation coefficient between SAR scores and the mean error was
calculated. In addition, a two-tailed p-value was determined to assess the statistical significance
of correlation effects. These calculations revealed no notable correlation between the SAR con-
tinuity score and the prediction error, but a statistically significant correlation (p< 0.01) be-
tween the discontinuity score and the prediction error. The corresponding Pearson correlation
coefficient was 0.75 for MACCS and 0.61 for ECFP4, which indicated the presence of a moder-
ate positive correlation between the discontinuity scores and the mean test error. Thus, the
more discontinuous a data set was at the global SAR level, the higher was the prediction error.
In Fig. 3, the discontinuity scores of all data sets are plotted against their mean test errors,
which reflects this trend.
SVR-based reproducibility of SAR characteristics
Discontinuity scores based on predicted potency values. To further evaluate the findings
discussed above, we recalculated continuity and discontinuity scores on the basis of potency
values predicted for all training and test set compounds. The predicted training set continuity /
discontinuity was calculated on the basis of potency predictions for training set compounds
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and provides an estimate of the influence of the training error and model fit on SAR character-
istics. In contrast, the predicted test set continuity / discontinuity was calculated based on test
set potency predictions and reflects the generalization ability of the model and its influence on
prediction accuracy. Furthermore, in the following, observed continuity / discontinuity refers
Fig 2. Global regression performance. Reported are the mean R2 and mean absolute error values for each data set and fingerprint, determined on the test
set. Error bars give the standard deviations.
doi:10.1371/journal.pone.0119301.g002
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PLOS ONE | DOI:10.1371/journal.pone.0119301 March 5, 2015 10 / 18
to the respective scores calculated on the basis of experimental potency values. For score calcu-
lations on the basis of predicted values, the mean predicted potency of each test and training
set compound was determined over all trials. The few compounds that never occurred in any
of the randomly selected training or test sets were assigned their observed potency value.
Fig. 4 reports the comparison of predicted and observed SAR scores. Observed continuity
scores of all data sets were almost perfectly reproduced (Fig. 4a). By contrast, predicted discon-
tinuity scores were consistently and significantly lower than observed scores (Fig. 4b). For both
MACCS and ECFP4, predicted test set discontinuity scores were very low (mostly below 0.1).
The predicted training set scores were only slightly higher for MACCS, but substantially higher
Fig 3. SAR discontinuity vs. SVR error. For each data set and fingerprint, the global discontinuity score is plotted against the mean absolute error of the
SVRmodel, determined on the test set. Prediction errors display the tendency to increase with increasing discontinuity scores.
doi:10.1371/journal.pone.0119301.g003
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Fig 4. Observed vs. predicted SAR characteristics. The observed global (a) continuity and (b) discontinuity score of each data set and fingerprint is
plotted against the predicted training set (red) and test set (blue) value (blue and red data points are placed in the fore- and background, respectively).
doi:10.1371/journal.pone.0119301.g004
Support Vector Regression-Based Compound Potency Prediction
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for ECFP4. Nevertheless, even for ECFP4, scores for training set compounds were
consistently underpredicted.
Limited generalization ability in discontinuous SAR regions. The comparison of pre-
dicted training and test set continuity scores showed that the SVR models fit continuous train-
ing data subsets very well and were generalizable for yielding high-quality potency prediction
on continuous test data. In contrast, the comparison of predicted training and test set disconti-
nuity scores indicated that only the ECFP4-based models partly fit discontinuous training data,
but did not generalize well for potency predictions on test compounds in discontinuous SAR
environments. Thus, SAR characteristics substantially influenced the quality of SVR-based pre-
dictions. Potency patterns in discontinuous SAR regions were generally difficult to predict.
Influence of regularization on discontinuity scores. In light of these findings, we also ex-
amined how the choice of the regularization term C influenced the magnitude of discontinuity
scores based upon predicted potency values. Fig. 5 reports the discontinuity scores calculated
on the basis of predicted test and training set potencies plotted against the regularization term
for an exemplary data set (adenosine A3 receptor antagonists, TID 280). The horizontal black
line denotes the observed discontinuity score calculated from the experimental potency values.
Although observed discontinuity scores varied for all data sets, the trends in Fig. 5 were consis-
tently detected. Discontinuity scores calculated with MACCS based upon predicted potencies
gradually increased with increasing C values (consistent with the observation that training er-
rors decreased with increasing C, as discussed above). In this case, the largest regularization
terms yielded highest (albeit still substantially underpredicted) discontinuity scores. By con-
trast, for ECFP4, the discontinuity scores rapidly increased for small C values and then essen-
tially remained constant, with much higher scores achieved on the basis of predicted training
set than test set potency values.
Plausible rationale for potency prediction errors. Taking into consideration that the reg-
ularization term balances SVR model complexity with the amount of permitted training errors,
we reasoned that the consistent underestimation of discontinuity scores might result from in-
correctly predicted potency values in activity cliff regions, for the following reasons: Activity
cliffs are generally rare in compound data sets involving on average only ~20% of active com-
pounds [33]. Moreover, because activity cliffs consist of pairs of structurally analogous com-
pounds with largest potency difference in a data set, only a small percentage of highly potent
compounds (at most ~10%, but in practice often less [33]) is responsible for their formation. If
training errors are permitted for these highly potent compounds, the SVR algorithm is ex-
pected to produce an easy to derive, low-complexity model yielding overall accurate predic-
tions for many active compounds in low or intermediate potency ranges. This hypothesis is
fully consistent with the regularization profile of ECFP4 reported in Fig. 5, which showed that
a stable prediction model was obtained for small values of C, permitting training errors and a
limited underfit of the model for the benefit of enabling low-complexity predictions.
SVRmodeling effects on activity landscapes
In order to evaluate the hypothesis formulated above, we generated 3D activity landscapes [28]
for our data sets on the basis of experimental potency values and compared them to corre-
sponding landscapes generated on the basis of potency values predicted for the test sets. Since
essentially all data set compounds with only few exceptions occurred multiple times (or at least
once) in training and test sets (see Methods), these landscape views had conserved topology
and could thus be directly compared. Fig. 6 shows ECFP4-based activity landscape compari-
sons for two exemplary data sets that illustrate consistently detected effects. These data sets and
their observed landscapes were characterized by medium to high degrees of discontinuity
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Fig 5. Exemplary discontinuity score profile. For each value of the regularization term C, the discontinuity score resulting from the predicted training and
test set potency values is reported for data set TID 280. The black line denotes the observed discontinuity score of the data set. Regularization values are
evenly spaced on the horizontal axis, regardless of their magnitude.
doi:10.1371/journal.pone.0119301.g005
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Fig 6. Observed and predicted activity landscapes. For two representative data sets, observed and predicted 3D activity landscape representations are
compared and corresponding continuity and discontinuity scores are reported. Landscape surface elevation correlates with increasing potency. The activity
landscape views are represented applying a continuous spectrum from blue to red spanning a potency range of (a) 5 to 10 pKi (TID 100) and (b) 5 to 13 pKi
(TID 11). Hence, the positions of the most potent compounds in the landscapes are colored red.
doi:10.1371/journal.pone.0119301.g006
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(resulting from pairwise potency relationship contributions of similar data set compounds).
Rugged regions in the original landscapes delineate centers of SAR discontinuity where yellow-
to-red peaks represent most potent data set compounds involved in the formation of activity
cliffs with weakly potent structural analogs. In addition, blue valleys or blue-to-yellow plateaus
in these landscapes delineate continuous SAR regions. Comparing the observed and predicted
activity landscapes, major “smoothing” effects became apparent: In the predicted landscapes,
the most prominent peaks in the original landscapes disappeared and rugged regions were flat-
tened, consistent with the underprediction of SAR discontinuity. Artificial smoothing of activi-
ty landscapes directly resulted from incorrect predictions for the small proportion of highly
potent compounds. For these compounds, much too low potency values were predicted by the
SVR models and, consequently, the activity cliffs they formed were no longer detectable. Thus,
consistent with conclusions drawn from SVR vs. SAR analysis, mispredictions of the most po-
tent dataset compounds were the price to pay for obtaining statistically sound SVR models that
yielded accurate predictions for the weakly to moderately potent data set compounds.
Conclusions
In this study, we have analyzed in detail the use of SVR models for compound potency predic-
tion, which represents an increasingly popular QSAR strategy. A major attraction of the SVR
approach and other kernel methods are their principal ability to account for non-linear SARs,
which sets them apart from classical QSAR methods and enables potency predictions for struc-
turally heterogeneous data sets on a large scale. In order to better understand intrinsic features,
opportunities, and limitations of these SVR models, we have systematically analyzed general re-
gression metrics (such as coefficients of determination and error values), model regularization,
SAR characteristics, and observed vs. predicted activity landscapes. On the basis of our analysis,
a detailed picture of SVR model performance has been obtained, providing a number of impli-
cations for practical applications.
For the wide spectrum of high-quality compound data sets with different SAR characteris-
tics we investigated, SVR models with overall low prediction errors were obtained, without sub-
jective intervention. For the majority of compounds across all data sets, potency values were
correctly predicted within an order of magnitude, which is in accord with state-of-the-art
QSAR standards and within the range of experimental assay variations. These findings provide
general support for SVR modeling, consistent with a number of previous studies. We also
found that SVR model performance was substantially influenced by the use of alternative mo-
lecular representations, which is a known conundrum of machine learning applications
in chemoinformatics.
However, our detailed investigation of SVR model performance also yielded a number of
new insights, pointing at critical issues that should merit careful consideration. For example,
on the basis of regularization parameter analysis, SVR models were robust against data overfit-
ting (consistently stable models were obtained for ECFP4), but generally vulnerable to under-
fitting. Furthermore, prediction errors were statistically correlated with increasing global SAR
discontinuity of compound data sets. In light of these observations, we carefully examined SVR
predictions and identified systematic errors in the prediction of highly potent compounds.
Even with proper model regularization and a suitable molecular representation such as ECFP4,
only highly potent training set compounds could be predicted approaching acceptable accuracy
(cf. Fig. 5; only the discontinuity scores calculated on predicted training set potencies approach
the true data set discontinuity). By contrast, the SVR models lacked the generalization ability
to extrapolate from training data to new discontinuous test data and essentially failed to cor-
rectly predict high potency values for test compounds. These findings were rationalized by the
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intrinsic feature of the SVR algorithm to strive for a balance between acceptable training error
margins and model complexity. Because highly potent compounds typically represent only a
small proportion of a data set, prediction errors can be algorithmically tolerated in these in-
stances to derive a model that is of limited computational complexity but yields sufficiently ac-
curate predictions for the majority of data set compounds. However, for QSAR applications,
systematic errors in predicting highly potent compounds are a severe limitation, because such
compounds represent prime prediction targets.
When comparing activity landscapes of data sets based upon experimental potency mea-
surements with landscapes generated on the basis of SVR potency predictions, we found that
prominent activity cliffs were eliminated by consistently predicting artificially low potency val-
ues for highly potent cliff compounds. Thus, SVR-based prediction of activity landscapes re-
sulted in a substantial loss of SAR information. This also meant that the SVM paradigm of
nonlinearity, albeit enabling meaningful predictions for structurally heterogeneous data sets as
a whole, did not apply to modeling regions of high local SAR discontinuity formed by structur-
al analogs with large potency variations, indicating a principal limitation of the approach.
In summary, our analysis has revealed that care must be taken when utilizing SVR for SAR/
QSAR applications, despite promising SVR potency prediction statistics for many different
compound data sets. For practical applications, the consistently incorrect prediction of highly
potent compounds identified in our analysis represents a likely problem, because most attrac-
tive (highly potent) candidate compounds might be missed. However, these issues also present
attractive opportunities for future method development, for example, the design of algorithmic
SVR variants that would penalize prediction errors in most attractive property ranges.
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Summary
In this study, we have investigated the quantitative and qualitative performance of SVR
models for compound potency prediction. While their global performance in terms of
R2 scores was acceptable, we found several limiting factors for the quality of the models.
First, our analysis revealed a correlation between mean absolute error of the models
and discontinuity score of the data sets. It seems to be intuitive that compound data sets
with higher discontinuity scores are harder to model by computational means; however,
kernelized methods are often portrayed as able to deal with any kind of nonlinearity
or discontinuity, which they are obviously not. The dependency of potency modeling
success on SAR discontinuity has to our best knowledge not been shown before.
Second, we showed that while global data set continuity of varying magnitude could
be well preserved by regression modeling, discontinuity was constantly underpredicted.
This effect cannot simply be attributed to a poor regularization choice, as our analysis
clearly showed. It rather originated from the fact that high discontinuity is caused by
few highly potent compounds in the chemical neighborhood of many intermediate or
weakly potent ones. As a global optimization algorithm, SVR seeks to minimize the
overall training error, leading to a constant underprediction of highly potent ligands.
While this can be the desirable behavior in a number of application scenarios, it clearly
is not for potency prediction in the lead optimization stage. Here, one is interested most
in the few highly potent compounds and their neighboring SAR regions, as they serve
as focal points for SAR analysis.
In summary, our findings implicate that care must be taken when SVR models are
applied for the prediction of compound potency. Beyond global statistics, it is important
to build models that generalize well on interesting local regions. This could be achieved
by modifying optimization error functions or building discontinuity-sensitive kernels. We
hope that our study can contribute to a higher awareness of the problem of mispredictions
in underrepresented, yet important, SAR regions.
As this chapter has shown, not only the overall performance of an LBVS model is
of interest. It is also important to understand the algorithmic procedures to be able
to identify and circumvent possible mispredictions. Hence, the next part of this thesis
deals with the interpretation of prediction models. In the upcoming chapters, two intu-
itive methods for the analysis and interpretation of na¨ıve Bayes and SVM models are
introduced.
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Part III
Interpretation of Predictors for
Virtual Screening
97
98
5
Introduction of a Methodology for
Visualization and Graphical
Interpretation of Bayesian
Classification Models
Introduction
In the last chapter, we have used 3D activity landscapes to visualize predictions and
qualitatively compare observed and predicted SAR characteristics. For SAR analysis,
many visualization methods have been developed to provide an intuitive assessment for
data analysis and augment quantitative methods. However, not much effort has been
put into an analogously intuitive assessment of machine learning models. The next
study addresses this issue by introducing a visualization method for na¨ıve Bayes classi-
fication models. As such, it presents both models and individual predictions made using
na¨ıve Bayes classifiers in a directly accessible way. The abstract model and prediction
visualizations aim to bridge the gap between statistical analysis, which is carried out
by the machine learning expert, and the ligand-centric view of the medicinal chemist.
While statistical analysis is used to create the interactive visualization, the prediction
visualization can be transferred into a weight mapping onto the molecular graph.
Reprinted with permission from
Balfer, J.; Bajorath, J. Introduction of a Methodology for Visualization and Graph-
ical Interpretation of Bayesian Classification Models. J. Chem. Inf. Model. 2014,
54, 2451–2468.
Copyright 2014 American Chemical Society.
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Introduction of a Methodology for Visualization and Graphical
Interpretation of Bayesian Classification Models
Jenny Balfer and Jürgen Bajorath*
Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische
Friedrich-Wilhelms-Universitaẗ, Dahlmannstrasse 2, D-53113 Bonn, Germany
ABSTRACT: Supervised machine learning models are widely used in chemoinformatics,
especially for the prediction of new active compounds or targets of known actives. Bayesian
classification methods are among the most popular machine learning approaches for the
prediction of activity from chemical structure. Much work has focused on predicting
structure−activity relationships (SARs) on the basis of experimental training data. By
contrast, only a few efforts have thus far been made to rationalize the performance of
Bayesian or other supervised machine learning models and better understand why they
might succeed or fail. In this study, we introduce an intuitive approach for the visualization
and graphical interpretation of naïve Bayesian classification models. Parameters derived
during supervised learning are visualized and interactively analyzed to gain insights into
model performance and identify features that determine predictions. The methodology is
introduced in detail and applied to assess Bayesian modeling efforts and predictions on
compound data sets of varying structural complexity. Different classification models and
features determining their performance are characterized in detail. A prototypic
implementation of the approach is provided.
■ INTRODUCTION
Machine learning models are used for a variety of applications in
chemoinformatics including, for instance, the prediction of
compound activity and other molecular properties or biological
targets of known actives.1−3 When a set of known positive
(active) and negative (inactive) training compounds is available,
supervised machine learning is an approach of choice for building
predictive models of activity.1,2 In the chemoinformatics
community, the currently most frequently applied supervised
machine learning methods include random forests, support
vector machines, and Bayesian classifiers.1,2 Random forest
models utilize ensembles of decision trees to arrive at consensus
predictions, support vector machines derive separating hyper-
planes for class label prediction in feature spaces of increasing
dimensionality, and Bayesian classifiers are probabilistic models
based upon Bayes theorem.
In general, supervised learning is used to build complexmodels
from training data that go beyond the derivation of simple rules
to determine a classification outcome. Model building requires
the definition of a suitable molecular descriptor space for
classification and the selection of preferredmodels on the basis of
preset performance criteria. If sufficient training data is available
and meaningful reference (feature) spaces can be generated,
effective models can often be derived for a variety of classification
or regression tasks.4−7
Areas in which supervised learning is applied can roughly be
divided into those in which a computer should learn a concept
that is intuitively known to humans as opposed to those where
the concept itself is not fully understood by human experts. An
example for the first area is image classification. Humans can
usually identify and distinguish different objects in images. Yet,
successful recognition is the result of very complex reasoning
and neural functions, which cannot be easily transferred to a
computer.8 Hence, supervised classification is applied in such
situations to let the computer “learn” the concept from examples.
However, many chemoinformatics problems fall into the second
area mentioned above. For example, even an experienced
medicinal chemist can typically not predict the activity of given
compounds against biological targets in a consistent manner and
without error. Thus, much research is dedicated to rationalizing
and predicting structure−activity relationships (SAR)9−11 as
there are no generally applicable rules governing compound-
target interactions that could be consistently applied. Even in the
presence of significant amounts of experimental data, the exact
mechanism of compound-target interactions is often difficult to
determine.12 Therefore, if a machine learning model for activity
prediction can be derived, it should be important to understand
the characteristics of the model that determine its decisions.
However, this is in general difficult to accomplish. Clearly,
obtaining such insights would help to reduce or eliminate the
well-known “black box” character of many machine learning
approaches, which often limits their utility. In interdisciplinary
research, gaining insights into the mechanisms by which
computer models function is often a prerequisite of their
acceptance and for the willingness to build experimental projects
around predictions. Hence, the importance of chemical inter-
pretability of machine learning models and their predictions
should not be underestimated.
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Molecular feature spaces used in chemoinformatics are
typically large and high-dimensional, as millions of biologically
relevant compounds and thousands of chemical descriptors are
available.13 For the navigation of such feature spaces and
property prediction, naïve Bayesian classifiers are often
applied.14−25 Their popularity can be attributed to their relatively
simplistic design, the ability to efficiently operate on large and
high-dimensional data sets, and their limited sensitivity to data
noise; an important aspect for chemoinformatics applica-
tions.14,15 In recent years, naïve Bayesian classifiers have been
applied to identify therapeutically relevant targets16 as well as
novel active compounds for given targets,17−20 further improve
docking scores,15,21−23 or predict absorption, distribution,
metabolism, and excretion (ADME) properties24 and multidrug
resistance reversal activity.25 For such studies, compounds have
mostly been represented using binary fingerprints.14−20,26
Although a number of successful naïve Bayesian models have
been reported, only very few studies have thus far attempted to
address the question how exactly these models work and why
they might succeed or fail. As Klon et al. point out in their study
to predict ADME properties, “understanding why a compound
has undesirable ADME characteristics is just as important as
knowing that it does”.24 These authors have also aimed to
rationalize their classification models. For instance, it was
attempted to explain the success of a naïve Bayesian classifier
in enriching favorable docking scores by training alternative
models on only subsets of features from preferred models.21
Other investigators have addressed the interpretability issue by
using intuitive molecular representations such as chemical
fragment descriptors19 or by focusing on specific compounds
whose activity could only be predicted using naïve Bayesian
classification or other machine learning approaches.27
In this study, we introduce an intuitive approach for the
visualization and graphical interpretation of naïve Bayesian
classification models. Previous work on graphical interpretation
of machine learning models has primarily focused on depicting
features in heat maps28 or similarity maps29 that are important for
prediction of individual molecules. The methodology introduced
herein also enables the assessment of individual predictions but
goes far beyond the analysis of single compounds by providing a
visualization scheme for an entire classification model. Further-
more, it also reveals the contributions of features that are absent in
test compounds.
■ CONCEPTS AND METHODS
Naïve Bayesian classification.The naïve Bayesian classifier
makes use of Bayes’ theorem to predict the probability P(y|x) of
an instance x to belong to class y:30
| = |P y x P x y P y
P x
( )
( ) ( )
( ) (1)
It is called naïve because it assumes all features xd in x to be
independent of each other;31 applying this feature independence
assumption, eq 1 can be rewritten as
| =
∏ |
∏
P y x
P x y P y
P x
( )
( ) ( )
( )
d d
d d (2)
To build a naïve Bayesian model, a training set of labeled
instances with different class labels is utilized for supervised
learning. Although there are no principal assumptions concern-
ing the nature of x and y, one often focuses on binary features and
class labels, i.e., x,y∈{0,1}, for example, “active” vs “inactive”. In
this case, given a set of n training instances X and corresponding
labels Y, the terms required for naïve Bayesian classification can
be estimated as follows:30
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Here, δij is the Kronecker delta function, which is 1 for i = j and 0
otherwise. The notations x(i) and y(i) refer to the i’th training
instance and label, respectively. The term α is a Laplacian
smoothing factor used to prevent the introduction of ill-defined
probabilities, e.g., if a feature is never set in the training data.
Since both class labels y and features xd are binary, we can infer
= | = ̂ = − = | = ̂P x y y P x y y( 0 ) 1 ( 1 )d d (5)
= = − =P y P y( 0) 1 ( 1) (6)
Figure 1. Motivating example. Shown is a theoretical “minimalist”
example of a training and test set for supervised classification,
represented as binary features. Blue squares indicate that a feature is
set and white squares that it is not set. (a) Six training examples are
given; three of which are positive, and the remaining three are negative.
(b) The test set contains two examples with unknown class labels.
Table 1. Estimated Parameters for a Naïve Bayesian Modela
d P(xd = 1|y = 0) P(xd = 1|y = 1) P(y = 1)
0 0.9688 0.9688
0.5
1 0.3438 0.9688
2 0.9688 0.3438
3 0.6562 0.3438
4 0.3438 0.0313
aReported are the conditional feature probabilities and the prior
probability for the model of the motivating example discussed in the
text.
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The meaning of these equations can be illustrated by a simple
example. Let us derive a naïve Bayesian model from a theoretical
training set of three positive and negative examples each, which
are each represented by five features, as illustrated in Figure 1a. In
the following, we refer to this example as the “motivating
example” because it can be used to illustrate the opportunities of
model visualization.
By applying eqs 3 and 4 and by setting α = 0.1, the probabilities
reported in Table 1 are obtained. Using eqs 5 and 6, all missing
probabilities are derived. One now can make predictions for test
Figure 2. Principles of model visualization. The model for the motivating example is visualized. Each point represents a feature, and the distance to the
pole corresponds to its absolute log odds ratio. Positive and negative influence on the classification is indicated by color coding and likelihood by size
scaling, as detailed in the text.
Table 2. Odds Ratios for a Naïve Bayesian Modela
d ORd log ORd
0 1.00 0.00
1 2.82 1.04
2 0.35 −1.04
3 0.52 −0.65
4 0.09 −2.40
aReported are the odds ratios of features x0−x4 in the model of the
motivating example. The closer the odds ratio of a given feature is to 1,
the smaller is its influence on the classification.
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instances such as z(0) and z(1) in Figure 1b. For each instance, we
can calculate the class likelihood P(z(i)|y = y)̂ and the evidence
P(z(i)) as follows:
∏
∏
∏
∏
∑ ∏
∑ ∏
| = = = | = =
| = = = | = =
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The posterior probabilities are then given as
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In this case, the positive class label would be predicted for the
first and the negative class label for the second test instance.
Model Interpretation. The motivating example discussed
above illustrates two important points: First, for classification, the
marginal probability P(z) is only used as a normalization factor
and can hence be omitted if knowledge of exact posterior
probabilities is not required. In fact, it has been shown that
successful naïve Bayesian classification models often produce
rather poor probability estimates.32 Given that exact probability
values are not required, the classification rule can be simplified:
= | = ̂ ̂
̂∈
y P x y y P yarg max ( ) ( )
y Y (7)
Second, prior class probabilities, which might be utilized to
incorporate user knowledge or a measure of data imbalance, are
relatively easy to interpret. However, estimated class likelihoods
mostly determine the classification decision. Each of the c class
likelihoods are a product of d conditional feature probabilities,
with c being the number of classes and d the number of
dimensions. Unfortunately, these probabilities cannot be easily
interpreted. This is the case because a high conditional feature
probability does not necessarily indicate that a given feature is
important for predicting a certain class and a low probability does
not always mean that the feature is irrelevant. For example, let us
consider feature x0 of the motivating example. It is set in all
instances, regardless of the class label, and thus has a high
conditional feature probability for both the positive and the
negative class. This feature provides no relevant information for
classification, and the same applies to features that are never (or
almost never) set in the training data, such as feature x4. On the
other hand, features x1 and x2 are always set in one of the classes
and only once in the respective other class. In this case, the
conditional feature probabilities of the active or inactive class,
respectively, are three times higher than of the other one, which
renders these two features highly descriptive.
A formal way to account for these feature probability
relationships is provided by the so-called “odds ratio” (OR) of
conditional probabilities:
= = | =
= | =
P x y
P x y
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( 1 1)
( 1 0)d
d
d (8)
The odds ratios for the motivating example are reported in
Table 2. The approach of considering the odds ratios is
theoretically established by rearranging the classification rule:
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Figure 3. Principles of prediction visualization. The prediction for test
instances (a) z(0) and (b) z(1) is visualized. Each bar represents the log
odds ratio of a given feature for the test instance. Their sum is reported
as a blue line and the difference between logarithmic prior probabilities
as a red line.
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The larger the odds ratio is, the higher is a feature’s influence
on the class likelihood; on the other hand, the smaller the odds
ratios are, the smaller the class likelihood becomes. The closer
the ratio is to 1, the less classification information is associated
with the feature. Because two features with ORi = x and ORj = 1/x
encode the same magnitude of classification information, a log
transformation is applied such that log ORi =−logORj (cf. Table 2;
in log space, features x1 and x2 have equal influence). The
absolute value of the log odds ratio can then be regarded as a
measure of an individual feature’s importance for a given
classification task. If it is negative, the presence of the feature is an
indicator of the negative class label; if it is positive, it is an
indicator of the positive class label.
Visualization. As rationalized in the previous section, a naïve
Bayesian model contains only two parameters that must be
learned for classification: the class prior probabilities (priors) and
the class likelihood. For binary classification, there are two class
priors that are related as follows:
= = − =P y P y( 0) 1 ( 1) (10)
However, there are four conditional probabilities for each
dimension (feature) of the input space. For each pair of
probabilities, eq 5 applies: P(xd = 0|y = y)̂ = 1 − P(xd = 1|y = y)̂.
If one would like to understand how a given model reaches a
decision, one has to consider the odds ratio of each dimension in
the input space.
Our primary goal is the visualization and interactive graphical
analysis of a naïve Bayesian classification model with Bernoulli
features. Formodel visualization, we introduce a scatter plot of its
input dimensions using polar coordinates. The area of the plot is
subdivided by features. Each point p = (r,θ) represents one
dimension of the input space. Its radius is determined by the
absolute value of its log odds ratio in the model, and the angles of
all points are evenly distributed over the interval [0,2π]. Hence,
the larger the distance between a point and the pole, the more
important it is for classification. Coloring distinguishes features
that indicate the positive class from features indicating the
negative class, i.e., features with a negative log odds ratio are
colored red and features with positive log odds ratio blue.
Furthermore, points in the plot are scaled in size according to
their maximum conditional probability for one of the classes:
= = | = = | =s P x y P x ymax{ ( 1 0), ( 1 1)}d d (11)
Therefore, it is possible to distinguish features occurring in
most of the examples in one class from those occurring only in a
few examples. The log odds ratio alone does not account for
these different frequencies of occurrence.
In Figure 2, the model for our motivating example is visualized.
It is evident that feature x4 mostly determines the prediction,
whereas features x1−x3 are less important and feature x0, which
maps to the pole, is not relevant. Furthermore, features x2−x4 (red)
support negative class label predictions, whereas x1 (blue) supports
positive class label predictions (given its positive log odds ratio).
In addition to global model visualization, it is also possible to
visualize and interpret individual predictions, which is relevant
for assessing unexpected predictions and for model refinement.
For prediction visualization, one can exploit the fact that an
instance obtains a positive class label if the following inequality
applies (cf. eq 9):
∏ | =| = >
=
=
P x y
P x y
P y
P y
( 1)
( 0)
( 0)
( 1)d
d
d (12)
This inequality can also be expressed in log space:
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Through the log transformation the product in eq 12 becomes
a sum. Accordingly, a single prediction can be represented in a
bar chart. In this chart, each bar represents a given feature, and
the difference between the conditional probability given the
active and inactive class is plotted. For model visualization, the
conditional probability P(xd = 1|y = y)̂ is utilized, as discussed
above. However, for prediction visualization, we use the actual
probability P(xd = zd|y = y)̂, with z being the example to be
predicted. In addition, the sum of log probabilities is reported by
a blue line and the sum of log priors by a red line. Hence, the final
classification decision can be visualized in combination with the
features that mostly influence the decision.
Figure 3 shows the prediction visualization for our motivating
example. The priors for both classes are constant, but the class
likelihood changes as a consequence of different input data. The
test instances z(0) and z(1) differ in dimensions x0, x1, and x3.
Because x0 has no impact on the classification (which can also be
inferred from model visualization in Figure 2), it is not shown in
Figure 3. For both instances, the fact that x2 is not set in the
training examples (Figure 1b) serves as an indicator for the
positive class (i.e., it results in a positive odds ratio of x2 in Figure 3),
whereas the presence of x4 is indicative of the negative class (i.e., it
results in a negative odds ratio of x4). Furthermore, features x1 and
x3 in z
(0) make small contributions to the overall class likelihood.
Taken together, these probabilities result in a positive class label
prediction for z(0). By contrast, in z(1), x1 is not set and x3 is set,
which results in a large negative contribution to the likelihood for x1
and a smaller negative contribution for x3. As a consequence, the
sum of log likelihoods falls below the sum of log priors. Accordingly,
for z(1), the negative class label is predicted.
■ MATERIALS AND PROTOCOLS
Compound Data Sets. Three compound data sets of
increasing complexity were used for Bayesian modeling and
visualization. These data sets included two sets from ChEMBL
(version 18),33 i.e., carbonic anhydrase I inhibitors (CAI) and
calcitonin gene-related peptide type 1 receptor ligands
(CGRPR), and, in addition, a set of ATP-site directed inhibitors
primarily focused on mitogen-activated protein kinase 14
Table 3. Compound Data Setsa
data set no. of compds no. of BMS no. of CSK
CAI 1306 407 179
MAPK14 (active) 265 86 45
MAPK14 (inactive) 164 80 45
CGRPR 305 133 78
aFor all three data sets, the number of compounds, unique Bemis-
Murcko scaffolds (BMS), and corresponding carbon skeletons (CSK)
is reported. For MAPK14, active and confirmed inactive compounds
are listed separately. The other two data sets only consist of active
compounds. In these cases, a random subset of ChEMBL was used as
inactive compounds (see text). Scaffolds were calculated using
OpenEye’s OEChem toolkit.40
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(MAPK14)34 originating from the ProQinase free choice
biochemical assay system.35 The composition of the data sets
is reported in Table 3.
Selected ChEMBL compounds were required to be tested in a
direct binding assay with a ChEMBL confidence score of 9.
Furthermore, only compounds were considered for which a Ki
value of less than 10 μMwas available. Using in-house scripts, all
candidate compounds were filtered for duplicates, undesired
reactive groups, and PAINS36 liabilities to arrive at a final
selection. From compounds in all three data sets, Bemis-Murcko
scaffolds (BMS)37 and corresponding carbon skeletons (CSK),38
in which all heteroatoms are converted to carbons and all
bond orders set to 1, were systematically extracted. Decreasing
compound-to-BMS and compound-to-CSK ratios generally
indicate increasing structural diversity.
The CAI set was selected because it contained small inhibitors
mostly sharing a sulfonamide group (992 of 1306 compounds),
which is a hallmark for carbonic anhydrase inhibition. Hence, in
this case, a defined chemical moiety was known to be a major
determinant of activity. This inhibitor set yielded 407 BMS, 179
CSK, and compound-to-BMS and -CSK ratios of 3.21 and 7.30,
respectively.
The MAPK14 set consisted of 429 ATP-site directed kinase
inhibitors, 265 of which inhibited the MAP14 kinase. Hence, the
remaining compounds were confirmed to be inactive against
this kinase (but, in part, active against other kinases). All 429
Table 4. Model Performancea
no. of training compds no. of test compds
data set active inactive active inactive precision recall F1-score
CAI 1044 8000 262 2000 0.5360 0.9084 0.6742
MAPK14 212 131 53 33 0.8200 0.7736 0.7961
CGRPR 244 8000 61 2000 0.5495 1.0 0.7093
aFor each set, the number of active and inactive training instances used to build a naïve Bayesian classification model, and the number of active and
inactive test compounds are given. In addition, the classification performance is reported. Precision is calculated as the ratio of true active predictions
over all active predictions, recall is the ratio of correctly predicted actives over all actives, and the F1-score is the harmonic mean of both.
Figure 4. CAI model visualization. All 22 MACCS features associated with the signature sulfonamide are combined into one group. Graphical analysis
confirms the hypothesis that the classification model is primarily emphasizing sulfonamide-associated features (see text for further details).
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inhibitors contained a conserved pyridinyl-imidazole core with
varying substitutions. Hence, this data set was selected as a
structurally homogeneous set enabling the derivation of
predictive models of MAP14 kinase activity.
The CGRPR set was characterized by a much higher degree of
structural diversity than the other two sets, with compound-to-
BMS and -CSK ratios of 2.29 and 3.91, respectively, and was
therefore selected for our analysis. It should be noted that this
compound set had the lowest ratios among 122 structurally
heterogeneous candidate sets extracted fromChEMBL for which
we have internally built and evaluated naïve Bayesian
classification models.
For classification of CAI and CGRPR ligands, a random
sample of 10,000 other compounds was taken from ChEMBL to
serve as negative training and test instances. For the kinase data
set, confirmed inactive compounds were used.
Molecular Representation.MACCS structural keys39 were
used as an exemplary molecular representation. The public
version of the MACCS fingerprint consists of a set of 166
structural fragments or patterns, which were generated using an
in-house program based uponOpenEye’s OEChem toolkit40 and
SMARTS patterns adapted from RDKit.41 For visualization,
MACCS features were organized into different groups:
1. “ring”: All ring-related features, e.g., “4M ring” (13 MACCS
features),
2. “count”: Occurrence count features, e.g., “O > 2” (13
features),
3. “group”: Features representing a periodic table group, e.g.,
“actinide” (11 features),
4. “element”: Features representing single specific element,
e.g., “P” (9 features),
5. “substructure”: Specific substructures, e.g., “ON(C)C” (39
features),
6. “pattern”: Substructures with wildcards or exclusions, e.g.,
“QAAA@1” (76 features),
7. “other”: All remaining features (5 features).
Features potentially falling into multiple categories were
assigned to a single group in the order of decreasing priority from
groups 1−6. For example, the feature “Aromatic Ring >1” was
assigned to the “ring” group.
The visualization is also applicable to other types of binary
fingerprint representations such as fragment or extended
connectivity fingerprints. In the current study, we limit the
application to the MACCS fingerprint because of its small size
and ease of interpretation. A prototypic implementation of the
visualization method is made available (see below), which also
provides a basis for further studies with other molecular
representations.
Model Building and Evaluation.Models were generated as
described in the Concepts and Methods section using the naïve
Bayesian formulation with Bernoulli features of the freely
available Python machine learning toolkit Scikit-learn.42 A
smoothing factor α = 1 and example weights inversely
proportional to the class balance were used, which prevented
potential smoothing artifacts due to imbalanced data and
resulted in assumed uniform prior probabilities. As reported in
Table 4, each model was trained on a random subset of 80% of
the active compounds. The remaining 20% were used as positive
test instances. For CAI and CGRPR, 8000 and 2000 randomly
chosen ChEMBL compounds were used as negative training and
test examples, respectively. For MAPK14, 80% and 20% of the
confirmed inactive compounds were used as negative training
and test examples, respectively (Table 4). Hence, the
composition of training and test sets for MAPK14 modeling
principally differed from CAI and CGRPR.
■ RESULTS AND DISCUSSION
The principles of model visualization and prediction visualization
are illustrated in Figure 2 and Figure 3, respectively, and have
been discussed in the Concepts and Methods section. In the
following, we present a number of data set applications to
evaluate the visualization techniques in greater detail and analyze
models and predictions. First, the prediction performance of the
different Bayesian classification models is reported.
Model Performance. In Table 4, the performance of the
naïve Bayesian classifiers derived for the three compound data
sets is summarized. For CAI and CGRPR from ChEMBL, recall
is very high (∼0.91 and 1.00, respectively) but precision only
intermediate (∼0.54 and ∼0.55, respectively). For MAPK14, a
smaller and more balanced data set, recall performance is lower
(∼0.77) but precision higher (0.82) than for the ChEMBL data
models, which results in a higher F1-score (∼0.80). Overall, the
classifiers derived for compound data sets of different
composition and structural complexity display reasonable to
high accuracy, a prerequisite for meaningful evaluation of
classification models and predictions.
Model Visualization. CAI. In Figure 4, the naïve Bayesian
model for CAI is visualized. In this case, an additional feature
group was defined to which the 22 MACCS features were
assigned that are associated with the sulfonamide substructure
“*S(=O)(=O)N”. Thus, in the scatter plot, all features related to
the sulfonamide group are easily identified. Blue coloring of these
features confirms that the classification model associates features
set in sulfonamide-containing inhibitors with activity. In
addition, the size of the corresponding feature points indicates
that these features are set in most of the active compounds. While
115 of the 166 MACCS features have an absolute log odds ratio
smaller than one, 13 of the 22 sulfonamide features have an
Table 5. Log Odd Ratios and Class Likelihoods of Selected
CAI Model Featuresa
feature group
log odds
ratio
class
likelihood
4 M ring ring −5.0271 0.0169
3 M ring ring −3.8505 0.0502
QAAA@1 pattern −3.4860 0.0036
OS(O)O substructure 3.3418 0.0844
7 M ring ring −3.1828 0.0488
S−O substructure 2.8918 0.0853
NC(C)N substructure −2.4876 0.2433
Si element 2.3116 0.0049
OQ(O)O substructure 2.2906 0.0863
group IVa,Va,VIa rows 4−6 group 2.2683 0.0011
CC(Q)Q pattern −2.2216 0.1423
P element −2.1154 0.0089
QAA@1 pattern −2.0519 0.0009
group IIIA (B...) group 2.0500 0.0164
QQH sulfonamide 2.0193 0.8227
NS sulfonamide 2.0088 0.7787
aReported are all MACCS features from the CAI prediction model
having an absolute log odds ratio greater than two. If the log odds ratio
is negative, the class likelihoods are reported for the negative class; if
the log odds ratio is positive, they are reported for the positive class.
Log odds ratios and class likelihoods reflect the radius and size of the
feature points in Figure 4.
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absolute log odds ratio larger than one, which confirms their
relevance for the model. However, the visualization also reveals
that there are other features with much larger absolute log odds
ratios than the sulfonamide features, which include three “ring”
and three “pattern” features indicating inactivity, two features
from the “element” group (one promoting activity and the other
inactivity), and four features from the “substructure” group
(three indicating activity and one inactivity). All features having
an absolute log odds ratio greater than two are summarized in
Table 5. However, while the log odds ratio of these features is
high, their class likelihood is rather low, as reflected by smaller
points. This is indicative of an underrepresentation of these
features in the data. Exceptions include the substructure NC(C)
N and the pattern CC(Q)Q, which are present in 24.3% and
14.2% of the inactive compounds, respectively, and have log odds
ratios of −2.49 and −2.22. This means that these features are
approximately 12 and 10 times more likely to appear in inactive
than active compounds. Furthermore, the two sulfonamide
features QQH and NS are contained in 82.3% and 77.9% of the
active compounds, respectively, and have a log odds ratio of 2.02
and 2.01, indicating that they are approximately 7.5 times more
likely to appear in active than inactive compounds.
Taken together, the visualization of the CAI model clearly not
only confirms a critically important role of the sulfonamide moiety
for the prediction of activity but also demonstrates that there are
other features the model regards as even more important for
prediction of activity than the sulfonamide. The relatively small
class likelihoods of these features point at data imbalance during
training, consistent with the limited precision of the model.
MAPK14.The visualization of theMAPK14 model is shown in
Figure 5. Here, we again observe that most of the MACCS
features have an absolute log odds ratio smaller than one and can
hence be considered less important for activity prediction.
However, there are a number of features with absolute log odds
ratios between one and two, and most of these features promote
activity. Finally, a substructure and a pattern feature (CN and
N=A) have absolute log odds ratios larger than three and thus
elicit the largest influence on the prediction of activity, provided
they are set in the fingerprint of a given compound. Interestingly,
both features have a negative log odds ratio, meaning that they are
used by the model to deselect inactive compounds, rather than
select active ones. By contrast, the features “QCH2A > 1” and
“CH3AACH2A” support prediction of activity. All features with an
absolute log odds ratio greater than one are listed in Table 6.
Figure 5. MAPK14 model visualization. Features important for selection of active and deselection of inactive compounds are identified.
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CGRPR. The CGRPR model is visualized in Figure 6. For this
structurally diverse compound set, the visualization of the model
notably differs from the others. Here, all of the features that
promote activity have a log odds ratio smaller than two, whereas
the absolute value of the negative log odds ratios even exceeds six,
which corresponds to a more than 400 times higher class
likelihood for inactive over active compounds. The features
with the highest positive log odds ratios are NC(O)N, the
7-membered ring, and S−S with ORs of 1.85, 1.78, and 1.58,
respectively. This corresponds to a class likelihood for active
compounds that is 4.8−6.3 times higher than for inactive ones.
However, the probability of the count feature “QQ > 1” to be set
in the negative class is 429 times higher than its probability to be
set in the positive class, and similar values are observed for
substructures N−O and NO. Features with an absolute log odds
ratio of more than three are summarized in Table 7. It can be seen
that features with absolute log odd ratios greater than four occur
in only a small fraction of randomly chosen ChEMBL
compounds. However, there are also features such as OAOO
of A$A!S that appear in more than 10% of all assumed negative
instances.
The Bayesian classification model of CGRPR successfully not
only recovers all active test compounds but also has only
intermediate precision. Visualization of the model reveals that
nearly all features with a large absolute log odds ratio promote
the prediction of inactivity, provided they are present in a
compound. This indicates that the model primarily deprioritizes
inactive compounds instead of prioritizing active ones. This
observation is consistent with the fact that many active
compounds in this data set are structurally diverse and cannot
be easily distinguished from negative instances by only a few
descriptive features. Instead, the model focuses on features that
predominantly occur in inactive compounds.
Model Characteristics. Taken together, model visual-
izations for the three compound data sets reveal the presence
of different model characteristics. The CAI model primarily
prioritizes compounds containing the sulfonamide signature (as
to be expected) and deprioritizes compounds with specific ring
systems or patterns. The MAPK14 selects compounds on the
basis of specific features that are preferentially set in active
compounds. By contrast, the CGRPR model primarily deselects
inactive compounds instead of prioritizing actives. Hence,
classification models derived for data sets of varying composition
and structural complexity display different model characteristics.
Graphical analysis clearly reveals key feature for predictions using
the different models.
Feature Selection. Another interesting application of model
visualization is the rationalization of feature selection effects. To
illustrate this point, we have subsequently removed the features
with the highest log ORs from our models and monitored the
change in model performance (data not shown). Removal of the
first few features from the CAI model did not alter performance
significantly. This might seem surprising at first glance. However,
Figure 4 shows that features with highest log OR were only very
infrequently set. Therefore, removal of these features did not
influence the majority of new predictions. By contrast, when
features with a higher probability to be set were removed, for
instance, the larger circles from the “substructure” and
“sulfonamide” areas, classification performance changed signifi-
cantly. Equivalent observations were made for the MAPK14
model. Removal of features with high log odd ratios only slightly
affected predictive performance, if these features were only rarely
set. Removal of additional features resulted in further improved
recall but reduced precision−a direct consequence of predicting
more compounds as active. This effect can also be rationalized by
analyzing Figure 5 where the outermost features were
responsible for compound deselection. Finally, removing the
most important features from the CGRPR model resulted in
reduced precision, which can also be attributed to the fact that
Table 6. Log Odd Ratios and Class Likelihoods of Selected
MAPK14 Model Featuresa
feature group log odds ratio class likelihood
CN substructure −3.6285 0.1091
N=A pattern −3.6285 0.1091
BR element −1.8536 0.0484
S−O substructure −1.8304 0.0181
OS(O)O substructure −1.8304 0.0181
OQ(O)O substructure −1.8304 0.0181
CH2=A pattern 1.7671 0.0170
A$A($A)$A pattern −1.5894 0.4279
CH3AAACH2A pattern 1.5042 0.3546
QCH2A > 1 (&...) count 1.4754 0.4109
CH3AACH2A pattern 1.4627 0.1436
S heterocycle ring 1.4436 0.0123
NS substructure 1.4436 0.0123
CSN substructure 1.4436 0.0123
CC(Q)Q pattern 1.4436 0.0123
CH3ACH2A pattern 1.4289 0.2655
CH3 > 2 (&...) count 1.3799 0.1623
N−O substructure −1.2919 0.1471
NAAAN pattern −1.2141 0.4203
CH2QCH2 pattern 1.1404 0.2702
QHAQH pattern 1.0849 0.0310
aReported are all MACCS features from the MAPK14 prediction
model having an absolute log odds ratio greater than one. Log odds
ratios and class likelihoods reflect the radius and size of the feature
points in Figure 5.
Table 7. Log Odd Ratios and Class Likelihoods of Selected
CGRPR Model Featuresa
feature group log odds ratio class likelihood
QQ > 1 (&...) count −6.0607 0.0520
N−O substructure −6.0139 0.0496
NO substructure −6.0139 0.0496
4 M ring ring −4.9351 0.0169
QHQH (&...) pattern −4.9277 0.0167
QCH2Q pattern −4.8661 0.0157
P element −4.2923 0.0089
OQ(O)O substructure −4.2781 0.0087
I element −4.2637 0.0086
CH2=A pattern −3.9807 0.0065
OAAO pattern −3.7200 0.1741
ON(C)C substructure −3.7182 0.0050
A$A!S pattern −3.5099 0.1411
CQ(C)(C)A pattern −3.4631 0.0039
QAAA@1 pattern −3.3963 0.0036
NS substructure −3.2094 0.1045
OS(O)O substructure −3.2069 0.0030
CSN substructure −3.1716 0.1006
QHAAAQH pattern −3.1219 0.0957
aReported are all MACCS features from the CGRPR prediction model
having an absolute log odds ratio greater than three. All log odds ratios
are negative indicating that all features support prediction of inactivity.
Journal of Chemical Information and Modeling Article
dx.doi.org/10.1021/ci500410g | J. Chem. Inf. Model. 2014, 54, 2451−24682459
only deselecting features were removed. Clearly, overall
prediction performance is predominantly affected by distinguish-
ing features that are frequently set in compounds, which can be
well appreciated on the basis of model visualization.
Prediction Visualization. It is important to note that the
model visualization emphasizes log odds ratios given features are
set in compound fingerprints, i.e.,P(xd = 1|y = 1)/(P(xd = 1|y = 0))
(cf. eq 8). However, if a feature is not set in the fingerprint of a
compound, the term entering the classification rule is changed to
= | =
= | =
= − = | =
− = | =
P x y
P x y
P x y
P x y
( 0 1)
( 0 0)
1 ( 1 1)
1 ( 1 0)
d
d
d
d (14)
This means that features with a high log odds ratio given their
presence can have low log odds ratios in their absence, which can
further complicate the understanding of model decisions. Hence,
to better understand individual predictions, rather than global
model performance, a prediction visualization method has also
been introduced.
Table 8 summarizes true and false positive and negative
predictions for the test sets of the three models. We will use
compounds from these different subsets as examples for
prediction visualization.
CAI. Exemplary true and false positive predictions of the CAI
model are visualized in Figure 7. In the fingerprint of the
correctly predicted active compound, 53 of 166 features are set,
33 of which have a positive and 20 a negative log odds ratio.
However, 42 and 71 of the 113 MACCS substructures not
present in the fingerprint have a positive and negative log odds
ratio, respectively. Considering eq 14, this means that the 71
features that are not set and have a negative log odds ratio in the
Figure 6. CGRPR model visualization. The prediction model for the structurally diverse CGRPR class strongly deselects inactive compounds based on
features with negative log odd ratios (red circles).
Table 8. True or False Positive and Negative Predictionsa
data set
no. of cpds predicted
to be active
no. of cpds predicted
to be inactive
CAI no. of active compounds 238 24
no. of inactive compounds 206 1794
MAPK14 no. of active compounds 41 12
no. of inactive compounds 9 24
CGRPR no. of active compounds 61 0
no. of inactive compounds 50 1950
aFor each model, the number of true positives (correctly predicted
active compounds), true negatives (correctly predicted inactive
compounds), false positives (inactive compounds predicted to be
active), and false negatives (active compounds predicted to be
inactive) is reported.
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global model actually make a positive contribution to the
prediction of activity for this compound. In total, the presence or
absence of 104 (33 plus 71) of 166 MACCS features contributes
to the prediction of activity, whereas the remaining 62 support
prediction of inactivity. The actual weight of their respective
contributions is depicted in Figure 7a. It is evident that most of
the negative contributions are small (none of them exceeds −1).
On the other hand, many of the positive contributions fall in the
range between +1 to +2. In total, the sum of positive log class
likelihoods is 51.66, which results in a clear positive prediction,
considering that the smallest ratio of class log priors to be
exceeded for a positive prediction is 0. Taking the group coloring
in Figure 4 into account, one can immediately conclude that the
most positive contributions result from the sulfonamide group
(light gray), followed by the pattern (green), the substructure
(red), and the count group (dark gray). By contrast, significant
negative contributions come from the feature “Heterocyclic
atom >1” (count group; dark gray), the ring features “5 M ring”
and “N Heterocycle” (yellow), and the patterns “NAAN” and
“QAAAA@1” (green). According to the model, these features
are more likely to be set by inactive compounds, but the presence
or absence of features that support prediction of activity
outweighs these contributions.
Figure 7b shows the visualization for a false positive prediction
by the CAI model. In this case, there are more negative
contributions from different feature groups than for the example
in Figure 7a. Yet, the sum of log odd ratios still is 13.63, giving rise
to a positive prediction. The features with the largest influence
on this prediction include the patterns “A$A!S” and “SA(A)A”
(green), the substructures “CSN” and “CSO” (red), and most of
the features associated with the sulfonamide group (light gray).
The latter contributions are largely responsible for the false
positive prediction, although other infrequently observed
structural features render this compound inactive. This reflects
a limitation of the model for predicting compounds that contain
the sulfonamide but are nonetheless inactive for other reasons
Figure 7. Prediction visualization for CAI. Shown is the prediction visualization for two compounds predicted to be active and representing a (a) true
positive and (b) false positive, respectively.
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(such as, for example, steric hindrance due to the presence of
other groups).
Exemplary true and false negative CAI predictions are
visualized in Figure 8. For the correctly predicted inactive
compound, many negative contributions are observed resulting
in a sum of class log likelihoods of −43.29 (Figure 8a). By
contrast, the active compound has a more balanced ratio of both
positive and negative contributions resulting in a sum of class log
likelihoods of −9.99 (Figure 8b). Although many positive
contributions are detected for the active compound, the negative
prediction is mostly due to the absence of a sulfonamide group in
this compound, which again reflects the focus of the classifier on
this signature group shared by the majority of active compounds.
Features associated with this group (light gray) make the
strongest negative contribution due to their absence.
MAPK14. Figure 9a visualizes a true positive prediction by the
MAPK14 model. Here, both positive and negative contributions
of the count group (dark gray), the pattern group (yellow), and
the substructure group (light gray) become apparent. Features
resulting from single elements (purple), groups (blue), or rings
(red) only make minor positive contributions to the class
likelihood. In total, however, the positive contributions outweigh
the negative ones; hence, the compound is predicted to be active.
The largest positive contributions come from the presence of the
patterns “QHAQH”, “S=A”, and “QA(Q)Q” and the largest
negative terms from the absence of the patterns “AQ(A)A” and
“QCH2A”. Overall, this prediction clearly reflects the presence of
a cumulative effect of many small-magnitude contributions
accounted for by the model. Figure 9b visualizes a true negative
prediction using this model, which helps to better understand its
strong tendency to deselect inactive compounds, as discussed
above. There are positive contributions from count features,
substructures, and patterns, but the magnitude of negative
contributions is by far larger. The absence of a sulfur atom
(purple) and of the patterns “A!N$A”, “QA(Q)Q”, and
“AN(A)A” (yellow) have the strongest negative influence. In
fact, most influential terms come from the absence of
substructural features. Hence, the finding from the global
Figure 8. Prediction of inactivity for CAI. Shown is the prediction visualization for two compounds predicted to be inactive and representing a (a) true
negative and (b) false negative, respectively.
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model analysis that the MAPK14 model preferentially deselects
inactive compounds is further substantiated at the level of
individual predictions.
CGRPR. Figure 10 analyzes active and inactive compounds
correctly predicted by the CGRPR model, respectively. For the
true positive prediction in Figure 10a, there are a four major
negative terms in the log likelihood sum accounting for the
absence of the pattern “C$=C($A)$A” and the substructure
“CCN” and for the presence of the patterns “QHAAQH” and
“QHAQH”. On the other hand, there are two peaks indicating
positive contributions including the 7-membered ring (red) and
the substructure “NC(O)N” (light gray), which are both set in
the fingerprint of this compound. The remaining positive
contributions are comparably small. Hence, in this case, there
also is a cumulative effect leading to the prediction of activity
for this compound. This is consistent with the structural
heterogeneity of the CGRPR set and the absence of
simple structural rules that distinguish active from inactive
compounds (such as the presence or absence of specific
functional groups).
In Figure 10b, a completely different picture emerges. Here,
the majority of features in the fingerprint have a positive log odds
ratio, although all of these contributions are of rather low
magnitude. In addition, there are a few small and medium-size
contributions to negative class log likelihood, with three major
feature peaks. These include the absence of patterns “NAN” and
“QHAAACH2A” and of the substructure “NH”. In other words,
the model does not strictly require any active compound to
possess these features but strongly deprioritizes compounds that
do not have these features set in their fingerprints.
The visualization of the inactive prediction in Figure 10b also
illustrates another important aspect: While the model visual-
ization in Figures 4−6 can highlight features that (according to
the model) make significant contributions to the prediction of
activity or inactivity, it cannot fully represent the decision process
for any new test instance. For example, Figure 6 indicates that
features “QQ > 1″, “N−O”, and “NO” might dominate the
predictions. However, this is only the case if these features are
present in a test compound. The prediction for compounds
where these features are not set, as the one depicted in
Figure 9. Correct predictions for MAPK14. Shown is the prediction visualization for two compounds representing a (a) true positive and (b) true
negative, respectively.
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Figure 10b, is hardly influenced by any of them. For example, let
us consider the feature “QQ> 1”. If it is present, its log odds ratio
is given by
= | =
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In this case, other features play a by far more important role. It
follows that both a careful analysis of global model performance
as well as of individual predictions is required to fully rationalize
why classification models might yield−or not yield−accurate
predictions.
Feature Mapping. Depending on the chosen molecular
descriptors, features that are most important for a prediction can
be back-projected onto test compounds, which aids in the
exploration of SARs. Fragment fingerprints such as MACCS are
suitable descriptors for feature mapping. Figure 11 shows
examples of correctly predicted active and inactive compounds
and of key features that are present in these compounds and
make major contributions to the prediction of activity or
inactivity. For each compound, only features with a log odds ratio
of at least 90% of the maximum or minimum OR are mapped.
These features are reported in Table 9. For example, features of
the compound in Figure 11a have a minimum and maximum log
odds ratio of−0.89 and 2.02, respectively. Requiring at least 90%
of this value, we highlight features with log odds ratios smaller
than 0.8 or greater than 1.82. By contrast, no color-coding can be
applied for the compound in Figure 11b because it is predicted to
be inactive since it is missing essential substructures. This
illustrates limitations of feature mapping approaches. The
examples in Figure 11 reveal that features that are present in
Figure 10. Correct predictions for CGRPR. Shown is the prediction visualization for two compounds representing a (a) true positive and (b) true
negative, respectively.
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compounds and determine predictions cover substructures of
different size. However, feature mapping only provides an
incomplete account of predictions, in contrast to prediction
visualization, because of the frequent importance of feature
absence, as revealed in our analysis.
Figure 12 shows two active and two inactive compounds from
the CAI test set. The two compounds at the top were correctly
predicted as active, whereas the bottom left compound
represented a true negative and the bottom right compound a
false positive prediction. Color shading indicates the magnitude
of the mapped features’ log odds ratio (only features with a
log OR of at least 25% of the maximum absolute log OR were
considered for mapping). Interestingly, the compounds
predicted to be active also contain a rather large red area, i.e.,
features that the model utilized to deselect inactives. However,
nonset features that cannot be mapped often had a major
influence on the predictions. For instance, the sum of log ORs of
the features that are set in the compound in Figure 12a is −0.14.
This means that this compoundwould be predicted to be inactive
if the prediction would only be based on mapped substructures.
However, the sum of log ORs of the nonset features is 2.52,
which hence leads to the prediction of activity. The other two
compounds predicted to be active have a log OR sum of 5.63 and
23.94 for their set features, and 6.77 and 22.08 for their nonset
features, respectively. The true negative prediction in Figure 12c
has an overall log OR sum of −3.8 (with both the sum of the set
Figure 11. Feature mapping. Features with at least 90% log odds ratio compared to the maximum or minimum are back-projected onto test compounds.
Shown are correctly predicted active and inactive compounds for which predictions are visualized in Figures 7−10: (a) active/CAI, (b) inactive/CAI, (c)
active/MAPK14, (d) inactive/MAPK14, (e) active/CGRPR, and (f) inactive/CGRPR. Red and green coloring indicates features with negative and
positive log odd ratios, respectively. The depiction of the feature mapping was created using OpenEye’s OEDepict Toolkit.43
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(−2.13) and the nonset (−1.68) features being negative). Hence,
in this case, the influence of set and nonset features is of
comparable magnitude.
■ CONCLUDING REMARKS
In this work, a visualization approach for Bayesian classification
models and their predictions has been introduced. Naïve
Bayesian classifiers are widely used in chemoinformatics.
Although Bayesian classification is methodologically less
complex than other machine learning approaches such as
support vector machines or neural networks, analyzing
classification models and rationalizing their performance are far
from being trivial tasks. Features that determine the performance
of Bayesian models and their potential interplay are difficult to
identify, especially if classification proceeds in high-dimensional
reference spaces, which is usually the case. In a few instances in
which it has thus far been attempted to rationalize the
performance of machine learning models, statistical consider-
ations have been applied, for example, in the context of feature
selection. Others have used visualization schemes in terms of
feature mapping, where they could by design only account for
present but not absent features. We have designed a new
graphical analysis scheme for “model anatomy” and demon-
strated the utility of model visualization and prediction
visualization to better understand how Bayesian classification
models work. Exemplary compound data sets of different
composition and structural heterogeneity, with known or
unknown SAR determinants, were used to build Bayesian
classification models for activity prediction. On the basis of
graphical analysis, we have been able to determine that
classification models respond differently to structural character-
istics of these compound sets and that feature absence and
deselection of inactive compounds often contributes as much (or
even more) to prediction accuracy as feature presence and
preferential selection of active compounds. The identification of
signature features and/or cumulative feature effects play
comparably important roles for global model performance and
individual predictions. Graphical analysis of the CAI model and
representative predictions has demonstrated how the visual-
ization approach introduced herein helps to rationalize model
performance and focus on key features. For the more complex
data sets MAPK14 (containing kinase inhibitors that are
structurally very similar to inactives) and CGRPR (with high
structural heterogeneity among actives), the visualizations have
enabled us to better understand why classification models reach
reasonable to good predictive performance even in these rather
difficult cases. Here, our findings highlight the role of compound
deselection and cumulative feature effects referred to above.
Taken together, our results suggest that model visualization, as
introduced herein, should aid in the rationalization and further
refinement of Bayesian classification methods. The visualization
approach should also be adaptable for other supervised machine
learning methods and help reduce their often cited “black box”
character. A prototypic Python implementation of our visual-
ization methodology is made freely available via the public
Zenodo platform.44 This implementation should provide a
basis for further exploration and extension of our visualization
approach.
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Table 9. Features Most Important for Individual Predictionsa
compound feature presence OR
(a) CSN + 1.85
NS + 2.01
OSO + 1.84
QSQ + 1.84
SO + 1.84
AS(A)A + 1.82
QQH + 2.02
S=A + 1.85
NAAN + −0.89
QAAAA@1 + −0.85
(b) CC(C)C - 1.28
QQH - −1.61
S=A - −1.71
S - −1.60
(c) QHAQH + 1.08
QA(Q)Q + 0.99
AQ(A)A - −0.73
QCH2A - −0.71
(d) AN(A)A - −1.68
OACH2A + 0.99
ACH2CH2A + 0.98
(e) 7 M ring + 1.78
C$=C($A)$A - −2.14
NC(O)N + 1.85
CCN - −2.03
(f) CC(C)(C)A + 1.10
NAN - −8.45
QHAAACH2A - −8.38
A$A!O > 1 + 1.18
NH - −7.78
aListed are the most important features for the prediction of the
compounds shown in Figure 11. Features that are present can be
mapped, whereas the influence of features that are absent can only be
inferred from the prediction visualization. The odds ratios are reported
for feature presence or absence, i.e., ORd = P(xd = 1 | y = 1)/P(xd =
1 | y = 0) for present and ORd = P(xd = 0 | y = 1)/P(xd = 0 | y = 0) for
absent features.
Figure 12. Feature mapping of selected CAI compounds. Features with
at least 25% log odds ratio compared to the maximum absolute log OR
are back-projected onto four selected CAI compounds including a (a)
true positive, (b) true positive, (c) true negative, and (d) false positive.
Color shading indicates the magnitude of the log odd ratios.
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Summary
In this chapter, we have introduced a method for the visualization of na¨ıve Bayes classi-
fication models and individual predictions. The method is suitable for binary fingerprint
representations, and a prototypic implementation is made freely available under the DOI
10.5281/zenodo.11371.
The model visualization takes into account the probability of a feature to occur in a
class, the sign and the magnitude of a feature’s log odds ratio. It then provides an intu-
itive explanation of the features that are prioritized by the model. Individual predictions
can be visualized to better understand why a certain compound was predicted active
or inactive, respectively. The approach was illustrated using three different data sets,
and it was shown that the na¨ıve Bayes classifier works not only by prioritizing, but also
by deprioritizing compounds based on certain features. Furthermore, a backprojection
onto the molecular graph is possible.
The visualization of na¨ıve Bayes classification models is the first contribution towards
intuitively interpretable machine learning models for drug discovery. In the next chapter,
a similar approach for the visualization of SVM predictions using the Tanimoto kernel
is introduced.
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Visualization and Interpretation of
Support Vector Machine Activity
Predictions
Introduction
In the last chapter, an interactive visualization for na¨ıve Bayes classification models and
predictions was introduced. In addition to na¨ıve Bayes, SVM modeling has extensively
been used throughout this thesis. The success of SVMs in drug discovery applications
motivated the development of a visualization method for SVM activity predictions.
However, in contrast to na¨ıve Bayes, SVMs are “black box” models and hard to inter-
pret. This is due to their formalization in dual space and the use of kernels. Therefore, it
is not possible to derive a general model visualization in terms of input features, as was
done for na¨ıve Bayes models in the previous chapter. Instead, we provide a visualization
of individual SVM predictions using the linear or Tanimoto kernel on fingerprints. The
approach is investigated on different data sets, and the differences between both kernels
are highlighted. Furthermore, a mapping of the features onto the molecular graph is
used to make the results chemically accessible.
Reprinted with permission from
Balfer, J.; Bajorath, J. Visualization and Interpretation of Support Vector Machine
Activity Predictions. J. Chem. Inf. Model. 2015, 55, 1136–1147.
Copyright 2015 American Chemical Society.
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Visualization and Interpretation of Support Vector Machine Activity
Predictions
Jenny Balfer and Jürgen Bajorath*
Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische
Friedrich-Wilhelms-Universitaẗ, Dahlmannstr. 2, D-53113 Bonn, Germany
ABSTRACT: Support vector machines (SVMs) are among the
preferred machine learning algorithms for virtual compound
screening and activity prediction because of their frequently
observed high performance levels. However, a well-known
conundrum of SVMs (and other supervised learning methods) is
the black box character of their predictions, which makes it difficult
to understand why models succeed or fail. Herein we introduce an
approach to rationalize the performance of SVM models based
upon the Tanimoto kernel compared with the linear kernel. Model
comparison and interpretation are facilitated by a visualization
technique, making it possible to identify descriptor features that
determine compound activity predictions. An implementation of
the methodology has been made freely available.
■ INTRODUCTION
Support vector machines (SVMs) are among the most widely
used machine learning algorithms in chemoinformatics,1
especially for compound activity prediction. SVMs were
originally used for binary object classification (e.g., active vs
inactive compounds),2 but have also been adapted for
multitarget predictions3−6 and compound ranking.7,8 The
popularity of SVMs is due to their ability to reach higher
performance levels than other prediction methods in many
applications.1 A foundation of the SVM approach is the use of
kernel functions to project data sets into higher-dimensional
space representations in which a linear separation of positive
and negative training instances is feasible. For ligand-based
virtual screening, the Tanimoto kernel9 is often used in
combination with binary fingerprints as molecular representa-
tions. The Tanimoto kernel utilizes the well-known Tanimoto
similarity formalism10 and is parameter-free, which renders it
attractive for chemoinformatics applications.
A conundrum of the SVM approach (and also other machine
learning methods, such as neural networks) is its black box
character, which refers to the inability to rationalize why
prediction models succeed or fail and interpret them in
chemical terms. This also means that it is generally difficult to
modify models or molecular representations for specific
applications. Only a few attempts to rationalize SVM modeling
and performance have been made to date. Previous work on
SVM model interpretation has usually focused on linearly
separable data,11,12 thereby avoiding analysis in high-dimen-
sional kernel-dependent reference spaces. In the presence of
nonlinear data−property relationships, data were partitioned
into several local Voronoi regions prior to SVM modeling, and
local SVM models were separately built for each of these
regions.11 The weights of the support vectors from which the
models were generated were then used to assess the importance
of each chosen molecular descriptor.13,14 Another approach to
assess the importance of descriptors in nonlinear SVMs
internally stores information during kernel calculation and
then readjusts these weights with linear SVM coefficients.15
This method is only applicable if feature importance
information is available for the given kernel. In addition, partial
derivatives of a kernel function were used to identify descriptors
with the largest gradient components, which were hypothesized
to be the most important for prediction.16 In this case, only the
derivatives of the kernel function need to be provided.
Different from model internal analysis, “rule extraction” from
SVMs has also been attempted.17 In this case, one tries to
mimic the classification of an SVM model as closely as possible,
without interpreting the model itself, to derive a set of rules
approximating SVM classification. Hence, these approaches aim
at an indirect assessment of SVM predictions. Rule extraction
often suffers from the lack of clear rule definitions and is
difficult to apply in high-dimensional reference spaces,17 a
hallmark of SVM modeling.
Following a different approach, Hansen et al.18 have
proposed a method for prediction visualization in which the
most important support vectors are displayed together with
their factors. This method has the principal advantage that it
does not require any prior knowledge about the kernel function
used. However, in this case it is not possible to explain the
influence of single descriptors or features on SVM classification.
For this purpose, “explanation vectors” representing local
gradients of input descriptors are derived. Therefore, the SVM
model must also be mimicked by another classifier such as
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Parzen windows.19 The utility of such explanation vectors
typically depends on the data sets under study.
Herein we introduce a new methodology for visualization
and interpretation of SVM predictions using the Tanimoto
kernel in comparison with the linear kernel. It provides intuitive
access to descriptor features that are the most important for a
given SVM prediction and enables mapping of features onto
molecular graphs. An interactive graphical user interface is
employed for visualization. The methodology clearly reveals
how the Tanimoto kernel facilitates many accurate activity
predictions and rationalizes failures of the linear kernel.
■ CONCEPTS AND METHODS
Support Vector Machine Theory. SVMs aim to solve a
classification task by finding a hyperplane in feature space that
best separates training examples having different binary class
labels.20 Test instances are then classified on the basis of the
side of the separating hyperplane on which they fall, as
determined by the following decision function:
= ⟨ ⟩ −f bx w x( ) sign( , ) (1)
where w is the normal vector of the separating hyperplane, x is
the test instance, and b is the so-called bias of the hyperplane. If
{(x(i), y(i)) | i = 1, ..., n} is a set of n training examples x(i) with
known class labels y(i) ∈ {−1, +1}, the parameters w and b of
the hyperplane are derived by solving the following
optimization problem:20
∑ ξ|| || +
=
Cwmin
1
2 i
n
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(3)
Minimizing w yields the hyperplane with the maximum
distance to training examples on either side, the so-called
margin. The parameter C needs to be adjusted to control the
balance between correct classification of training examples and
permitted prediction errors, which is of critical importance for
model generalization. Misclassifications are represented by the
slack variables ξ(i) introduced to allow a certain number of
training errors.21
Instead of directly solving the primal optimization problem, it
is also possible to formulate an equivalent dual problem using
Lagrangian multipliers.20 In this formulation, the constraints of
the original problem are added to the objective function, and
the resulting dual problem must be optimized. By application of
the Karush−Kuhn−Tucker conditions,22 it is possible to
formulate the dual problem for the primal optimization
problem in eq 2 as follows:
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where λ(i) are the Lagrangian multipliers that are introduced
when the constraints of the primal problem are embedded into
the objective function of the dual problem. This formulation
makes it possible to compute the normal vector of the
hyperplane as
∑ λ=
=
yw x
i
n
i i i
1
( ) ( ) ( )
(6)
Since the Lagrangian multipliers λ(i) can be nonzero only for
training examples that lie on or in the margin of the hyperplane
or are misclassified, it is also possible to reduce eq 6 to this
subset of training examples, the so-called support vectors.20
Hence, the majority of training examples can be discarded
following the training phase, which makes SVM modeling
suitable for large data sets.
Another advantage of the dual formulation is that it enables
the application of the “kernel trick”.23 The underlying idea is
that data that cannot be linearly separated in the original feature
space are projected into a higher-dimensional kernel space in
which linear separation might become feasible. In this case, the
normal vector w has the higher dimensionality of the kernel
space, and training examples are projected into this new space
via a mapping function ϕ(x). This changes only the constraints
in eq 3:
ϕ ξ⟨ ⟩ − ≥ − ∈y b i nw x( , ( ) ) 1 , {1, ..., }i i i( ) ( ) ( ) (7)
Analogously, the dot product of the examples in eq 4 is
replaced by the dot product of their mappings:
∑ ∑ ∑λ λ λ ϕ ϕ− ⟨ ⟩
= = =
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Using Mercer’s theorem,24 we can replace the dot product in
the dual objective function by a kernel function K(u, v) that
implicitly computes ⟨ϕ(x(i)), ϕ(x(j))⟩ without explicitly
mapping x(i) and x(j) into the high-dimensional kernel space.
To compute the normal vector of the hyperplane in kernel
space, one would need to apply the explicit mapping ϕ(x):
∑ λ ϕ= yw x( )i i i
support vectors
( ) ( ) ( )
(9)
In practice, this explicit derivation of w is not required because
the decision function can also be expressed using the kernel:
∑
ϕ
λ
= ⟨ ⟩ −
= −
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟
f x b
y K b
w x
x x
( ) sign( , ( ) )
sign ( , )i i i
support vectors
( ) ( ) ( )
(10)
This procedure enables the use of kernel spaces that are
theoretically infinite because the mapping functions do not
need to be computed explicitly. A variety of kernel functions
have been developed, including the Gaussian or radial basis
function kernel, the Tanimoto kernel, and more complex graph
kernels.9,25,26 SVMs utilizing kernels usually have much higher
prediction capacity than linear models.1 However, the use of
kernel functions comes at the price of black box character and
lack of model interpretability. If the explicit mapping ϕ(x) is
not available, it is impossible to determine contributions of the
features to the classification.
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Feature Weighting. For the linear kernel, feature
importance can be easily interpreted because it can be
expressed as a sum of individual feature contributions:
∑= ⟨ ⟩ =
=
K u vu v u v( , ) ,
d
D
d dlinear
1 (11)
Thus, it is readily possible to weight each feature by λ(i)y(i) and
calculate the classification function as a sum of weighted feature
contributions. However, nonlinear kernels often cannot be
expressed as a sum of feature contributions. Nevertheless, they
might be modified accordingly. For example, let us consider the
Tanimoto kernel, defined as
∑
= ⟨ ⟩
⟨ ⟩ + ⟨ ⟩ − ⟨ ⟩
=
∑
⟨ ⟩ + ⟨ ⟩ − ⟨ ⟩
=
⟨ ⟩ + ⟨ ⟩ − ⟨ ⟩
=
=
K
u v
u v
u v
u v
u u v v u v
u u v v u v
u u v v u v
( , )
,
, , ,
, , ,
, , ,
d
D
d d
d
D
d d
Tanimoto
1
1 (12)
Under the condition that the denominator is constant, it is
possible to express the Tanimoto kernel as a sum of feature
contributions. Since u and v are constant for any single kernel
calculation, the condition of a constant denominator is
applicable in this case. To calculate fc(x, d), the contribution
of feature d to an individual SVM prediction, the following
equations are applied:
∑ λ=d y x xxfc ( , ) i i di dlinear
support vectors
( ) ( ) ( )
(13)
∑ λ=
⟨ ⟩ + ⟨ ⟩ − ⟨ ⟩
d
y x x
x
x x x x x x
fc ( , )
, , ,
i i
d
i
d
i i i
Tanimoto
support vectors
( ) ( ) ( )
( ) ( ) ( )
(14)
The denominator in eq 14 is constant only for each individual
support vector. Nonetheless, it is possible to express the feature
contribution as a sum. To clarify this point, we consider an
exemplary case with three support vectors and five features, as
shown in Figure 1. Here the three support vectors are labeled as
x(1), x(2), and x(3) and colored blue, red, and green, respectively,
while the fingerprint of the compound to be predicted is shown
in black and labeled as z. For the linear kernel (left), the
derivation is straightforward. The first two support vectors
share one bit with the test compound and the third shares
three. Accordingly, the feature contributions are derived (lower
left). Here only λ(i)xd
(i)xd is shown, and the y
(i) have been
omitted for clarity. Since the second and fifth bits in the model
fingerprint make no contribution to the kernel values, their
feature contributions are zero. By contrast, the contributions of
the first, third, and fourth bits are derived from the support
vectors making a nonzero contribution to the respective sum.
On the right in Figure 1, the same calculations are reported
for the Tanimoto kernel. Here the similarities of the support
vectors and the test compound are weighted according to eq 12
and are therefore not the same for the first two support vectors.
The denominator of each single kernel calculation is constant,
but there are different denominators for each support vector.
On the lower right, the derivations of the feature contributions
are shown. Again, the second and fifth features do not
contribute to the final prediction. However, the other three
contributions are derived as weighted sums from the support
vectors, in which not only λ(i) but also the different
denominators contribute to the weighting. In the example
shown, λ(3) has consistently higher weights than λ(1) or λ(2).
Prediction Visualization. To visualize SVM predictions,
we use a graphical method reminiscent of the user interface
previously introduced for visualization of naıv̈e Bayesian
classification models.27 Each descriptor feature is visualized as
a single point in a polar coordinate system. The more a feature
contributes to the prediction, the more remote it is from the
pole. Feature points making negative and positive contributions
to a prediction are colored red and blue, respectively. Features
can be organized into structural subsets displayed in different
regions of the polar coordinate system. In the prototypical
implementation we provide (see below), feature points can be
interactively selected to access associated information. Figure 2
shows an exemplary visualization of a theoretical prediction
wherein only three features make nonzero contributions to the
prediction. These features include the substructure “NC(O)O”
with a contribution of −0.1, the pattern “S=A” (where A refers
to any aliphatic atom) with a contribution of 0.3, and the
feature “halogen” with a contribution of 0.4. Hence, the final
sum of these contributions is 0.6, meaning that this compound
would be predicted as active in any model with a bias lower
than 0.6. The bias, as defined above, can also be rationalized as
a model threshold for the prediction of activity (i.e., if the sum
of feature contributions exceeds the bias, a compound is
predicted to be active). The relative percentage scale in Figure
Figure 1. Example calculation. Shown is a minimal example consisting of three support vectors x(1)−x(3) and one test compound z, represented as
fingerprints with five features. Filled and unfilled squares represent features that are set on and off, respectively. The support vectors are colored
according to their contributions to the formulas shown below. On the left and right, example kernel and feature contribution calculations are shown
for the linear and Tanimoto kernels, respectively.
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2 can be used to easily access the relative importance of each
feature. For instance, the halogen feature accounts for almost
67% of the final sum. While the distance of each point from the
pole represents the magnitude of a feature contribution, colors
refer to positive (blue) or negative (red) absolute contributions.
Feature Mapping. In addition to visualization of SVM
predictions, feature contributions are also mapped back onto
the molecular graph of the classified compound. For this
purpose, we use an approach similar to that of Rosenbaum et
al.12 Each atom and bond in the molecular graph is assigned a
weight accounting for its accumulated feature contributions. In
the case of fingerprint descriptors, we first determine each
feature that is set on and then locate the corresponding
substructures in compound x. Each participating atom ax and
bond bx is then assigned a feature contribution, and the
contributions of overlapping features are added:
∑=
| ∈
w b dx( ) fc( , )
d b d
x
{ }x (15)
For mapping, feature contributions are normalized with respect
to the numbers of atoms and bonds in the corresponding
substructures:
∑= +| ∈
w b
n d d
n d n d
x
x x
( )
( )fc( , )
( , ) ( , )d b d
x
{ } atoms bondsx (16)
where n(d) is the number of times a substructure must occur in
the molecule for feature d to be set. Usually, one occurrence of
a substructure is required for a bit to be set on, but there are
also features requiring more than one occurrence, such as
“more than two nitrogens”, for which n(d) = 3. This
normalization is applied to ensure that atoms and bonds in
large or recurrent substructures are assigned only a fraction of
the feature weight while single-atom features are fully taken into
account in the mapping.
The resulting weights are color-coded such that white
corresponds to a weight of zero, red to a negative weight, and
green to a positive weight. A weight of zero may occur if a
certain atom or bond is not part of any substructure feature
encoded by a fingerprint or if the contributions of overlapping
features add up to zero. The color shading scales with the
magnitude of negative or positive contributions (i.e., the darker
the shading, the larger the magnitude).
■ MATERIALS AND PROTOCOLS
Compound Data Sets. From ChEMBL version 20,28 three
large sets of compounds active against different G-protein-
coupled receptors with available high-confidence activity data
for individual human targets were extracted, as summarized in
Table 1. Compounds were required to be tested in direct
binding assays with Ki values of at most 10 000 nM. In-house
filters were applied to remove duplicate, highly reactive, and
PAINS29 compounds. Additionally, a set of mitogen-activated
protein (MAP) kinase p38 alpha inhibitors was selected using
the same criteria as above (Table 1). However, in this case, only
IC50 measurements were available. Furthermore, 10 000
compounds not contained in these three data sets were
randomly extracted from each of ChEMBL version 20 and
ZINC version 1230 and used as negative training examples.
Molecular Representation. In this study, we used the
MACCS substructural fingerprint as a molecular representa-
tion.31 The MACCS fingerprint consists of 166 bits, each of
which encodes a predefined substructure or pattern. Fingerprint
representations were computed with an in-house implementa-
tion using OpenEye’s OEChem toolkit32 and SMARTS
patterns adapted from RDKit.33 For visualization, MACCS
features were organized into seven different groups, including
“ring”, “count”, “group”, “element”, “substructure”, “pattern”,
and “other”.27 This approach is applicable to any fingerprint.
Parameter Selection. First, we divided each data set into a
training set containing 80% of its compounds and a test set with
the remaining 20%. To select the best regularization term C for
SVM models, 10-fold cross-validation was performed on the
training set. For this purpose, the training set was randomly
divided into 10 equally sized subsets. Each of these subsets was
used once as a validation set, and models were built with
varying C parameter on the remaining nine subsets. To assess
the performance of all intermediate and final models, we used
the F1 score, defined as
=
+ +
F
2TP
2TP FP FN1 (17)
where TP refers to true positive, FP to false positive, and FN to
false negative predictions. Following parameter variation, the
value of C yielding the best mean F1 score across all subsets was
selected.
Figure 2. Principles of prediction visualization. Features are shown as
points on a polar coordinate system and color-coded by positive (blue)
and negative (red) feature contributions. The distance of a feature
point from the pole reflects the magnitude of its contribution. Feature
points are organized into groups and shown on differently colored
backgrounds. A relative scale is provided that gives the percentage
contribution of the feature to the overall sum.
Table 1. Data Setsa
TID target name no. of compounds
252 adenosine A2a receptor 2646
259 cannabinoid CB2 receptor 2202
72 dopamine D2 receptor 2200
10188 MAP kinase p38 alpha 1485
aFor each data set, the ChEMBL target ID (TID), the target name,
and the number of active compounds is reported.
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To account for typically unbalanced SVM classification tasks
(i.e., with more inactive than active compounds available), two
adjusted versions of C, denoted as C+ and C−, can be used to
account for the slack variables of positive and negative training
examples, respectively:34
∑ ∑ξ ξ|| || + ++
| =+
−
| =−
C Cwmin
1
2
i
i
i
i2
{ y 1}
( )
{ y 1}
( )
i i( ) ( ) (18)
The terms C+ and C− are often derived such that their ratio is
equal to the inverse ratio of active and inactive compounds:34
=+
−
C
C
no. of negative examples
no. of positive examples (19)
During cross-validation, C− was first varied on a coarse grid
of {2x | x ∈ {−5, −3, ...,15}} to preselect the best values, which
was followed by cross-validation on a finer grid around
preselected values of {2x | x ∈ {Cbest − 2, Cbest − 1.75, ...,
Cbest + 2}}, leading to the final selection of C−.
35 For each value
of C−, two models were trained: one with C+ = C− and the
other with a C+ value derived via eq 19. The value combinations
giving the best F1 scores are summarized in Table 2. With one
exception, the C+ = C− setting was preferred, indicating that a
potential influence of data imbalance was mostly negligible
here.
Final SVM Models. For each combination of activity class
and kernel, the C+ and C− values reported in Table 2 were then
used to train the final SVM prediction models on 80% of the
compounds randomly selected from each activity class. Final
model performance was assessed on the basis of F1 scores
derived on the test sets. All of the models were generated using
the freely available implementation SVMlight.36
Software Used and Implementation. For feature
mapping and compound display, OpenEye’s OEChem and
OEDepict toolkits32,37 were used. Visualizations of predictions
were generated using Matplotlib.38 A prototypical Python
implementation of the visualization methodology reported
herein was made freely available via the open access platform
Zenodo.39
■ RESULTS AND DISCUSSION
Interpretability of machine learning models is of high value for
structure−activity relationship analysis.12,16,18,27,40,41 For this
purpose, we introduce an approach for the visualization of
individual SVM predictions and identification of key features
that determine activity predictions. Initially, as a basis for our
investigation, we analyze SVM model performance for
exemplary data sets and compare kernels. Then we focus on
visualization, feature identification, and mapping.
Model Performance. Figure 3 summarizes the perform-
ance of the final SVM models using the ChEMBL subset as
inactive training compounds. Generally high prediction
accuracy was observed, with F1 scores ranging from 78.5% to
97.3%. As anticipated, the use of the Tanimoto kernel led to
more accurate prediction than the simple linear kernel, with
differences in F1 scores ranging from 6.6% (adenosine A2a
receptor ligands) to 18.8% (cannabinoid CB2 receptor ligands).
The models derived using ZINC compounds as inactive
training examples yielded overall similar performance, with
deviations below 2%. The only exception was the linear model
for the cannabinoid CB2 receptor, which performed 7% better
using ZINC compounds as inactives than ChEMBL com-
pounds. Hence, unless stated otherwise, we will focus on the
models derived using ChEMBL compounds as inactives in the
following discussion.
Kernel Comparison. Tables 3−6 report predictions for the
four activity classes to compare the two kernels at the level of
individual compounds, distinguishing between true positives
(TPs), false negatives (FNs), true negatives (TNs), and false
positives (FPs). Consistent with the overall high prediction
accuracy, most of the compounds were correctly predicted to
be active or inactive using both kernels (and are thus reported
on the diagonal of the tables). However, for SVM model
diagnostics and visualization, compounds yielding different
predictions with alternative kernels (represented by off-diagonal
numbers in tables) are prime examples.
From the subsets for which the Tanimoto models yielded
correct predictions and the linear model incorrect predictions,
Table 2. Model Parametersa
TID kernel C− C+
252 linear 8.00 8.00
252 Tanimoto 45.25 45.25
259 linear 45.25 45.25
259 Tanimoto 26.91 128.74
72 linear 64.00 64.00
72 Tanimoto 32.00 32.00
10188 linear 0.11 0.11
10188 Tanimoto 64.00 64.00
aGiven are the best values of C− and C+ for each compound set and
kernel function as determined via cross-validation (see the text).
Figure 3. SVM model performance. Reported are the F1 scores of the
final models for the four target sets.
Table 3. Predictions for Adenosine A2a Receptor Ligandsa
linear
TP FN TN FP
Tanimoto
TP 469 38
FN 6 8
TN 1935 45
FP 7 22
aFor the final SVM models, the numbers of true positives (TPs), false
positives (FPs), true negatives (TNs), and false negatives (FNs) are
reported. The results are presented in a matrix format. For example,
there were 469 TPs and 1935 TNs shared by SVM models using the
Tanimoto and linear kernels, whereas six FNs using the Tanimoto
kernel were TPs using the linear kernel and 45 TNs using the
Tanimoto kernel were FPs using the linear kernel.
Journal of Chemical Information and Modeling Article
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test compounds were selected having the largest difference of
the predictive function:
| − |f fx xarg max ( ) ( )x linear Tanimoto (20)
These compounds are given in Table 7, and their predictions
are analyzed in the following. Table 7 also reports for each
compound the sum of feature contributions from each
prediction as well the SVM model biases for prediction of
activity determined during the training phase. Cumulative
feature contributions can be negative or positive. With
increasing positive magnitude, the likelihood of positive activity
predictions increases. A compound is predicted to be active if
the sum of the feature contributions exceeds the model bias.
Visualization of Predictions and Feature Mapping.
The graphical analysis of predictions aims to identify descriptor
features that make important contributions to correct and
incorrect SVM predictions of compound activity using different
kernel functions.
Adenosine A2a Receptor Ligands. Figure 4 shows
prediction visualizations using the linear and Tanimoto kernels
and mappings of MACCS fingerprint features for an active
adenosine A2a receptor ligand. The compound was incorrectly
predicted to be inactive by the linear kernel but correctly
predicted to be active by the Tanimoto kernel. The
visualization for the linear model (Figure 4 top) identified
one feature with a large positive contribution to the prediction
(“six-membered ring”), two features with intermediate positive
contributions (“aromatic ring >1” and “C:N”, where “:” denotes
an aromatic bond), and one feature with an intermediate
negative contribution (“N heterocycle”). Despite the preva-
Table 4. Predictions for Cannabinoid CB2 Receptor
Ligandsa
linear
TP FN TN FP
Tanimoto
TP 318 89
FN 5 10
TN 1937 74
FP 4 4
aFor the final SVM models, the numbers of true positives (TPs), false
positives (FPs), true negatives (TNs), and false negatives (FNs) are
reported. The data representation is according to Table 3.
Table 5. Predictions for Dopamine D2 Receptor Ligandsa
linear
TP FN TN FP
Tanimoto
TP 384 45
FN 3 16
TN 1911 53
FP 7 21
aFor the final SVM models, the numbers of true positives (TP), false
positives (FP), true negatives (TN), and false negatives (FN) are
reported. The data representation is according to Table 3.
Table 6. Predictions for MAP Kinase p38 Alpha Inhibitorsa
linear
TP FN TN FP
Tanimoto
TP 239 37
FN 1 12
TN 1962 32
FP 5 10
aFor the final SVM models, the numbers of true positives (TPs), false
positives (FPs), true negatives (TNs), and false negatives (FNs) are
reported. The data representation is according to Table 3.
Table 7. Details of Individual Predictionsa
linear Tanimoto
TID CID ∑fc(x, d) b ∑fc(x, d) b
252 CHEMBL411685 5.16 9.15 4.46 3.46
252 CHEMBL11113 12.94 9.15 3.15 3.46
259 CHEMBL1834525 −4.32 2.17 3.45 2.81
259 CHEMBL585041 5.10 2.17 2.15 2.81
72 CHEMBL419792 1.51 5.90 2.89 2.83
72 CHEMBL12028 8.14 5.90 2.12 2.83
10188 CHEMBL320069 2.08 5.74 4.33 3.33
10188 CHEMBL57 7.35 5.74 2.84 3.33
aFor individual predictions discussed in the text, the ChEMBL target
ID (TID), compound ID (CID), sum of feature contributions
∑fc(x, d), and model bias b for each kernel are reported. If the sum of
the feature contributions is larger than the bias, the compound is
predicted to be active; otherwise, it is predicted to be inactive.
Figure 4. Visualization of predictions and feature mapping for
ChEMBL compound 411685. Individual predictions using SVM
models with the (top) linear and (bottom) Tanimoto kernels are
visualized, and key structural features are mapped. In each panel
showing predictions for a given compound, the relative scale of the
visualizations has been adjusted such that the magnitudes of feature
contributions can be directly compared. This adenosine A2a receptor
ligand was predicted to be inactive by the linear and active by the
Tanimoto model.
Journal of Chemical Information and Modeling Article
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lence of three features making large or intermediate positive
contributions, the linear model yielded a false negative
prediction. All of the other MACCS features mapped to the
center of the graph, corresponding to small-magnitude
contributions. Although the six-membered ring made a feature
contribution of almost 70% to the overall sum, the feature
mapping shown in Figure 4 revealed that negative contributions
of smaller magnitude also occurred at several ring atom
positions, which reduced the positive contribution of the six-
membered ring. Ultimately, the individual contributions led to a
sum of feature contributions of 5.16, which was smaller than
the bias of 9.15 for the linear model (Table 7). Therefore, the
compound was predicted to be inactive. By contrast, the
visualization of the correct prediction by the Tanimoto model
(Figure 4 bottom) provides a different picture. All of the
features made contributions of small magnitudes below 10% to
the overall sum, and most of these contributions were positive.
The feature mapping also showed that there was no single atom
or bond in the molecule with a negative cumulative weight. In
this case, the sum of feature contributions (4.46) clearly
exceeded the relatively low bias of the Tanimoto model (3.46;
Table 7), leading to a correct prediction of activity.
Figure 5 shows the results for an inactive test compound
from the adenosine A2a receptor modeling, which was
predicted to be active by the linear model. The visualization
for the linear model (Figure 5 top) also identified the six-
membered ring as a single dominant positive feature, although
in this case it only accounted for less than 30% of the overall
sum. Furthermore, there were a number of additional features
with relatively small positive or negative contributions between
10% and 20%. Feature mapping identified a number of features
with negative contributions centered at nitrogen and oxygen
atoms throughout the molecule, similar to observations made
for the linear model in Figure 4. However, in this case, the
contribution of the six-membered ring and a part of the
adjacent thiophene ring involving the sulfur atom clearly
dominated the prediction, leading to a sum of 12.94 and a false
positive assignment. The Tanimoto model correctly predicted
this compound to be inactive. The visualization of this
prediction (Figure 5 bottom) reveals the presence of many
positive and negative contributions, especially from patterns.
However, these contributions are of relatively small magnitude.
As a result of the presence of a variety of positive and negative
feature contributions in the Tanimoto model, which partly
compensated for each other, the sum of contributions (3.15)
for the compound in Figure 5 did not reach the model bias
(3.46), leading to a correct prediction of inactivity.
Furthermore, feature mapping showed that there were only
few oxygen atoms with an overall negative weight.
In general, features shared by predictions using the linear and
Tanimoto kernels often made contributions of lesser magnitude
to the Tanimoto model. This difference is a direct consequence
of the denominator in the Tanimoto kernel, which weights the
numbers of fingerprint bits set on for two compounds by the
total number of possible commonly set bits. Thus, different
from the linear kernel, the Tanimoto kernel further differ-
entiates between compound pairs sharing a large number of bits
but differing in their sizes and total numbers of bits set to 1.
Cannabinoid CB2 Receptor Ligands. Figure 6 shows an
active cannabinoid CB2 receptor ligand that was predicted to
be inactive by the linear model and active by the Tanimoto
model. The visualization of the prediction using the linear
model (Figure 6 top) highlights the dominance of a single
feature (pattern “QSQ”, where Q refers to any heteroatom)
that makes a strong negative contribution of over 90% of the
cumulative sum. In addition, a comparable number of other
features with intermediate positive or negative contributions
became apparent. Feature mapping revealed that the “QSQ”
pattern was centered on an individual sulfur atom contained in
this compound. However, the neighboring carbon and oxygen
atoms made only minor or no negative contributions to the
prediction, while the sulfur atom itself had a strong negative net
effect. Furthermore, the nitrogen atom made a significant
contribution to the negative prediction because it was a part of
several features with moderately negative effects. This example
illustrates the utility of the feature mapping to highlight focused
contributions in cases where individual atoms participate in
multiple features influencing a prediction. The prediction of
this compound using the Tanimoto kernel is visualized at the
bottom of Figure 6. In this case, many features with positive
contributions of small magnitude were observed, but only few
with negative contributions approaching the 10% limit, thus
rationalizing the positive prediction. This was also consistent
with the view obtained from feature mapping, which revealed
that all of the atoms, including the nitrogen and sulfur, and all
of the bonds had positive cumulative weights.
Figure 7 visualizes predictions for a negative test example
subjected to cannabinoid CB2 receptor ligand modeling, which
was predicted to be active by the linear model and inactive by
the Tanimoto model. In this case, the prediction visualization
using the linear kernel (Figure 7 top) shows different
Figure 5. Visualization of predictions and feature mapping for
ChEMBL compound 1113, represented according to Figure 4. This
compound is a negative test example for prediction of adenosine A2a
receptor ligands. Predictions: active (linear model) and inactive
(Tanimoto model).
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characteristics than the one discussed above. There were four
features with strong positive contributions, three of which were
patterns (“S=A”, “A!N$A”, and “NAO”, where A refers to any
aliphatic atom) and one was from the “other” group
(“aromatic”). In addition, four features with negative
contributions exceeding 30% of the overall sum included two
rings (“N heterocycle”, “ring”), a substructure (“OC(N)C”),
and an element (“N”). Because two of the positive features and
three of the negative features contained a nitrogen feature,
mapping was crucial in this case to determine the contributions
of these atoms. Mapping revealed that all of the nitrogen atoms
ultimately made net contributions to the prediction of
inactivity, whereas oxygen and sulfur atoms made contributions
to the false prediction of activity, exceeding the bias of the
linear model (Table 7). Interestingly, the feature mapping for
the Tanimoto model (Figure 7 bottom) indicated that most of
the atoms and patterns, except nitrogens and a few bond
patterns, made positive contributions. This was also reflected in
the prediction visualization, where the occurrence of a single
nitrogen did not make any notable contribution; the only
feature with a negative contribution exceeding the 10% limit
was “A$A!O>1”, which covered all of the nitrogen atoms in the
compound. Hence, some of the nitrogens had a small
cumulative negative weight, but overall there were many
compensatory effects, and the sum of all contributions (2.15)
was slightly smaller than the bias of the Tanimoto model (2.81;
Table 7), leading to the correct prediction of inactivity.
However, the numerical difference between the sum arising
from multiple positive and negative feature contributions and
the bias was relatively small in this case, consistent with the
visualization in Figure 7.
Dopamine D2 Receptor Ligands. The active compound
depicted in Figure 8 is small, consisting of only a condensed
three-ring system. It was predicted to be inactive by the linear
model and active by the Tanimoto model. The visualization of
the prediction using the linear kernel (Figure 8 top) reveals a
substructure feature (“CN(C)C”) with a large positive
contribution of more than 200% of the final sum. However,
two patterns (“AN(A)A” and “AQ(A)A”, where A refers to an
aliphatic atom and Q to a heteroatom) with negative
contributions of about 100% of the final sum nearly nullified
this effect because the substructure CN(C)C matched both of
these patterns. Aside from these features, the “aromatic” feature
made the largest contribution. Feature mapping showed that
cumulative negative contributions were mostly centered on the
three nitrogen atoms, while positive contributions were
distributed over the ring atoms (resulting in small atom-centric
contributions). Overall, the negative and positive feature
contributions were nearly compensatory, resulting in a
cumulative feature contribution of 1.51, which was much
smaller than the model bias of 5.90 (Table 7). The prediction
using the Tanimoto model (Figure 8 bottom) was numerically
vulnerable to boundary effects since the cumulative positive
contribution of 2.89 only slightly exceeded the model bias of
2.83 (Table 7). However, the prediction visualization reveals a
Figure 6. Visualization of predictions and feature mapping for
ChEMBL compound 1834525, represented according to Figure 4.
This compound is a cannabinoid CB2 receptor ligand. Predictions:
inactive (linear), active (Tanimoto).
Figure 7. Visualization of predictions and feature mapping for
ChEMBL compound 585041, represented according to Figure 4. This
compound is a negative test example for prediction of cannabinoid
CB2 receptor ligands. Predictions: active (linear), inactive (Tanimo-
to).
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5
variety of positive feature contributions (more so than negative
ones), also including the “CN(C)C” substructure at the 10%
level. However, all of the contributions were of low magnitude
(with a maximum value of 0.33, corresponding to 11.34% of the
overall sum). Nonetheless, despite the overall low cumulative
feature contribution comparable to the model bias, feature
mapping revealed only positive net contributions at atoms and
bonds across the molecule.
Figure 9 visualizes predictions for a negative test example in
dopamine D2 receptor ligand modeling that was predicted to
be active by the linear model and inactive by the Tanimoto
model. This molecule is much larger than the active compound
in Figure 8. The visualization for the linear model (Figure 9
top) reveals the largest positive contributions to come from a
substructure (“CN(C)C”), a pattern (“QN”), and another
feature (“aromatic”), while negative contributions mostly
originated from patterns (“AQ(A)A”, “AN(A)A”, and “QQ”).
Again, contributions of these features largely compensated for
each other because the substructure CN(C)C also matched
AQ(A)A and AN(A)A and the same fragment matched
patterns QN and QQ. Nonetheless, the sum of contributions
from predictions using the linear kernel in Figure 9 was 8.14,
which clearly exceeded the model bias of 5.90 (Table 7),
leading to a false positive prediction. Feature mapping showed
that negative contributions, mostly from nitrogen atoms, were
too small to match cumulative positive contributions from the
linker and ring systems of the compound. The visualization of
the prediction using the Tanimoto kernel (Figure 9 bottom)
provides a different picture. In this case, many features with
positive or negative contributions of varying magnitudes were
identified, and there were no individual features that largely
determined the predictions. Feature mapping revealed the
presence of multiple positive and negative contributions in
corresponding regions of the negative test compound using the
linear and Tanimoto kernels. However, in the case of the
Tanimoto model, nitrogen atoms mostly made positive
contributions, while oxygen and sulfur atoms made negative
contributions, which was different from the linear model.
Furthermore, the contributions of the aromatic ring systems to
the prediction using the Tanimoto kernel were of lesser
magnitude compared with the linear kernel. Overall, the
Tanimoto kernel yielded a number of compensatory positive
and negative feature contributions, and the final sum (2.12) did
not reach the model bias of 2.83 (Table 7).
MAP Kinase p38 Alpha Inhibitors. Figure 10 shows an
active MAP kinase p38 alpha inhibitor that was incorrectly
predicted to be inactive by the linear kernel and correctly
predicted to be active by the Tanimoto kernel. The prediction
visualization revealed that there were many features in the
linear prediction that contributed in a similar way. The
strongest positive features were the substructure “NH”, the
ring feature “aromatic ring >1”, and the pattern “NA(A)A”. The
features with strongest negative contributions included the
substructure “C−N” and the pattern “NACH2A”. Overall, the
mapping showed that nitrogen and oxygen atoms made overall
positive contributions, while the linker in the lower part of the
molecule made the only considerable negative contribution.
The overall sum of feature contributions was 2.08, which was
Figure 8. Visualization of predictions and feature mapping for
ChEMBL compound 419792, represented according to Figure 4. This
compound is a dopamine D2 receptor ligand. Predictions: inactive
(linear), active (Tanimoto).
Figure 9. Visualization of predictions and feature mapping for
ChEMBL compound 12028, represented according to Figure 4. This
compound is a negative test example for prediction of dopamine D2
receptor ligands. Predictions: active (linear), inactive (Tanimoto).
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considerably smaller than the threshold of 5.74, meaning that
the few cumulative positive contributions were not sufficient to
yield a prediction of activity. By contrast, the visualization of the
Tanimoto prediction revealed a different picture. Here only one
substructure (“NH”) having a considerable positive contribu-
tion was identified, in addition to many smaller positive
contributions. There were very few if any negative contribu-
tions, as was also confirmed by feature mapping, which
identified only cumulative positive contributions. Here the sum
of the feature contributions of 4.33 exceeded the model bias by
1 (Table 7).
Furthermore, Figure 11 shows the prediction visualization
and mappings for an inactive compound that was predicted to
be active by the linear model and inactive by the Tanimoto
model. The linear prediction visualization identified two
important positive contributions, including a seven-membered
ring and the pattern “A!:A:A!:A” (where “:” refers to an
aromatic bond and “!” denotes negation). Many other features
contributed only less than 10% to the overall sum. Here the
prediction visualization showed that there were more features
with positive contributions than negative ones. Features
covering nearly the entire compound contributed to the
positive prediction, leading to a large sum of 7.35 (Table 7).
By contrast, the Tanimoto kernel’s contributions yielded a sum
of 2.84, which did not reach the model bias of 3.33, leading to a
correct inactive prediction. In this case, three features
contributed more than 10% to the overall sum: the pattern
“A!:A:A!:A”, the three-membered ring, and the substructure
“NH”. There were also several features with small positive or
negative contributions. Feature mapping revealed that three
nitrogen atoms made much smaller contributions compared
with the linear case, leading to a smaller sum and thus the
prediction of inactivity.
Taken together, the visualizations of the exemplary
predictions in Figures 4−11 in combination with feature
mapping helped to rationalize kernel-dependent differences in
activity predictions. While several predictions using the simple
linear kernel were dominated by individual feature contribu-
tions, the Tanimoto kernel  given its design, as discussed
above  better differentiated feature contributions and their
relative magnitudes. The Tanimoto kernel also generally
reduced the magnitude of feature contributions, thereby
balancing the influence of individual features on the predictions.
Feature mapping complemented the visualization of predictions
by focusing on atoms, bonds, or other substructures (e.g., rings)
that were involved in multiple features and accounting for net
effects. The exemplary predictions summarized in Table 7 also
illustrate that cumulative feature contributions were rarely
negative, even for compounds correctly predicted to be inactive
 a previously unobserved effect. In these cases, the positive
cumulative contributions were smaller than the model biases.
Variation of Inactive Training Compounds. All of the
calculations discussed herein with negative training examples
taken from ChEMBL were repeated with an equally sized
negative training set randomly selected from ZINC. In order to
analyze the effect of different inactive training sets on our
visualization method, prediction visualization and feature
Figure 10. Visualization of predictions and feature mapping for
ChEMBL compound 320069, represented according to Figure 4. This
compound is a positive test example for prediction of MAP kinase p38
alpha ligands. Predictions: inactive (linear), active (Tanimoto).
Figure 11. Visualization of predictions and feature mapping for
ChEMBL compound 57, represented according to Figure 4. This
compound is a negative test example for prediction of MAP kinase p38
alpha ligands. Predictions: active (linear), inactive (Tanimoto).
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mappings of active compounds were compared. Figure 12
shows the comparison of the linear and Tanimoto models for
the adenosine A2a receptor ligand analyzed in Figure 4 using
the ZINC training set. The compound was predicted to be
inactive by the linear model and active by the Tanimoto model,
regardless of the choice of the inactive training set. Feature
mapping revealed that the same atoms and bonds contributed
positively or negatively to the prediction in both cases.
However, the prediction visualization showed that the features
leading to these cumulative contributions differed. For instance,
the most important positive and negative features for the linear
ChEMBL-based models were the six-membered ring and the N
heterocycle, respectively, as discussed above. By contrast, for
the linear ZINC-based model, the “aromatic” feature from the
“other” group was the most important positive feature and the
“N>1” feature from the “count” group the most important
negative feature. However, the Tanimoto models derived using
ChEMBL and ZINC subsets did not differ notably.
Figure 13 shows the active cannabinoid CB2 receptor ligand
from Figure 6 together with its prediction visualization and
feature mappings for the linear and Tanimoto models based
upon the inactive training set from ZINC. The compound was
predicted to be inactive by the linear model and active by the
Tanimoto model. However, both prediction visualization and
feature mapping of the linear model differed from those shown
in Figure 6. For example, the pattern “S=A” made by far the
largest positive contribution in the linear ZINC model. This
contribution caused a change in the feature mapping from the
sulfur atom making a negative contribution (ChEMBL-based
model, Figure 6) to a positive contribution (ZINC-based
model, Figure 13). Other features with contributions of ∼50%
to the overall sum in the ChEMBL model made smaller
contributions to the ZINC model. By contrast, the Tanimoto
models using the ChEMBL and ZINC subsets displayed very
similar characteristics in prediction visualization and feature
mapping. The examples in Figures 12 and 13 show how the
choice of negative training data might influence an SVM model
and how prediction visualization and feature mapping can be
used to analyze this influence.
■ CONCLUSIONS
In this study, we have introduced a visualization method for
SVM predictions using the Tanimoto kernel compared with the
linear kernel. Our analysis has revealed how activity predictions
are determined by contributions from varying numbers of
fingerprint features. The study can be extended to other kernel
functions for which feature contributions can be expressed as
sums. Visualization complemented by feature mapping provides
a direct diagnostic for SVM models and reduces the black box
character of SVM predictions. An implementation of the
visualization approach introduced herein has been made freely
available to aid in the assessment of SVM models and their
successes and failures.
Figure 12. Visualization of predictions and feature mapping for the
adenosine A2a receptor ligand from Figure 4 obtained using a subset
of ZINC compounds as inactive training instances and the (top) linear
and (bottom) Tanimoto models.
Figure 13. Visualization of predictions and feature mapping for the
cannabinoid CB2 receptor ligand from Figure 6 obtained using a
subset of ZINC compounds as inactive training instances and the
(top) linear and (bottom) Tanimoto models.
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Machine Interpretation. Neurocomputing 2006, 69, 1754−1759.
(12) Rosenbaum, L.; Hinselmann, G.; Jahn, A.; Zell, A. Interpreting
Linear Support Vector Machine Models with Heat Map Molecule
Coloring. J. Cheminf. 2011, 3, No. 11.
(13) Franke, L.; Byvatov, E.; Werz, O.; Steinhilber, D.; Schneider, P.;
Schneider, G. Extraction and Visualization of Potential Pharmacophore
Points Using Support Vector Machines: Application to Ligand-Based
Virtual Screening for COX-2 Inhibitors. J. Med. Chem. 2005, 48,
6997−7004.
(14) Devos, O.; Ruckebusch, C.; Durand, A.; Duponchel, L.;
Huvenne, J.-P. Support Vector Machines (SVM) in Near Infrared
(NIR) Spectroscopy: Focus on Parameters Optimization and Model
Interpretation. Chemom. Intell. Lab. Syst. 2009, 96, 27−33.
(15) Mohr, J.; Jain, B.; Sutter, A.; Laak, A. T.; Steger-Hartmann, T.;
Heinrich, N.; Obermayer, K. A Maximum Common Subgraph Kernel
Method for Predicting the Chromosome Aberration Test. J. Chem. Inf.
Model. 2010, 50, 1821−1838.
(16) Carlsson, L.; Helgee, E. A.; Boyer, S. Interpretation of Nonlinear
QSAR Models Applied to Ames Mutagenicity Data. J. Chem. Inf.
Model. 2009, 49, 2551−2558.
(17) Martens, D.; Huysmans, J.; Setiono, R.; Vanthienen, J.; Baesens,
B. Rule Extraction from Support Vector Machines: An Overview of
Issues and Application in Credit Scoring. Stud. Comput. Intell. 2008,
80, 33−63.
(18) Hansen, K.; Baehrens, D.; Schroeter, T.; Rupp, M.; Müller, K.-R.
Visual Interpretation of Kernel-Based Prediction Models. Mol. Inf.
2011, 30, 817−826.
(19) Baehrens, D.; Schroeter, T.; Harmeling, S.; Kawanabe, M.;
Hansen, K.; Müller, K.-R. How To Explain Individual Classification
Decisions. J. Mach. Learn. Res. 2010, 11, 1803−1831.
(20) Vapnik, V. N. The Nature of Statistical Learning Theory, 2nd ed.;
Springer: New York, 2000.
(21) Cortes, C.; Vapnik, V. N. Support Vector Networks. Mach.
Learn. 1995, 20, 273−297.
(22) Kuhn, H. W.; Tucker, A. W. Nonlinear Programming. Proc.
Berkeley Symp. Math., Stat. Probab., 2nd 1950, 481−492.
(23) Boser, B. E.; Guyon, I. M.; Vapnik, V. N. A Training Algorithm
for Optimal Margin Classifiers. Proc. Annu. Workshop Comput. Learn.
Theory, 5th 1992, 144−152.
(24) Mercer, J. Functions of Positive and Negative Type, and their
Connection with the Theory of Integral Equations. Philos. Trans. R.
Soc. London, Ser. A 1909, 209, 415−446.
(25) Gar̈tner, T.; Flach, P.; Wrobel, S. On Graph Kernels: Hardness
Results and Efficient Alternatives. In Learning Theory and Kernel
Machines; Springer: Berlin, 2003.
(26) Kashima, H.; Tsuda, K.; Inokuchi, A. Marginalized Kernels
between Labeled Graphs. Proc. Int. Conf. Mach. Learn., 20th 2003,
321−328.
(27) Balfer, J.; Bajorath, J. Introduction of a Methodology for
Graphical Interpretation of Naıv̈e Bayesian Classification Models. J.
Chem. Inf. Model. 2014, 54, 2451−2468.
(28) Bento, A. P.; Gaulton, A.; Hersey, A.; Bellis, L. J.; Chambers, J.;
Davies, M.; Kruger, F. A.; Light, Y.; Mak, L.; McGlinchey, S.;
Nowotka, M.; Papadatos, G.; Santos, R.; Overington, J. P. The
ChEMBL Bioactivity Database: An Update. Nucleic Acids Res. 2014,
42, 1083−1090.
(29) Baell, J. B.; Holloway, G. A. New Substructure Filters for
Removal of Pan Assay Interference Compounds (PAINS) from
Screening Libraries and for Their Exclusion in Bioassays. J. Med. Chem.
2010, 53, 2719−2740.
(30) Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.;
Coleman, R. G. ZINC: A Free Tool To Discover Chemistry for
Biology. J. Chem. Inf. Model. 2012, 52, 1757−1768.
(31) MACCS Structural Keys; Accelrys: San Diego, CA, 2011.
(32) OEChem Toolkit, version 2.0.2.; OpenEye Scientific Software:
Santa Fe, NM; http://www.eyesopen.com.
(33) RDKit: Open-Source Cheminformatics. http://www.rdkit.org.
(34) Morik, K.; Brockhausen, P.; Joachims, T. Combining Statistical
Learning with a Knowledge-Based ApproachA Case Study in
Intensive Care Monitoring. Proc. Int. Conf. Mach. Learn., 16th 1999,
268−277.
(35) Hsu, C.-W; Chang, C.-C.; Lin, C.-J. A Practical Guide to Support
Vector Classification. Technical Report; Department of Computer
Science, National Taiwan University: Taipei, Taiwan, 2003.
(36) Joachims, T. Making Large-Scale Support Vector Machine
Learning Practical. In Advances in Kernel Methods; Schölkopf, B.,
Burges, C. J. C., Smola, A. J., Eds.; MIT Press: Cambridge, MA, 1999;
pp 169−184.
(37) OEDepict Toolkit, version 2.2.4.; OpenEye Scientific Software:
Santa Fe, NM; http://www.eyesopen.com.
(38) Hunter, J. D. Matplotlib: A 2D Graphics Environment. Comput.
Sci. Eng. 2007, 9, 90−95.
(39) Balfer, J.; Bajorath, J. Visualization and Interpretation of Support
Vector Machine Activity Predictions. DOI: 10.5281/zenodo.17718.
(40) Marcou, G.; Horvath, D.; Solov’ev, V.; Arrault, A.; Vayer, P.;
Varnek, A. Interpretability of SAR/QSAR Models of Any Complexity
by Atomic Contributions. Mol. Inf. 2012, 31, 639−642.
(41) Polishchuk, P. G.; Kuz’min, V. E.; Artemenko, A. G.; Muratov,
E. N. Universal Approach for Structural Interpretation of QSAR/
QSPR Models. Mol. Inf. 2013, 32, 843−853.
Journal of Chemical Information and Modeling Article
DOI: 10.1021/acs.jcim.5b00175
J. Chem. Inf. Model. 2015, 55, 1136−1147
1147
D
ow
nl
oa
de
d 
by
 B
O
N
N
 L
IB
RA
RI
ES
 o
n 
Se
pt
em
be
r 8
, 2
01
5 
| ht
tp:
//p
ubs
.ac
s.o
rg 
 
Pu
bl
ic
at
io
n 
D
at
e 
(W
eb
): 
Ju
ne
 2,
 20
15
 | d
oi:
 10
.10
21/
acs
.jci
m.
5b0
017
5
Summary
In this study, we have compared the linear and Tanimoto kernel in SVM modeling using
molecular fingerprints. It was shown how individual compounds were predicted by the
different kernels, and how individual features influenced the predictions. Furthermore,
the cumulative feature contributions were rarely found to be negative. Instead, the SVM
model bias, which was positive in all discussed cases, prevented false positive predictions.
A prototypic Python implementation of the method is freely available under the DOI
10.5281/zenodo.17718.
This publication aims to extend the model and prediction visualization approach of
the previous chapter to more complex models. We hope that our contribution motivates
further research into the direction of intuitive model assessment. While the approach
shown in this study is only applicable to SVMs using fingerprints and linear or Tanimoto
kernels, similar methods could be developed for other models and kernel functions.
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Conclusion
Computational drug discovery is an interdisciplinary field at the interface of a variety
of disciplines, first and foremost medicinal chemistry and computer science. Today,
many problems of the drug development process are attempted to be solved via in silico
modeling. In part I of this thesis, two such methods were introduced and discussed.
Sometimes even more important than the successful application of machine learning
models is the ability to understand and interpret them in chemical terms. Part II of
this thesis provided important insights into in silico models for activity and potency
prediction. Chapter 3 highlighted how chemogenomics data can be used for compound
structure-independent activity prediction. This methodology allows the application of
LBVS outside the applicability domain of the prominent similarity-property principle.
In chapter 4, it was shown that even models that give globally satisfying results are not
always reliable for compound potency prediction. Careful analysis revealed that they
tend to predict continuous SARs and therefore miss the most potent compounds, which
fall into discontinuous regions.
Eventually, part III introduced two visualization methods for fingerprint-based na¨ıve
Bayes classifiers and SVMs using the Tanimoto kernel. The main contribution here is
the presentation of a method to analyze successful LBVS models in a way that is both
formally precise and chemically interpretable. To our best knowledge, the visualization of
the model and prediction itself is the first attempt in this direction. It complements the
feature mapping onto the molecular graph, which is often used for model interpretation.
We hope that these methods can contribute to an easier communication between the
different domain experts involved in drug discovery.
Finally, we would like to stress potential opportunities for future research. Chapter 4
revealed systematic modeling artifacts in SVR for potency prediction, yet no solution
to this issue has been offered thus far. One possibility would be the design of a kernel
function that takes discontinuity information into account. Previously, it has been shown
that it is possible to predict whether a pair of compounds form an activity cliff or not
[91]. If this method was extended to predict the potency difference of a compound pair,
this information could be incorporated into the final SVR kernel.
Another open subject is the extension of the methods provided in part III to new
machine learning models or SVM kernels. Then, not only a quantitative comparison of
model performances could be made, as is often done in classical LBVS benchmarking
studies. Instead, one could pursue a more qualitative comparison of different models in
terms of feature prioritization.
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Support Vector Machine Derivations
Linearly separable data
We can compute the margin as:
ρ(w, b) = min
{x(i)|y(i)=+1}
x(i) ·w
||w|| − max{x(i)|y(i)=−1}
x(i) ·w
||w|| (56)
Considering the constraints in equation (19), the following hold:
min
{x(i)|y(i)=+1}
x(i) ·w
||w|| =
1
||w|| (57)
max
{x(i)|y(i)=−1}
x(i) ·w
||w|| =
−1
||w|| (58)
ρ(w, b) =
2
||w|| (59)
Here, it becomes directly apparent that maximizing the margin can be done by mini-
mizing ||w||. Usually, literature reports the minimization of 1
2
w ·w for cosmetic reasons,
which does not affect the solution [68].
The Lagrangian of the primal optimization problem for the classification SVM of
linearly separable data is given by the primal optimization plus the linear constraints,
for each of which a multiplier is added [71]. The constraints are first rearranged:
1− y(i)(w · x(i) − b) ≤ 0 (60)
Then, the Lagrangian can be formulated and rearranged to arrive at Vapnik’s formu-
lation [60], which is also given in equation (20):
Λ(w, b, λ) =
1
2
w ·w +
n∑
i=1
λ(i)[1− y(i)(w · x(i) − b)] (61)
=
1
2
w ·w −
n∑
i=1
λ(i)[y(i)(w · x(i) − b)− 1] (62)
The dual problem, which is maximized with respect to λ(i) ≥ 0, has to satisfy the KKT
conditions [71]. They are given by the primal and dual constraint, the complementary
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slackness in equation (65) which follows from the strong duality [71], and the fact that
the gradient of the Lagrangian has to be zero at the solution.
1− y(i)(w · x(i) − b) ≤ 0 (63)
λ(i) ≥ 0 (64)
λ(i)[1− y(i)(w · x(i) − b)] = 0 (65)
∆Λ(w, b, λ) = 0 (66)
The partial derivatives of the Lagrangian are then given as:
∂Λ(w, b, λ)
∂w
= w −
n∑
i=1
λ(i)y(i)x(i) (67)
∂Λ(w, b, λ)
∂b
=
n∑
i=1
λ(i)y(i) (68)
∂Λ(w, b, λ)
∂λ(i)
=
n∑
i=1
(y(i)b− y(i)x(i) ·w + 1) (69)
It follows from equation (67) and ∂Λ(w,b,λ)
∂w
= 0 that w can be expressed as:
w =
n∑
i=1
λ(i)y(i)x(i) (70)
The Lagrangian can be rearranged, and by inserting equation (70), the final dual
optimization problem is derived:
Λ(b, λ) =
1
2
w ·w −
n∑
i=1
λ(i)[y(i)(w · x(i) − b)− 1] (71)
=
1
2
w ·w −
n∑
i=1
λ(i)y(i)(w · x(i)) + b
n∑
i=1
λ(i)y(i) +
n∑
i=1
λ(i) (72)
=
1
2
n∑
i=1
λ(i)y(i)x(i) ·
n∑
i=1
λ(i)y(i)x(i) −
n∑
i=1
λ(i)y(i)
(
n∑
j=1
λ(j)y(j)x(j) · x(i)
)
+ b
n∑
i=1
λ(i)y(i) +
n∑
i=1
λ(i) (73)
=
1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j))−
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(j) · x(i))
+ b
n∑
i=1
λ(i)y(i) +
n∑
i=1
λ(i) (74)
=
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j)) + b
n∑
i=1
λ(i)y(i) (75)
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We know that ∂Λ(w,b,λ)
∂b
=
∑n
i=1 λ
(i)y(i) has to be zero, and therefore, the last term can
be omitted:
Λ(λ) =
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j)) (76)
Furthermore, the third KKT condition from equation (65) implies that either one of
the following holds:
λ(i) = 0 (77)
1− y(i)(w · x(i) − b) = 0 (78)
Together with the primal constraints in equation (60), it follows that λ(i) 6= 0 only
where y(i)(w ·x(i)−b) = 1. This leads to the reduction of the summands in equation (70)
to the support vectors, as shown in equation (21).
Since for all support vectors, w ·x(i)−b ∈ {−1,+1}, b can be obtained using arbitrary
x+,x− from the set of support vectors with a positive and negative label, respectively:
w · x+ − b = −(w · x− − b) (79)
⇔ 1
2
(w · x+ + w · x−) = b (80)
Noisy data
As a consequence of changing the primal problem formulation to equation (23) with
constraints in equation (24), the dual problem changes to:
Λ(w, b, ξ, λ, ν) =
1
2
w ·w + C
n∑
i=1
ξ(i) +
n∑
i=1
λ(i)[1− ξ(i) − y(i)(w · x(i) − b)]
−
n∑
i=1
ν(i)ξ(i) (81)
Here, an additional set of dual variables ν is required to account for the constraints
ξ(i) ≥ 0. From the new primal and dual problems, the KKT conditions are given as:
1− ξ(i) − y(i)(w · x(i) − b) ≤ 0 (82)
ξ(i) ≥ 0 (83)
λ(i) ≥ 0 (84)
ν(i) ≥ 0 (85)
λ(i)[1− ξ(i) − y(i)(w · x(i) − b)] = 0, (86)
−ν(i)ξ(i) = 0, (87)
∆Λ(w, b, ξ, λ, ν) = 0 (88)
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In this case, the partial derivatives are:
∂Λ(w, b, ξ, λ, ν)
∂w
= w −
n∑
i=1
λ(i)y(i)x(i) (89)
∂Λ(w, b, ξ, λ, ν)
∂b
=
n∑
i=1
λ(i)y(i) (90)
∂Λ(w, b, ξ, λ, ν)
∂ξ(i)
= C − λ(i) − ν(i) (91)
Interestingly, the partial derivatives with respect to w and b remain the same as in
the linearly separable case, which means that equation (70) and equation (21) still hold.
Rearranging the Lagrangian in equation (81) and inserting equation (70) yields the
following:
Λ(b, ξ, λ, ν) =
1
2
w ·w + C
n∑
i=1
ξ(i) −
n∑
i=1
λ(i)[y(i)(w · x(i) − b)− 1 + ξ(i)
−
n∑
i=1
ν(i)ξ(i) (92)
=
1
2
w ·w + C
n∑
i=1
ξ(i) −
n∑
i=1
λ(i)y(i)(w · x(i)) + b
n∑
i=1
λ(i)y(i)
+
n∑
i=1
λ(i) −
n∑
i=1
λ(i)ξ(i) −
n∑
i=1
ν(i)ξ(i) (93)
=
1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j)) + C
n∑
i=1
ξ(i)
−
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j)) + b
n∑
i=1
λ(i)y(i)
+
n∑
i=1
λ(i) −
n∑
i=1
λ(i)ξ(i) −
n∑
i=1
ν(i)ξ(i) (94)
=
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j))
+ C
n∑
i=1
ξ(i) + b
n∑
i=1
λ(i)y(i) −
n∑
i=1
λ(i)ξ(i) −
n∑
i=1
ν(i)ξ(i) (95)
Furthermore, rearranging equation (91), which has to be zero at the solution, gives
two more equations:
λ(i) = C − ν(i) (96)
C = λ(i) + ν(i) (97)
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Considering that equation (90) has to be zero and incorporating equation (97) into
the Lagrangian, we arrive at:
Λ(λ) =
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j))
+ C
n∑
i=1
ξ(i) + b
n∑
i=1
λ(i)y(i) −
n∑
i=1
λ(i)ξ(i) −
n∑
i=1
ν(i)ξ(i) (98)
=
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j))
+ C
n∑
i=1
ξ(i) −
n∑
i=1
(C − ν(i)ξ(i) −
n∑
i=1
ν(i)ξ(i) (99)
=
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j))
+ C
n∑
i=1
ξ(i) − C
n∑
i=1
ξ(i) +
n∑
i=1
ν(i)ξ(i) −
n∑
i=1
ν(i)ξ(i) (100)
=
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j)) (101)
Here it becomes apparent that the slack variables and their corresponding dual vari-
ables ν vanish from the problem.
Altogether, the same function as in the linearly separable case is derived, which has
to be maximized subject to:
n∑
i=1
λ(i)y(i) = 0 (102)
0 ≤ λ(i) ≤ C (103)
Here, the box constraints on λ follow from equation (85) and equation (97).
Hence, the computation of w and the classification rule stays the same; only to com-
pute b, x+ and x− from equation (80) have to be chosen such that:
x+ ∈ {x(i)|y(i) = +1 ∧ λ(i) < C} (104)
x− ∈ {x(i)|y(i) = −1 ∧ λ(i) < C} (105)
This follows from equation (87), which tells us that either ν(i) = 0 or ξ(i) = 0. Hence,
it can be inferred that ξ(i) = 0 where ν(i) 6= 0.
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Nonlinear data
The mapping function only affects the constraints of the primal optimization problem,
and thereby two of the KKT conditions in equation (82) and equation (86):
1− ξ(i) − y(i)(w · φ(x(i))− b) ≤ 0 (106)
λ(i)[1− ξ(i) − y(i)(w · φ(x(i))− b)] = 0 (107)
Consequently, the derivation of w and the rearranged Lagrangian Λ(λ) change ac-
cordingly:
w =
n∑
i=1
λ(i)y(i)φ(x(i)) (108)
Λ(λ) =
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(φ(x(i)) · φ(x(j))) (109)
Using a kernel function K(u, v), the Lagrangian, the derivation of b, and the decision
function can be rewritten as:
Λ(λ) =
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)K(x(i),x(j)) (110)
b =
1
2
∑
support vectors
λ(i)y(i)
[
K(x(i),x+) +K(x(i),x−)
]
(111)
f(x) =
∑
support vectors
λ(i)y(i)K(x(i),x)− b (112)
Imbalanced problems
Introducing two regularization terms C+, C− changes the primal optimization function
shown in equation (36). The Lagrangian is then defined as:
Λ(w, b, ξ, λ, ν) =
1
2
w ·w + C+
∑
{i|y(i)=+1}
ξ(i) + C−
∑
{i|y(i)=−1}
ξ(i)
+
n∑
i=1
λ(i)[1− ξ(i) − y(i)(w · x(i) − b)]−
n∑
i=1
ν(i)ξ(i) (113)
The KKT conditions remain the same as in the soft margin case, and only the partial
derivative with respect to ξ(i) changes:
∂Λ(w, b, ξ, λ, ν)
∂ξ(i)
=
{
C+ − λ(i) − ν(i) {i|y(i) = +1}
C− − λ(i) − ν(i) {i|y(i) = −1}
(114)
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Furthermore, equation (95) changes to:
Λ(b, ξ, λ, ν) =
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j))−
n∑
i=1
ν(i)ξ(i)
+ C+
∑
{i|y(i)=+1}
ξ(i) + C−
∑
{i|y(i)=−1}
ξ(i) + b
n∑
i=1
λ(i)y(i) −
n∑
i=1
λ(i)ξ(i) (115)
We can then insert λ(i) + ν(i) for C+ and C− analogously to arrive at the same formu-
lation as in the soft margin case:
Λ(λ) =
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j))−
n∑
i=1
ν(i)ξ(i)
+
∑
{i|y(i)=+1}
(λ(i) + ν(i))ξ(i) +
∑
{i|y(i)=−1}
(λ(i) + ν(i))ξ(i)
+ b
n∑
i=1
λ(i)y(i) −
n∑
i=1
λ(i)ξ(i) (116)
=
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j))−
n∑
i=1
ν(i)ξ(i)
+
n∑
i=1
(λ(i) + ν(i))ξ(i) + b
n∑
i=1
λ(i)y(i) −
n∑
i=1
λ(i)ξ(i) (117)
=
n∑
i=1
λ(i) − 1
2
n∑
i=1
n∑
j=1
λ(i)λ(j)y(i)y(j)(x(i) · x(j)) (118)
Hence, only the maximization constraints and the choice of x+,x− for the computation
of b are altered:
0 ≤ λ(i) ≤ C+ i ∈ {i|y(i) = +1} (119)
0 ≤ λ(i) ≤ C− i ∈ {i|y(i) = −1} (120)
x+ ∈ {x(i)|y(i) = +1 ∧ λ(i) < C+} (121)
x− ∈ {x(i)|y(i) = −1 ∧ λ(i) < C−} (122)
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